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SUMMARY 
This thesis uses data from three cohort studies in order to investigate the effects of foetal 
and infant growth on respiratory disease in preterm-born children, and the onward effects 
of this disease on measures of physical activity. Firstly, I investigated change in foetal 
growth using biometry obtained from antenatal ultrasounds scans, and related this to rates 
of respiratory symptoms obtained from the Respiratory and Neurological Outcomes of 
Children Born Preterm Study. I followed-up this work by reporting the effect of accelerated 
weight gain during infancy on the respiratory health of preterm-born children. The second 
half of my thesis then used measures of lung function, as well as data on respiratory 
symptoms, to investigate whether the decrements associated with preterm birth 
manifested as reduced participation in objectively measured physical activity. Data from 
the Avon Longitudinal Study of Parents and Children, and from the Millennium Cohort 
Study, were used in these analyses. 
My results noted that change in foetal growth trajectory (acceleration or deceleration) 
between the trimesters of pregnancy was associated with increased respiratory symptoms 
in preterm-born children. Accelerated infant weight gain was also associated with 
increased odds of wheeze; this was in a dose-dependent manner across the spectrum of 
gestation, with the effect being the greatest at ≤32 weeks’ gestation. Moreover, maternal 
smoking, as well as gestation, were noted to be a mediator of the relationship between 
infant weight gain and childhood respiratory health.  
A reduction in moderate-to-vigorous physical activity at 7 years of age was noted in boys 
who were born at ≤32 weeks’ gestation. This reduction remained after inclusion of other 
explanatory variables. No differences were noted at the ages of 11 and 15 years. The 
reduction in physical activity over the course of childhood may explain this observation.  
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1 Introduction 
 Preface 
The common theme within this thesis relates to preterm birth and its effect on the 
respiratory system. Thus, it is appropriate that this introduction begins with an outline of 
normal lung development and of neonatal lung disease. I will describe the ‘state of the art’ 
in terms of current literature on respiratory outcomes in childhood following preterm birth. 
I will also summarise the literature in relation to respiratory sequelae in adolescence and 
adulthood, which are important for contextualising the long-term impact.  
My research is presented in four chapters, each of which were conducted as independent, 
but complementary studies. Chapters two and three investigate foetal, and then infant 
growth in preterm-born children and explored associations with respiratory outcomes in 
childhood.  Therefore, this introduction presents background on low birthweight, 
intrauterine growth restriction, and the ‘Developmental Origins of Health and Disease’ 
hypothesis. It further summarises postnatal growth following preterm birth. The current 
literature in regards to respiratory outcomes are then presented in detail.   
Chapters four and five investigate the levels of physical activity in preterm born children. In 
all cases, comparing data with ‘term’ (>37 weeks’ gestation). The current literature on 
these topics will be detailed in this introduction to identify gaps in the evidence which 
guided my research aims. Lastly, the hypotheses generated from the review of the 
literature will be presented. 
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 Organogenesis 
 Normal lung development 
Lung development begins in the embryonic stages of growth with the appearance of the 
lung bud (respiratory diverticulum), derived from the endoderm, during the 4th week of 
gestation (Larsen, 1998). By week five, the bud has branched into both left and right main 
bronchi and formed secondary buds from which the bronchi will develop. The start of the 
pseudoglandular phase, at week seven, is characterised by further branching of the bronchi 
to produce tertiary structures under regulation of growth factors such as epithelial growth 
factor (EGF). The continuing expansion of the respiratory tree results in terminal 
bronchioles by the end of the seventeenth week (Kotecha, 2000). During the canalicular 
phase the surrounding mesodermal tissue becomes vascularised, and the supporting 
muscles and cartilage begin to develop from the same body cavity. The terminal 
bronchioles split in to respiratory bronchioles during the seventeenth to twenty-seventh 
week. The airway wall and epithelium are essentially in mature form; surfactant protein is 
detectable during the latter stages of this phase. The following saccular phase, between 
twenty-eight and thirty-sixth weeks, is characterised by growth of the peripheral airways 
and the final branching of the bronchioles and terminal branches. These will eventually be 
invested in a dense bed of capillaries thus forming nascent alveoli- terminal saccules, as 
well as thinning of the airway walls. The alveolar phase sees the continuing development of 
the terminal saccules and their maturation in to alveoli just prior to birth. After birth, 
alveolar fluid is absorbed and surfactant synthesis reduces the surface tension of the gas 
exchange interface. This facilitates the rapid expansion of the surface area available for gas 
exchange (Joshi and Kotecha, 2007).  
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 Postnatal development of the lung 
Following birth, airway calibre continues to improve. Alveolar development and 
multiplication continues rapidly after birth and in to childhood, with size and surface area 
continuing to increase longer still (Larsen, 1998, Joshi and Kotecha, 2007).  
Historically, it has been assumed that as the lung grows and matures, the length and 
diameter of the airways increases proportionally with the lung parenchyma. This facilitates 
an improvement in gas exchange, mechanics and haemodynamic function. However, it is 
increasingly evident that the relationship between lung size and airflow is not consistent. 
This was first demonstrated by Green and colleagues who noted the variation in the forced 
expiratory volume in one second FEV1 to forced vital capacity (FVC) ratio (FEV1/FVC) 
comparing normal individuals with similar lung size (Green et al., 1974). The concept of 
disproportionate growth between lung size and airway calibre was termed ‘dysanapsis’, 
and debate still exists in regards to its clinical importance (Thompson, 2017). Preterm-born 
children are at heightened risk for dysregulated lung growth, both pre-and-postnatally 
(Merkus, 2003), and thus may be more susceptible to this developmental mismatch. For 
example, moderately preterm-born children (32-34 week’s gestation) were noted to have 
no difference in FVC compared to term controls but had reduced forced expiratory flows 
and lower FEV0.5/FVC ratios at two months of age (Friedrich et al., 2007). Accelerated 
weight gain (Den Dekker, et al. 2016 ) and subsequent overweight have recently been 
demonstrated to be associated with airway dysanapsis. Asthmatic children with dysanapsis 
also exhibited a greater number of exacerbations and daily bronchodilator use (Forno et al., 
2017).  
Recent hyperpolarised 3-helium MRI studies indicate that the alveolar surface area 
continues to increase at least in to adolescence (Narayanan et al., 2012), challenging the 
previously widely held view that alveolar development only continues up to 2 years of age. 
The lungs of preterm-born children are thought to contain fewer, larger alveoli, which 
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reduces the available surface area for gas exchange. Altered permeability of the alveolar 
membrane, which introduces a ventilation-perfusion mismatch, is identified by the 
decreased diffusing capacity of carbon monoxide (DLCO) (Hakulinen et al., 1996). 
Historically, the data on alveoli size has been based on limited histological data of young 
children with fatal lung disease. However, recent innovations in hyperpolarised 3He MRI 
scanning have provided novel insights into the lung structure of preterm-born children. A 
recent study by Flors and colleagues noted a higher apparent diffusion coefficient of 
inhaled 3He, but same lung volumes, in children porn preterm aged between 4-15 years of 
age when compared to age-matched healthy controls (Flors et al., 2017). This indeed 
suggests that bronchopulmonary dysplasia (BPD) survivors have fewer, larger, alveoli. 
Moreover, the possibility now exists that the lungs of preterm-born children may exhibit a 
degree of ‘catch-up’ alveolarisation by adolescence and beyond (Narayanan et al., 2013). 
Peak lung function is attained approximately at 21-22 years of age, by which time there has 
been a 30- fold increase in lung volume and a 20-fold increase in gas exchange surface 
since birth (Stocks and Sonnappa, 2013). From this plateau, both FEV1 and FVC gradually 
decline as lung elasticity is lost (Quanjer et al., 2012). 
 
 Preterm birth 
 Definition 
Preterm birth, defined as birth prior to 37 completed weeks of gestational age, accounts 
for 7-10% of all live births in the UK. This percentage is rising world-wide, especially in the 
later gestations (35-36 weeks’ gestation) (Blencowe et al., 2012). There have been large-
scale advances in the treatment of preterm birth in the last two decades and consequently 
many more of the most immature infants survive today with the limit of viability being 
around 23 weeks’ gestation. Infants born at ≤28 weeks’ gestation, often called ‘extremely 
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preterm’, now represent the group who are likely to require significant neonatal care 
immediately following birth, requiring hospital stays of weeks or months. Infants born at 
the limit of viability require substantial multidisciplinary follow-up post-discharge which 
places a significant burden on healthcare resources, and on families. 
 Risk factors for preterm birth 
Spontaneous preterm labour, encompassing both premature preterm rupture of the 
membranes (PPROM) as well preterm labour with intact membranes, accounts for the 
majority of preterm births. The multifactorial aetiology leads to the exact causes being 
unknown in up to half of all cases, however, maternal, social and environment factors are 
associated with increased risk.  Preterm birth is heavily linked to deprivation, which 
includes the domains of lower education and occupational status, and increased rates of 
obesity, tobacco smoking, diabetes and hypertension (Field et al., 2016). Maternal tobacco 
smoking is well recognised as a modifiable risk factor (Shah and Bracken, 2000) which also 
affects in utero lung growth. Nicotine is able to cross the placental boundary and is 
transferred to the foetus in proportionally higher concentrations than in the maternal 
serum (Luck et al., 1985). In animal models, lung hypoplasia was induced in rats exposed to 
cigarette smoke with fewer, more simple saccules observed (Collins et al., 1985). In lambs, 
nicotine exposure during the last trimester induced signs of proximal airway obstruction 
using a modified nitrogen washout technique (Sandberg et al., 2004). The exact causative 
mechanisms of tobacco smoke exposure in relation to preterm birth are not known, 
however both nicotine and carbon monoxide are potent vasoconstrictors, which may act 
upon the placenta to decrease blood flow to the foetus (Lo et al., 2015). Other 
complications relating to the placenta, including placenta praevia and placental abruption 
are also risk-factors for preterm birth. Previous history of preterm birth is also a strong risk 
factor, perhaps due to underlying or unresolved inflammation, especially if pregnancies are 
only separated by a short gestation.  
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A complex relationship exists between the risk of preterm birth and maternal body mass 
index (BMI), with associations being reported at both ends of the spectrum (Hendler et al., 
2005). Proportionally, a larger percentage of preterm births in women of low BMI occur 
spontaneously, rather than as indicated deliveries. In contrast, higher BMI appears 
protective, although of the preterm births which occur, a higher percentage of these are 
medically indicated due to maternal factors secondary to increased BMI including 
gestational diabetes and pre-eclampsia (Figure 1-1). An increased risk for spontaneous 
preterm birth at low BMI may be explained by inadequate nutrient intake or placental 
insufficiency related to reduced blood flow (Neggers and Goldenberg, 2003). Pre-eclampsia 
itself is caused by dysregulated placental function and is also linked to reduced blood to the 
foetus as well as intrauterine growth restriction (IUGR). Preterm birth often results from 
pre-eclampsia, however, this is largely due to a medical decision to deliver early in order to 
reverse the condition (Steegers et al., 2010).  
 
Figure 1-1: Proportion of preterm births (PTB) born via spontaneous or indicated means 
separated by BMI group. Reproduced with permission from Hendler et al. Am J Obstet 
Gynecol. 2005 Mar;192:882-6. 
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Intrauterine infection and inflammation are probably the best understood risk factors for 
preterm birth. Infections within the uterus can occur in multiple locations, and when the 
infection involves the foetal membranes, this is termed ‘chorioamnionitis’. Infection may 
occur from a number of sources, however, ascension of bacteria from the vagina through 
the cervix is the most likely route for the organisms most frequently implicated. These 
include Mycoplasma, Ureaplasma and other anaerobic species (Maxwell et al., 2006). 
Ureaplasma spp. is the most common organism cultured from uterine samples and has 
been shown to be readily transferred from mother to foetus (Sanchez, 1993).  
Chorioamnionitis has been noted to increase with decreasing gestation (Hartling et al., 
2012) and thus up to 80% of women delivering at <28 weeks’ gestation have evidence of 
infection on histological examination, however, this often remains sub-clinical. Miralles et 
al. identified microbial genes in at least one tissue or fluid sample in 70% of deliveries after 
PPROM and in 80% of deliveries where the membranes remained intact (Miralles et al., 
2005). Post-infection, preterm labour then occurs when presence of such bacteria 
promotes the releases of cytokines from maternal leukocytes which stimulate production 
of inflammatory molecules involved in cervical ripening, weakening of the membranes and 
uterine contractions (Goldenberg et al., 2000). 
In summary, the risk factors for preterm birth may be separated in to broadly two groups, 
those associated with infection and inflammation (PPROM, chorioamnionitis, cervical 
insufficiency) and those associated with abnormal placentation (placenta praevia, placental 
abruption, pre-eclampsia and Intrauterine growth restriction).  
 
 Respiratory complications of the preterm neonate 
The most common complications of preterm birth stem from interruption to the normal 
development of the respiratory system. The most immature of preterm-born neonates are 
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delivered at the canalicular or early saccular stages of lung development where the 
respiratory system provides an inadequate gas exchange surface as surfactant is not 
produced in sufficient amounts (Joshi and Kotecha, 2007). Consequently, respiratory 
support in the form of mechanical ventilation and supplementary oxygen is often required. 
Historically such intervention was associated with invasive intubation and high oxygen 
concentrations, which contributed to the severe pathophysiology of early lung disease. 
Modern neonatal care utilises more gentle forms of ventilation, exogenous surfactant 
replacement therapy and maternal antenatal corticosteroids, which can aid the maturation 
of the lungs prior to delivery. Nonetheless it may still take some time for the associated 
inflammation secondary to these interventions to resolve. Even if infants can be managed 
in room air, exposure to the relatively hyperoxic extrauterine environment on the 
immature lung may still alter development (Stocks, 2013). 
Chronic Lung Disease of Prematurity (CLD) or BPD is the name given to ongoing respiratory 
insufficiency and inflammation. The definition has changed over time, latterly the need for 
supplemental oxygen at 28 days of life, or at 36 weeks’ postmenstrual age. 
Notwithstanding, both are associated with increased respiratory sequelae in childhood. 
However, it is now those of the earliest gestations (‘extremely preterm’, ≤28 weeks’ 
gestation) who constitute the majority of sufferers of BPD/CLD. The pathophysiology of 
their disease is different (Jobe and Bancalari, 2001, Jobe, 1999), with dysregulated 
development of the alveoli and microvasculature being the predominant features as 
opposed to smooth muscle hypertrophy, fibrosis, and thickening of capillary basement 
membranes in the historically affected more mature infants (Northway et al., 1967). 
As well as patent ductus arteriosus and fluid overload, a dysregulated pulmonary 
inflammatory response (Chakraborty et al., 2010) and bacterial infection are often 
implicated as risk factors in the development of BPD/CLD (Maxwell et al., 2006, Maxwell et 
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al., 2009). Both may have antenatal origins, as described above, with increased 
inflammatory markers, such as tumour necrosis factor-α, present in the amniotic fluid of 
mothers who deliver prematurely (Watterberg et al., 1996). My recent systematic review 
and meta-analysis has noted that Ureaplasma infection continues to be associated with 
BPD/CLD both at 28 days of life (OR 3.04; 95% Confidence Interval[CI] 2.41, 3.83) and at 36 
weeks’ postmenstrual age (OR 2.22; 95% CI 1.42, 3.47) (Lowe et al., 2014). This association 
was robust to correction for differences in gestational ages between exposed and 
unexposed groups (Figure 1-2). Thus, preterm infants, especially those born ≤28 weeks’ 
gestation are at risk of an initial ‘hit’ due to prenatal exposure to inflammation, which is 
then exacerbated by the adverse effects of the necessary neonatal care including 
ventilation pressures and supplemental oxygen. Moreover, the damage induced by both 
sets of insults may further modulate the immune system such that susceptibility to 
postnatal infections is increased (Kunzmann et al., 2013). Pro-inflammatory cytokines 
(Kotecha et al., 1996), chemokines (Kotecha et al., 1995), and neutrophils (Kotecha et al., 
2003) persist in the lung following birth, along with microbes such as Ureaplasma spp. 
which colonise the lung after being acquired in the antenatal or perinatal period. Whether 
empirical or targeted treatment of Ureaplasma infections with antibiotics could reduce the 
incidence of lung disease in the preterm new-born is unknown (Turner et al., 2012). 
Recent studies have also examined the role of pre-eclampsia in neonatal lung disease, 
however, the results have been inconclusive. The potential link relates to the exposure of 
the foetus to maternal anti-angiogenic factors associated with pre-eclampsia which 
contribute to dysregulated lung and vascular growth (Levine  et al., 2004). This has been 
described as the ‘vascular hypothesis’ for BPD/CLD, which is characterised by loss of small 
arteries and capillary density (Thebaud and Lacaze-Masmonteil, 2010). This raises concern 
in regards to adverse cardiopulmonary outcomes in childhood and beyond (Poon et al., 
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2013), although, a recent study noted only minor differences in systolic blood pressure and 
little evidence of endothelial dysfunction in preterm-born children (Edwards et al., 2014).   
 
Figure 1-2:  Meta-regression plot of association between Ureaplasma pulmonary 
colonisation and BPD/CLD at 28 days of life controlling for difference in gestational age 
between the colonised and non-colonised groups. There is little slope to regression line 
(p=0.96), indicating the risk of BPD/CLD attributed to Ureaplasma is not explained by 
lower gestational age. Reproduced with permission from Lowe et al. Pediatr Infect Dis J. 
2014;33:697-702.  
 
 Respiratory outcomes in relation to preterm birth 
1.4.4.1 Lung function and wheeze 
Commensurate with the information presented above on risk factors is evidence that lung 
function in preterm-born children is already sub-optimal at birth. Studies using rapid 
thoracoabdominal compression have demonstrated reduced forced expiratory volume at 
0.4 seconds, and decreased respiratory compliance in relation to low birthweight (Lucas et 
al., 2004). In healthy term-born children, Turner reported reduced maximal expiratory flow 
at functional residual capacity (V’maxFRC) at 1 month of age was associated with increased 
risk of asthma symptoms by age 3 (Turner et al., 2008). Friedrich et al. noted decreased 
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forced expiratory volume at 0.5 seconds (FEV0.5), forced expiratory flows, but normal FVC in 
a small group of preterm infants at the age of two months. Moreover, this resulted in a 
reduced FEV0.5/FVC ratio, indicating a mismatch between airway size and lung volume 
which tracked until longitudinal follow-up at the age of two years (Friedrich et al., 2007). 
These deficits are more pronounced in infants with a history of BPD/CLD. Thunquist and 
colleagues recently reported reduced indices of volume and flow compared to reference 
values both at 6 and 18 months of age which were exacerbated by active respiratory 
symptoms (Thunqvist et al., 2015). Similarly, Proietti reported a lower respiratory rate and 
increased tidal volume in preterm-born children at 44 weeks’ postmenstrual age which may 
relate to an adapted breathing pattern secondary to ventilation-perfusion mismatch 
(Proietti et al., 2014).    
The recent systematic review by Kotecha et al. noted decrements in lung function framed 
as reduction of approximately 7% in FEV1 for individuals born <37 weeks’ gestation when 
compared to term controls up to the age of 23 years (Figure 1-3) (Kotecha et al., 2013). 
Individuals with BPD/CLD had increased deficits of between approximately 16-19% when 
compared to controls. There is strong evidence that lung function tracks or deteriorates, 
but does not improve, through to the adult plateau which occurs between 20-25 years of 
age. For example, data from the Tuscon cohort indicates tracking of patterns of childhood 
wheezing and decrements in lung function in to adolescence (Morgan et al., 2005). Using 
the same cohort, Stern and colleagues noted that poor airway function in infancy framed as 
reduced V’maxFRC correlated to reduced FEV1/FVC ratio up to the age of 22 years (Stern et 
al., 2007). 
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Figure 1-3 Forest plot representing the pooled mean difference in %FEV1 between 
preterm born children and term-born controls. Reproduced with permission from 
Kotecha et al. Thorax 2013;68:760-6. 
 
These data are supported by results from a cohort in New Zealand which reported 
persistent wheezing from childhood to 26 years of age was associated with continually 
reduced FEV1/FVC ratio as well as increased bronchial hyper-responsiveness and sensitivity 
to house dust mite (Sears et al., 2003). Interestingly the slopes of FEV1/FVC decline were 
similar in each of the wheeze phenotypes, indicating that the decrements in lung function 
had their origins in childhood (Teig et al., 2012).  
These results are complementary to the review of childhood wheezing disorders described 
by Been and colleagues who noted increased risk of wheeze in preterm-born children 
(OR1.17; 95% CI 1.57-1.87) using a sample size of over 1.5 million subjects. Moreover, the 
authors also observed a strong dose-response effect of gestational age with a 6% decrease 
in risk of wheezing disorder for every additional week up until the fortieth week (Figure 
1-4). Interestingly, substantial heterogeneity (up to I2=80%) was also reported between the 
included studies which was somewhat explained by the variation in the age of the children 
included (Been et al., 2014).  However, the strength of the association between preterm 
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birth and wheezing disorder was similar when analysis was stratified by age group. Thus, 
these results are consistent with the concept of tracking of poor respiratory outcome 
throughout childhood.  
 
Figure 1-4 Forest plot representing a per-week dose-response effect of increasing 
gestation on the odds of wheezing disorders. The effect estimate is OR 0.94. Reproduced 
with permission from Been et al. PLOS Medicine 2014;11:e1001596 under Creative 
Commons Attribution (CC BY) licence. 
These observations have recently been extended by studies within our department. The 
first study suggested that atopy does not play a role in the phenotype of wheezy disorder 
experienced by preterm-born children (Edwards et al., 2016). Rates of wheeze were noted 
to be similar in both preterm-born children with a family history of atopy (OR 2.0; 95% CI 
1.6, 2.4) and those without a family history (OR 1.90; 95% CI 1.7, 2.1) when compared to 
term controls (Figure 1-5). The use of inhaled medication was also reported to be 
significantly higher in the preterm-born groups (especially ≤32 weeks’ gestation), however, 
the efficacy of this treatment is not known. The second study reported that increased 
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respiratory symptoms could be demonstrated even up until 37-38 weeks’ gestation; this 
has consequences as many elective caesarean sections are performed at this point of 
pregnancy (Edwards et al., 2015a). Often, preterm-born children are labelled as having 
asthma, however, there is growing evidence that the mechanisms and phenotypes of 
disease may be different. For example, preterm-born children have been shown to have 
airway inflammation which is mediated by neutrophils as oppose to eosinophils; 
furthermore, some studies do not show an increased risk for asthma (Astle et al., 2015) in 
preterm-born children when compared to those born at term. 
 
Figure 1-5: The prevalence of wheeze-ever within the RANOPS cohort for preterm-born 
children and term-born controls. The white bars denote family history of atopy and the 
grey bars denote no family history. The odds ratio for wheeze-ever is similar when 
comparing preterm-born children with, or without family history to term controls. 
Reproduced with permission from Edwards et al. PLOS One 2016;11:e0155695 under 
Creative Commons Attribution (CC BY) licence. 
Taken together, these studies provide strong evidence that respiratory morbidity in 
adulthood has its origins early in life, and that these deficits track over time. The onset of 
age-related decline in lung function is not clinically relevant due to the large lung reserves 
available, however, preterm birth exacerbates these deficits, and imposes an additional 
burden which may further prevent attainment of peak lung function.  
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The longer-term impact of preterm birth on lung health is now starting to be realised as 
graduates of neonatal care from the 1970s onwards enter early adulthood. The recent 
systematic review by Gough and colleagues collated data from 8 eligible studies and 
reported evidence of increased respiratory symptoms and airflow obstruction in preterm-
born adults, especially those with a history of BPD/CLD. This was accompanied by evidence 
of structural lung changes on radiological imaging which likely reflects lung injury during 
the neonatal period. (Gough et al., 2012).  
Primary data collected by the same group also reported increased respiratory symptoms 
and medication use in BPD/CLD adults. FEV1 and FEF25-75 was also significantly lower than 
non-BPD preterms and term controls. These decrements were also accompanied by a lower 
EQ-5D score, potentially reflecting a perceived lower quality of life (Gough et al., 2014). 
Follow-up work by Caskey noted that adult survivors of BPD/CLD had increased rates of 
fixed airway obstruction, greater impairment in gas transfer, and reduced exercise capacity 
when compared to the term-born group. Lung clearance index as measured by multiple 
breath washout was also higher in the BPD/CLD compared to term-born controls (Caskey et 
al., 2016).  These decrements may predispose preterm-born adults to an early and 
accelerated decline in pulmonary function later in life (Figure 1-6) and lead to early 
manifestation of chronic obstructive pulmonary disease (COPD) which impose restrictions 
on quality of life (Bush, 2008, Barker et al., 2013, Narang, 2010, Stocks, 2013); interventions 
have therefore been recommended to reduce the risk of chronic respiratory disease. 
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Figure 1-6 Diagrammatic representation of the potential early respiratory decline in 
individuals born with sub-optimal lung function. After failure to achieve peak FEV1 in 
early adulthood in comparison with a normal trajectory (blue line), symptoms of disease 
may occur at a younger age (red line). The effect is exacerbated in the presence of other 
risk factors, e.g. tobacco smoking (dotted red line). Reproduced with permission from 
Stocks et al. Lancet Respir Med 2013 Nov;1(9):728-42. 
 
1.4.4.2 Life course factors and the relationship between preterm birth and respiratory 
disease 
 
It is necessary to briefly review other important determinants of respiratory sequelae in 
children, especially as many may act as important confounders or covariates when 
investigating the relationship between preterm birth and respiratory outcomes in 
childhood. In common with preterm birth, exposure to environmental tobacco smoke and 
other environmental pollutants, for example particulate matter, is strongly linked to 
reductions in lung function and increased symptoms such as wheeze (Dick et al., 2014), 
perhaps by promoting susceptibility to lower respiratory tract infections (LRTIs). Both 
tobacco smoking and preterm birth are intrinsically liked to lower socio-economic status. 
Moreover, preterm birth is a substantial risk factor for severe respiratory syncytial virus 
(RSV) infection and subsequent severe bronchiolitis, even in healthy moderately preterm-
born children (Anderson et al., 2017). Historically, it has been difficult to assess the 
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direction of causality in terms of the effect of LRTIs and abnormal lung function. However, 
the ability to perform lung function testing in infancy has established that decrements in 
are present soon after birth, prior to infections such as RSV (Turner et al., 2008, Stern et al., 
2007). Thus, poor lung function and propensity to gain respiratory infections may have 
origins in foetal life. Notwithstanding, RSV infection itself may increase susceptibility to 
later respiratory disease (Perez-Yarza et al., 2007) by persisting in a latent form and 
avoiding immune detection in privileged areas of the lung (Schwarze et al., 2004). A trial of 
RSV immunoprophylaxis indicated that prevention of infection was associated with 
decreased incidence of wheeze in the first year of life for healthy preterm-born infants. The 
authors suggest that early RSV infection leads to immunologic remodelling of the 
pulmonary system and to airway hyper-responsiveness and wheezing (Blanken et al., 2013) 
 
 Low birthweight and intrauterine growth restriction 
 Definitions 
Low birthweight (LBW) is defined by the World Health Organisation (WHO) as <2500g, and 
is implicated in increased all-cause mortality in infancy and beyond (Watkins et al., 2016). 
However, it is important to realise that this definition may include infants who are born 
preterm at appropriate size for gestational age, or indeed, term-born infants with 
intrauterine growth restriction (IUGR) as gestation is not considered within the definition. 
IUGR is most commonly defined as birth <10th centile for gestational age (World Health 
Organisation, 2002), and reflects failure to reach growth potential, either due to genetic 
disposition to be constitutionally small, or due to pathological reasons. The latter 
represents a substantial challenge to healthcare professionals during pregnancy and the 
perinatal period (Gardosi et al., 2013). Often IUGR is described as ‘symmetrical’, where the 
whole body is in proportion, or ‘asymmetrical’, in which the body is proportionally small in 
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relation to head size (Pike et al., 2012). The latter may reflect in utero adaptation by the 
foetus to preserve development of the brain and other essential organs. Symmetrical 
restriction of foetal growth is thought to originate in early in gestation, whereas 
asymmetrical restriction reflects the modified deposition of soft tissues (Lucas et al., 2004). 
Moreover, preterm birth is associated with increased risk for IUGR (Zeitlin et al., 2000).  
 The development origins of health and disease hypothesis 
The concept that health outcomes throughout the life course may have their origins in 
foetal life (the ‘foetal origins hypothesis’) was established by Barker (Barker et al., 1989). 
This challenged the prevailing theory that the foetus existed in a ‘privileged’ environment 
which was protective against adverse exposures. In reality, disruption to the maternal 
environment during pregnancy from events such as exposure to noxious substances 
(tobacco smoke, alcohol) and under-nutrition (maternal diet or placental deficiency) can 
affect foetal development. In particular, the developmental origins of health and disease 
hypothesis encapsulates the paradigm of developmental plasticity (developmental 
programming) in which the foetus may make developmental adaptions in response to 
insults and adverse intrauterine conditions. The timing of the adverse exposure is critical in 
determining potential developmental effects on organ systems (Figure 1-7) (Gluckman et 
al., 2008); for example, in respect to the respiratory system, early growth faltering may 
influence the structural development of the respiratory tract such as the establishment of 
the trachea, main bronchi and airway epithelium.  Such adaptations may be beneficial or 
detrimental in postnatal life depending on whether the postnatal environment is 
favourable or not, and may subsequently contribute to disease susceptibility (Pike et al., 
2008).   
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Figure 1-7: Example of timing of in utero insults and subsequent effects on foetal growth 
trajectory with impact upon birthweight at term, and beyond in to infancy. Reproduced 
from Turner S. Clin Dev Immunol. 2012;2012:962923 under the Creative Commons 
Attribution (CC BY) licence. 
 
 Risk factors for low birthweight and IUGR 
Maternal hypertension and placental insufficiency are the key reasons for pathological low 
birthweight and IUGR. Thus, the important risk factors relate to those which cause 
impaired oxygen and nutrient exchange to the foetus secondary to dysregulated vascular 
development (Baschat, 2004). The extent to which this insufficiency affects the developing 
foetus depends upon the severity of the interference and the ability of the foetus to make 
an adaptive response. An example of metabolic adaptation is noted in sheep models where 
mild placental hypoglycaemia under hypoxaemia induces a compensatory increase in foetal 
glucose production (Jones et al., 1983). Early onset of this compromise may lead to 
permanent dysfunction or foetal demise, whereas late-onset may result in restricted 
growth velocity in the third trimester, but only sub-clinical metabolic effects. 
Elegant studies using data from the Dutch Famine Birth Cohort Study (Lumey et al., 2007) 
have described the importance of maternal undernutrition during pregnancy on the health 
of their offspring in adult life, including an increased incidence of diabetes, cardiovascular 
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disease and obesity. In relation to respiratory disease, the study by Lopuhää noted that 
exposure to famine in mid-gestation was associated with increased prevalence of 
obstructive airway disease as diagnosed by a physician, but not reduced lung function or 
serum concentrations of immunoglobulin E (IgE). Lower ponderal index (representing 
‘thinness’) was related to decrements in FEV1 and FVC, but not FEV1/FVC ratio, indicative of 
restrictive airway disease. Increased head circumference, reflecting growth faltering late in 
gestation, was related to increased IgE, which the authors speculate may promote an 
adverse Th2-mediated immune response and may predispose to atopy (Lopuhaä et al., 
2000). The underlying mechanisms explaining the effect of undernutrition on the 
developing lung have been best observed in animals models, for example, studies in 
guinea-pigs which noted reductions in the available surface area for gas exchange (Lechner, 
1985). Explanations for this include fewer alveolar attachment points (Elliot et al., 2003), 
fewer numbers of alveoli, which are increased in size, as well as thickened basement 
membrane. Moreover, numerous studies note reduced number and functionality of 
alveolar type-2 cells which are responsible for surfactant production (Pike et al., 2012). 
Maternal exposure to noxious substances, including tobacco smoke, are also heavily 
implicated as determinants of IUGR. From a lung development perspective, nicotine has 
also been shown to decrease both alveolar surface area and capillary density (Maritz and 
Harding, 2011) as well as increased airway smooth muscle (Elliot et al., 1999). 
 Respiratory outcomes in relation to low birthweight 
Increasing evidence demonstrates that low birthweight is associated with long term 
morbidities, including adverse respiratory outcomes, diabetes and cardiovascular disease. 
The first links between COPD and low birthweight in adults were reported over 25 years 
ago (Barker et al., 1991) and reductions in lung function have been confirmed in meta-
analysis (Lawlor et al., 2005). However, confusion remains over the independent effects of 
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birthweight and gestational age, especially as preterm-born children are more likely to be 
small. Both low birthweight children (Kotecha et al., 2015) and those born at term but with 
IUGR (Kotecha et al., 2010) have been demonstrated to have decrements in lung function 
and increased respiratory symptoms (Mebrahtu et al., 2015a). 
In exploring the foetal origins of health and disease hypothesis, authors investigating 
respiratory outcomes have historically used birthweight as a proxy for foetal growth. For 
example, Lucas and colleagues reported on foetal and early postnatal weight gain in term-
born infants of 5-14 weeks of age and measures of lung function (Lucas et al., 2004). They 
observed reduction in forced expiratory volume in 0.4 seconds (FEV0.4), total lung 
compliance and V’maxFRC per standard deviation (SD) decrease in birthweight, head 
circumference and crown-heal length. They conclude that it is plausible that increases in 
adult respiratory morbidity are in part related to impaired lung development in utero and 
during the postnatal period. Reduced lung compliance as a result of growth restriction may 
imply a reduction of established elastic tissue which may predispose to earlier declines and 
early onset restrictive lung disease.  
In an attempt to disentangle the relationship between preterm and IUGR birth, Kallen et al. 
investigated independent groups of children born preterm (with no IUGR) and term-born 
children with IUGR on rates of asthma as defined by inhaler prescription (Kallen et al., 
2013). They reported that the association for use of inhalers decreased as gestation 
increased. Similarly, IUGR was noted to also predict increased inhaler use when examined 
in the term group, but to a less extent than reduced gestational age. Kurukulaaratchy 
investigated the effect of low birthweight in 10-year old children in relation to three 
wheezing phenotypes which had been established using longitudinal questionnaire data 
(Kurukulaaratchy et al., 2005). The population included appears to be largely born at term, 
however, as there were no specific data on gestational age this was not investigated as a 
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risk factor in statistical models. Low birthweight was reported to be an independent 
predictor of ‘early transient wheeze’, but not persistent wheeze.  
In a term-born population, Caudri demonstrated increased respiratory symptoms as a 
result of the overall effect of decreased birthweight over a period of birth to five years of 
age which then attenuated over time (Caudri et al., 2007). The authors speculate that this 
may be due to the increase in lung size with age. However, there is still a possibility that 
smaller airways relative to lung size may result in suboptimal lung function and therefore 
increase the risk of a later onset respiratory disease. Further analysis was conducted to 
establish phenotypes from their longitudinal data on wheezing episodes, ‘shorter 
pregnancy duration’ was associated with transient early wheeze; birthweight was found to 
be an important perinatal factor for both transient early and intermediate-onset wheeze 
(Caudri et al., 2013). 
Finally, in a recent study Barker and colleagues noted, in term-born adults, the odds of 
asthma were reduced with increasing birthweight in a dose-dependent fashion. Comparing 
the lowest birthweight category to the highest resulted in an odds ratio (OR) of 2.4 for the 
≤2500g compared to >4000g group. These results were similar for length and head 
circumference and independent of gestation and preterm birth, concluding that asthma in 
adulthood was related to ‘slow intrauterine growth’ (Barker et al., 2013).  
 
 Respiratory outcomes in relation to foetal growth 
To date, few cohort studies have reported on the foetal origins of childhood respiratory 
symptoms using foetal size and growth patterns as a risk factor for childhood asthma. One 
advantage of these studies is the use of foetal biometric measurements obtained from 
routine antenatal ultrasound scans as opposed to the proxy measure of birthweight. 
However, the results presented have been inconsistent. This is perhaps due to 
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methodological differences including comparisons of absolute foetal size versus measures of 
growth velocity, prospective and retrospective data collection of differing anthropometric 
measurements, varying age within the cohort studies at the time of outcome measurement, 
differing outcome measures and selection bias (Turner, 2012, Duijts, 2012). 
The first study by Turner and colleagues demonstrated a 4% reduction in odds of wheezing 
(‘ever wheeze’), and a 5% reduction in doctor-diagnosed asthma for each millimetre increase 
of crown-rump length (CRL) at age five years, with 2nd trimester measurements also 
associated with reductions (Turner et al., 2010). At age 10 years, increase in CRL was 
significantly associated with reduced odds of doctor-diagnosed asthma and wheeze in the 
last 12 months; CRL was also positively associated with increased lung function (6ml increase 
in FEV1 per mm increase in CRL) (Turner et al., 2011). The effect of growth velocity between 
1st and 2nd trimesters was measured by dichotomising the population around the median of 
each measurement. For example, below the median z-score for CRL in the 1st trimester and 
for biparietal diameter (BD) in the 2nd trimester was considered as persistent low growth. 
Below the median z-score for CRL and above for BD was defined as growth acceleration, 
whereas above the median for CRL and above for BD was defined as persistently high growth.  
At 5 years of age those exhibiting growth acceleration were found to have increased odds of 
asthma; at age 10 years, odds of doctor-diagnosed asthma were increased in the persistently 
‘low growth’ group when compared to the persistently ‘high growth’ group.  
The third study from the Southampton group found in 3-year old children that reduced 
growth in abdominal circumference during the 2nd trimester was associated with increased 
risk of atopy, whereas reduced growth during the 3rd trimester was associated with 
decreased risk. Atopic wheeze was similarly associated with 2nd trimester growth 
acceleration but with decelerated growth in the 3rd trimester. This was compared with non-
atopic wheeze which was associated with early growth faltering of head circumference. This 
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suggests that factors restricting growth late in gestation influence development of atopy, 
whereas slow early growth may structurally affect the developing respiratory tract (Pike et 
al., 2010).  
In contrast, the forth study by Sonnnenschien-Van der Voort et al. investigated the effect of 
foetal growth on a composite outcome derived from asthma symptoms collected 
longitudinally up to the age of 4 years. Growth restriction or acceleration was defined as a 
change of ±0.67 of foetal measurement z-score between first trimester CRL and second and 
third trimester head circumference (HC) femur length (FL) and abdominal circumference (AC) 
(Sonnenschein-van der Voort et al., 2012). They did not find any evidence of associations 
with foetal growth and asthma symptoms. 
 
 Infant growth and weight gain 
 Growth in infancy 
Growth can be seen as a progression in metrics against a recognised standard. Weight, head 
circumference and length (height) are the most common measurements obtained in children 
to assess growth. In infancy, the method of feeding is an important determinant of weight 
gain and influences early growth trajectory. Infants may lose weight within the first days of 
life, with a greater effect in those whom are breast-fed compared to those who are formula 
fed (Crossland et al., 2008). However, breast-fed infants can generally be expected to gain 
weight more rapidly in the first two months of life, then grow at a slower rate up to 12-18 
months of age (Cole et al., 2002); velocity changes of various growth indices are common 
during this period (Mei et al., 2004), which may reflect regression to the mean and thus 
adjustment to a trajectory which represents an individual’s genetic potential for growth. 
Growth following the first year of life is a non-linear process which is characterised by periods 
of relatively small changes followed by unpredictable ‘spurts’ (Thalange et al., 1996). 
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Promoting appropriate growth in preterm-born infants both on the neonatal intensive care 
unit, and post discharge, is challenging; the optimal rates are not known. Considerable 
efforts have recently been made to provide charts which are specific to lower gestations at 
birth (Villar et al., 2014), however, these have been limited by the relatively small number of 
uncomplicated pregnancies which result in birth at less than 33 weeks gestation’ (Villar et 
al., 2016). Optimal nutrient intake during the neonatal stay can be limited due to the 
immaturity of the gastrointestinal system, the metabolic demands required to fight 
infections and combatting pulmonary insufficiency (Griffin et al., 2016). Although rates of 
growth failure have improved, a significant minority of infants are still <10th centile for weight 
at the time of discharge (Horbar et al., 2015). In particular, infants diagnosed with BPD/CLD 
have inadequate weight. 
 Catch-up growth 
‘Catch-up’ growth describes the phenomenon of accelerated growth over a specified 
period of time, such that subjects regress towards the population mean for a given 
measure. In reference to birthweight, catch-up growth observed during childhood may be 
seen as re-establishment of the normal growth trajectory following release from 
unsatisfactory conditions in utero such as exposure to maternal smoking during pregnancy.  
Preterm-born children are widely expected to catch-up in terms of weight, such that, by 
school age most are of similar size to their term-born peers. However, those born at the 
extremes of gestation, whilst exhibiting catch-up growth, remain smaller than term 
controls (Bracewell et al., 2008). Whilst weight may continue to improve, disparities in 
height may still be present and persist in to adolescence (Roberts and Cheong, 2014) and 
early adulthood (Euser et al., 2008). Of note in regard to the themes investigated in this 
thesis, BMI has been reported to be similar between preterm-born young adults and term 
born controls (Bracewell et al., 2008), indicating a more rapid trajectory of BMI in those 
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born preterm during childhood. This may place preterm-born children at an increased risk 
of adverse health outcomes due to the changes in metabolic profile associated with weight 
gain.   
 Infant growth and weight gain in relation to respiratory outcomes 
A growing number of studies have investigated the influence of weight gain during infancy 
and the association with later respiratory health. Van der Gugten investigated the effect of 
weight gain on spirometric measures in the first 3 months of life (van der Gugten et al., 
2012). Weight gain was calculated by difference between weight z-score at birth and at 3 
months of age. Rapid weight gain was defined as a change of >0.67 difference in z-score 
whilst the control population was limited to -0.67 to 0.67 change in z-score. At 1 year of 
age, rapid weight gain was significantly associated with more days of wheezing symptoms. 
At age 5 years, rapid weight again was associated with higher rates of GP consultations for 
wheezing illness and significant decrements in FEV1 and forced expiratory flow at 25-75% of 
vital capacity (FEF25-75). Both measures appeared to be independent of birthweight as 
addition of this variable this to the statistical model did not affect the results. These data 
are supported by the studies from the Southampton Women’s Study (Pike et al., 2010) and 
the Generation R cohort (Sonnenschein-van der Voort et al., 2012) who have also described 
that weight gain in infancy is associated with early childhood wheeze.  
Exploring similar themes in early childhood, Magnus and colleagues recently reported on 
peak weight velocity within the first 36 months of life and asthma symptoms at the ages of 
36 months and 7 years in their Norwegian cohort (Magnus et al., 2015). Peak weight 
velocity was noted to be associated with current asthma and increased lower respiratory 
tract infections at 36 months, and current asthma at 7 years. Flexeder et al. investigated 
peak weight velocity from birth to 24 months of age and reported that this was associated 
with asthma, but not wheeze at age 10 (Flexeder et al., 2012). In a follow-up study using 
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the same methodology for quantifying weight gain, lung function was noted to be 
negatively associated with peak weight velocity at 15 years of age (Claudia et al., 2015). 
Interestingly, the strongest associations were with lower measures of FEF25-75 as well as a 
reduction in the FEV1/FVC ratio. The absence of significant bronchodilation (only 200µg of 
salbutamol were administered due to adverse reactions observed at higher doses), along 
with the lung function data presented, suggest that structural deficits accrued during foetal 
life and in the first years after birth may be a plausible mechanism. These results are in 
keeping with other studies who have reported similar decrements in lung function, such as 
that presented by Turner et al. who demonstrated an association between a relative 
reduction in lung growth between 1 to 12 months of age, increased postnatal weight gain 
and early transient wheeze at 3 years of age (Turner et al., 2008). Also, researchers using 
data from the Avon Longitudinal Study of Parents and Children (ALSPAC) noted lower 
FEV1/FVC ratio for children who exhibited rapid weight gain in infancy (Sonnenschein-van 
der Voort et al., 2015).  
In the largest study to date, Sonnenschein-van der Voort conducted a meta-analysis of the 
influence of preterm birth and infant weight gain on the relationship with childhood 
asthma risk. Preterm birth was associated with increased respiratory symptoms in both the 
preschool wheezing and school-age asthma groups. Infant weight gain over the first year of 
life was also associated with increased respiratory symptoms (Sonnenschein-van der Voort 
et al., 2014). Both analyses were independent of birthweight, however, despite reporting 
odds ratios for preschool wheezing of 3.87 and school age asthma of 2.92 for ≤28 weeks’ 
gestation when compared to those born at term, it was unclear how many children were 
born at the lower gestations. This work was taken forward by Den Dekker and colleagues 
who confirmed that significant reductions in FEV1/FVC ratio, and increased respiratory 
symptoms, were associated with weight gain during infancy (den Dekker et al., 2016). FEV1 
was also reduced in preterm-born children and accompanied by reduction in forced 
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expiratory flow at 75% of vital capacity (FEF75), suggesting that peripheral airway patency is 
implicated in their phenotype of lung disease; preterm-born children with low birthweight 
had the largest deficits in lung function. Importantly, it was noted that these associations 
were present across the full range of gestation and birthweight.  
Popovic et al. also reported on infant weight trajectories and respiratory outcomes in term-
born infants aged 18 months using data from the NINFEA cohort (Popovic et al., 2016). 
Using the superimposition by translation and rotation method of modelling growth, they 
noted that infant size and weight gain velocity were both independently associated with 
infant wheezing. The authors propose that both the mechanical effects of increased weight 
gain, as well as an adipogenic immune response and hormonal imbalance may dispose 
children to respiratory disease. In one of the few studies specifically focused on preterm-
born children, researchers using data from the Infant Health and development programme 
in the US investigated both the effect of BMI gain in the first year of life, as well as linear 
growth, on doctor-diagnosed asthma at 8 years of age (Belfort et al., 2016).   Each z-score 
gain in BMI was associated with increase of doctor-diagnosed asthma, with the effect being 
independent of linear growth. Possible explanations were noted to include epigenetic 
factors as well as diet, physical activity and inflammatory factors. Thus, promotion of 
excess weight gain, which does not match other variables of growth, may be detrimental to 
lung health in preterm-born children. Data from the ‘Born in Bradford Cohort’ which noted 
that rapid, or inconsistent growth after birth at low birthweight (adjusted for gestation) 
was associated with increased risk of wheezing disorders (Mebrahtu et al., 2015b),  
supports the notion that optimising postnatal growth may be beneficial in managing the 
risk of poor respiratory outcome in childhood. 
In summary, there is evidence that both foetal growth trajectory, and accelerated infant 
weight gain are important determinants of respiratory health in childhood. However, there 
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is paucity of data specifically relating to outcomes in preterm-born children. Further 
investigation in to this vulnerable population is pertinent due to their additional pre-and-
postnatal risk factors for respiratory sequelae.   
 
 Physical activity 
 
Casperson describes physical activity (PA) as “any bodily movement produced by skeletal 
muscle that results in energy expenditure”(Caspersen CJ, 1985). There is little doubt PA is 
an important determinant of health and participation is associated with a broad range of 
health benefits including lower risk of all-cause mortality in adults. After tobacco, diet, and 
alcohol, inactivity is now recognised as one of the leading causes of non-communicable 
diseases by the World Health Organisation. 
Indeed, The Lancet recently published a five-part series concerning physical activity. 
Branding the culture of inactivity a pandemic, the series sets the agenda for future research 
strategy and policy making (Das, 2012). 
Thus it is unsurprising that promotion of PA amongst younger generations is a key public 
health message in order to advocate habit-forming behaviour, including avoiding obesity 
(Kohl et al., 2000). National guidelines recommend participation in 60 minutes of at least 
moderate activity per day for children to promote a wide range of health benefits 
(Department of Health, 2004, Strong et al., 2005). It is well recognised that participation in 
PA has been shown to be beneficial in attenuating risk factors for long term morbidities in 
adulthood with strong negative associations between PA, overweight, diabetes and some 
cancers. A recent meta-analysis showed that PA was beneficial in reducing the odds of 
obesity even in those genetically predisposed to being overweight (Kilpelainen, 2011). 
There is growing concern that such risk factors are present in young children and may lead 
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to early-onset chronic disease. Moreover, there is strong evidence that levels of PA decline 
through childhood and into adolescence. A clear gender effect also exists, with females less 
active than males across all domains of activity intensity, (Riddoch et al., 2004) Figure 1-8.
 
Figure 1-8 The age and gender distribution of time engaged in at least moderate-intensity 
physical activity in four European countries. The columns represent means and error bars 
represent standard deviation). A clear difference is demonstrated between males and 
females at both ages, with the decline evident between 9 and 15 years of age. 
Reproduced with permission from Riddoch et al. Med Sci Sports Exerc. 2004;36:86-92 
Children born preterm may be at risk of reduced levels of PA as they have increased 
respiratory symptoms as well as decrements in lung function, muscle bulk and exercise 
capacity. The evidence presented earlier in this chapter indicates that the effects are 
prevalent across the whole range of gestational age. In this section, the current literature in 
regards to levels of PA in preterm-born children are presented, and I shall also explore PA 
in cohorts of young adults in order to contextualise the possible impact on long term risks 
to respiratory health. However I begin with a summary of the methodology in regards to PA 
measurement. 
 Measurement of physical activity 
The objective measurement of physical activity under free-living conditions is challenging 
due to the need for ambulatory equipment which reliably and accurately records 
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movement. To ensure compliance with the protocol, it must be simple to use (for the 
technical staff and users) and well-tolerated outside of a clinical setting (so that sufficient 
duration of recording is obtained. As physical activity is defined in terms of energy 
expenditure (Caspersen CJ, 1985), data  obtained from devices such as heart rate monitors 
and accelerometers (both popular for use in large cohort studies) must be validated to a 
corresponding physiological measure of energy expenditure to allow for interpretation of 
results.  Three criterion standards are used to measure energy expenditure during physical 
activity: direct observation, doubly labelled water and indirect calorimetry (Sirad JR, 2001).  
1.7.1.1 Criterion standards 
Methods of direct observation utilise questionnaire-based reports of exercise intensity 
completed by trained researchers, which can be burdensome. Estimates of energy 
expenditure are made from the results based on validation against a physiological measure, 
e.g. heart rate monitoring. These methods are suitable for widespread use and allow the 
researchers to contextualise facilitators and barriers to physical activity at group level as 
well as for individuals (McKenzie et al., 2000). Direct observation can also be suitable for 
children who are not able to accurately recall information (Anderssen et al., 1995). 
However, they still rely on subjective reporting (although inter-observer agreement is often 
high), do not capture activity outside of the sample environment (i.e. school, youth groups) 
and may be bias as children may alter their natural behaviour in lieu of participation. 
Moreover, children’s activity varies on a daily basis thus repeatability of the results is a 
further limitation (Kohl et al., 2000).  
Activity energy expenditure (AEE) can be quantified using Total Energy Expenditure (TEE) 
and basal metabolic rate (BMR) over a given period of time using the doubly labelled water 
(DLW) technique. This involves ingesting water containing heavy hydrogen and heavy 
oxygen (2H218O), and calculating CO2 production by measuring the excretion of these 
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isotopes in urine over a 2-week period. 2H is eliminated as water, whilst 1802 is eliminated as 
water and CO2- the difference in elimination rates is proportional to energy expenditure 
(CO2 production converted to TEE using food quotients from patient diaries). Basal 
metabolic rate is derived from gender, age, weight and height; AEE is then calculated as 
TEE minus BMR (Ekelund U, 2001, Livingstone et al., 1992). However, the procedure is 
expensive and therefore of limited use in large scale epidemiological studies. 
The third standard, indirect calorimetry, has become more popular as a validation 
technique in recent years due to the development of portable equipment. Previously, 
participants in energy expenditure studies utilising this method of measurement may have 
been required to spend over 24 hours in an air-tight open-circuit chamber whilst 
performing a set routine of rest and exercise. The chamber is continuously ventilated by 
atmospheric air. A measure of CO2 production versus O2 consumption, the respiratory 
exchange ratio, is calculated periodically  by extracting air through a flow meter which 
records the difference in gas concentrations between air entering and leaving the chamber 
(Bitar et al., 1996). The resulting value can then be used to calculate energy expenditure 
during different levels of activity. Modern equipment such as portable metabolic units now 
allow for similar measures to be recorded outside of a fixed laboratory setting, and these 
devices (which require a facemask and chest harness) have been used in accelerometer 
calibration studies (Mattocks et al., 2007) 
Each criterion standard has its own limitations in terms obtaining optimal estimates of 
physical activity. Indeed, usage of these methods is limited to calibration studies involving a 
relatively small group of participants to validate other objective measures (Figure 1-9).  
Heart rate monitors and accelerometers are two such devices which have now found 
favour in large scale epidemiology studies. Both are minimally intrusive, simple to use, and 
accuracy has improved given advancements in technology.  
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Figure 1-9 Validation of methods for recording physical activity against acceptable 
criterion standards. Reproduced with permission from Sirad & Pate. Sports Med. 
2001;31:439.  
1.7.1.2 Heart rate monitors 
Heart rate monitors have shown linear relationships with 02 consumption, however it can 
be difficult to control for factors such as cardiovascular fitness (lower resting heart rate) 
and obesity (higher resting heart rate, slower recovery to resting rate following exercise) 
(Maffeis et al., 1995). Furthermore, the relationship is confounded at sedentary and low 
levels of activity by physiological and environmental factors which may raise the resting 
heart rate (e.g. stress, medication) (Livingstone et al., 1992). The effect of these 
confounders can be reduced by establishing a threshold heart rate which can discriminate 
between resting and exercise values. During continuous recording, this allows periods to be 
assigned as resting energy expenditure (under threshold heart rate) and activity energy 
expenditure (over threshold heart rate). The limitation of this method is that heart rate 
must be calibrated against volume of oxygen consumption (V̇O2) at five levels of exercise 
intensity to produce a regression line for calculation of energy expenditure (Bitar et al., 
1996). 
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1.7.1.3 Accelerometers 
Accelerometer technology can be seen as an evolution of pedometers. Whilst the former 
uses a mechanical component within the mechanism to register a ‘count’, the first 
accelerometers used a piezoelectric transducer to convert a detected motion in to an 
electric signal. Latterly, updated versions have used changes in capacitance which enable 
both static changes in g-force as well as those produced during motion to be recorded  
(John and Freedson, 2012).  A number of accelerometers have been well validated against 
criterion standards, however strength of correlations with energy expenditure are variable 
due to differences in methodologies employed in the studies (e.g. placement of 
accelerometer, activities performed). The Actigraph 7164 accelerometer, used in ALSPAC, 
has been calibrated in both children and adolescents using indirect calorimetry. In a 
validation study designed to reflect free-living conditions, children were asked to perform 6 
different activities for 5 minutes each whilst wearing the Actigraph to measure activity and 
a portable metabolic unit to measure V̇O2. Each activity represented an increased level of 
intensity as quantified by metabolic equivalent tasks (METs). A MET is defined as the 
energy cost of physical activity expressed as multiples of baseline V̇O2, with 1 MET 
equalling resting V̇O2 [mL kg-1 min-1]. Regression equations were then produced (corrected 
for age and gender) to predict both energy expenditure and V̇O2 from activity counts. The 
number of accelerometer counts accumulated at 3, 4 and 6 METS was then used to 
establish cut-points for intensity of activity when adjusted for age and gender(Mattocks et 
al., 2007). 
Worn on the right hip during waking hours (figure 1-10), the device recorded frequency and 
intensity of movement in a vertical plane; the signal from the Actigraph is sampled 10 times 
each second and movement counts summed over epochs of 1 minute (an epoch is defined 
as ‘counts per unit time’). Ten hours (600mins) of data recoded on at least 3 of 7 days has 
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been show as sufficient to be valid for inclusion in analysis. A weekend day was found not 
to be mandatory (Mattocks et al., 2008).The total counts per minute are averaged over the 
period of a valid recording to provide a measure of total activity. The total activity count is 
then sub-divided into categories of activity (as per cut-points derived from the calibration 
study): Sedentary behaviour, light intensity PA, moderate intensity PA, and vigorous PA. 
The latter two categories are often combined in to moderate to vigorous physical activity 
(MVPA), as this is a definition commonly used in activity guidelines (e.g. children are 
encouraged to engage in at least 60mins MVPA per day (Department of Health, 2004)). 
 
Figure 1-10 Position of accelerometer on the right hip. 
Some limitations apply to use of the Actigraph 7164 accelerometer. Water-based activity 
cannot be recorded, and as the device records movement in the vertical plane only, 
activities where the torso remains stationary, namely cycling and upper-body activities, are 
not well captured. Secondly, in order to capture a full week of activity, 1 minute epochs are 
used (owing to the storage capacity of the device). This may lead to a certain under-
estimation of activity levels. Finally, the upper limit of acceleration which can be detected is 
2.5g. Since more strenuous activities such as jogging/running and jumping elicit 
accelerations well above this threshold, the device is limited in its ability to detect these 
higher-impact activities. Finally, the device was not calibrated to specifically measure 
sedentary behaviour.  
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The use of an updated version of the Actigraph accelerometer (GT1M) in the Millennium 
Cohort study solved some of these limitations. However, it still needs to be removed for 
water-based activities, and has the same constraints in measuring upper-body activities. 
Technological advances allowed increased battery life, and crucially data storage capacity 
which allows a higher sampling rate (15 second epochs). Moreover, calibration was also 
performed to define sedentary behaviour as well as light, moderate and vigorous activity, 
using indirect calorimetry and a range of free-living and self-paced routines, as similarly 
performed for ALSPAC (Pulsford et al., 2011).  
 
 Physical activity and exercise capacity in relation to preterm birth 
Primary studies directly measuring PA in preterm-born children are relatively few, rather 
these data are often discussed as add-on elements to investigations of lung function, 
exercise capacity, neuromotor development, or a combination of these elements. 
Furthermore, most studies rely on subjective questionnaire data to quantify activity, 
whereas some secondary analyses of epidemiological data from longitudinal cohort studies 
have utilised objectively measured habitual PA from accelerometer recordings. One 
complication in comparing results is that some studies report associations based on 
birthweight rather than gestational age. Since such studies often include large numbers of 
preterm-born participants, all studies based on gestational age or birthweight are discussed 
below for completeness. 
1.7.2.1 In children and adolescents 
In the youngest cohort of neurologically unimpaired preterm-born 5-7 year olds with and 
without BPD/CLD, habitual PA, expressed in hours per week, has been reported using a 
questionnaire comparing results to matched term controls (Kriemler, 2005). Lung function 
and exercise capacity were assessed as the primary endpoints of the study. The authors did 
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not find statistically significant differences in parent-reported PA between the three groups 
under study despite preterm-born children having reduced lung function (worst in the 
BPD/CLD group) and higher degrees of reported exercise-induced bronchoconstriction 
(decrease in FEV1 of ≥15% at any time up to 10 minutes’ post-exercise) when compared to 
the term controls. Although there was no difference in maximal uptake of oxygen or 
exercise capacity, the oxygen cost of maximal power output was higher in the preterm-
born children with BPD/CLD. These children also had increased respiratory rate, lower tidal 
volumes but similar minute ventilation compared to preterm-born children without history 
of BPD/CLD and term-born controls. Together these findings indicated that there may be a 
higher metabolic cost of exercise which may limit participation in prolonged activities. A 
further study using the same cohort examined anaerobic performance in children born 
preterm (<32 weeks’ gestation)(Keller et al., 2000). Habitual PA was quantified using a self-
administered questionnaire, although the focus of the study was on impaired anaerobic 
muscle performance which was noted to be reduced in extremely low birthweight (ELBW, 
<1000g) when compared to very low birthweight (VLBW, 1000-1500g) and normal 
birthweight (>2500g). Anaerobic muscle peak-power was assessed by cycle ergometer 
using a supramaximal test. The authors suggested that reduced levels of PA could be a 
contributing factor in the reduction of muscle performance, perhaps due to impaired 
exercise capacity and thus increased amount of time spent sedentary. However, they did 
not observe differences in levels of PA between the different birthweight groups and 
presented very limited data on the results. PA was measured using an adapted 
questionnaire which reported participation in recreational activities in excess of normal 
physical education classes. 
In a further study, focusing on neurological outcomes, Wolcadlo investigated levels of PA in 
preterm-born 8 year old children both with and without Developmental Coordination 
Disorder (DCD)(Wocadlo and Rieger, 2008). The primary aim of the study was to assess 
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motor impairment and learning ability since other studies show deficits in ELBW and VLBW 
children. Measurement of PA was taken from verbal reports by the child and their parent 
of participation in after school sporting activities. Children with DCD scores of below the 
15th centile were more likely to be motor impaired, have lower intellectual performance 
and participated in less sporting activity. The authors suggest that withdrawing from 
participation due to movement difficulties, or through exclusion by peers may explain the 
difference in activity levels.  
Svien et al. investigated the ‘health-related fitness’ of a group of moderately preterm-born 
children (mean gestational age of 32 weeks’, excluding those with history of BPD/CLD or 
other complications of preterm birth) and well-matched controls at approximately 9 years 
of age (Svien, 2003). PA data were reported using a questionnaire completed by the child 
and by their parents which captured information on the child’s frequency of exercise or 
frequency of sports team participation in the past 7 days. Body fat was estimated using 
skinfold callipers, muscular strength and endurance measured by a battery of drills, and 
endurance measured via a treadmill protocol. The preterm group demonstrated deficits in 
muscle strength, endurance and coordination. However, no evidence of differences in 
cardiorespiratory endurance or in measures of PA (frequency of exercise or frequency of 
sports team participation in the past 7 days) were reported between those born preterm 
and those born at term. Of interest, a difference was noted in percentage body fat despite 
the groups being of similar weight, suggesting that the term controls had higher muscle 
mass contributing to higher cardiovascular endurance. There is a lack of detailed research 
relating to body composition in preterm-born children and results of available studies are 
conflicting. The study by Bott et al. reported that 4 to 8-year old children with BPD/CLD 
were smaller and leaner than healthy controls (Bott et al., 2007). Vardar-Yagli et al. 
compared a slightly older group of preterm-born children with BPD/CLD with term controls 
and reported fat-free mass was significantly lower in BPD/CLD children which correlated 
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with reduced distance covered on a six-minute walk test (Vardar-Yagli et al., 2015). In 
contrast, another study reported that fat mass, adjusted for height, is lower in preterm-
born children at 8-12 years of age when compared to term-born children, but observed no 
differences in fat-free mass (Fewtrell et al., 2004). 
Focusing on exercise capacity, Joshi et al. recently noted that preterm-born children with a 
history of BPD/CLD self-reported less time spent on PA when compared to preterm-born 
children without BPD/CLD and those born at term. The study team demonstrated 
exercised-induced bronchoconstriction, manifested as reduce (FEV1), in preterm-born 
children with and without BPD/CLD after formal exercise (Joshi et al., 2013). This was 
reversible following administration of salbutamol in the BPD/CLD group. The study also 
showed that at peak exercise, preterm-born children have different breathing patterns, 
using increased ventilatory reserve to maintain similar oxygen uptake at maximal or peak 
exercise (V̇O2) as term-born children. Investigators from the EPICure study focussed on 
extremely preterm birth (<25 completed weeks’ gestation) and associations with exercise 
capacity and PA using data from a national cohort of children at age 11 years (Welsh et al., 
2010). In contrast to studies relying on questionnaire responses, a strength of this study 
was the use of accelerometers to collect objective measurements of PA. Exercise capacity, 
assessed using cycle ergometer, and spirometry were also performed. Extremely preterm-
born children were noted to have reduced peak V̇O2, tidal volume, minute ventilation and 
used more of their ventilatory reserve. Despite these differences, there was only a weak 
correlation between peak V̇O2 and accelerometer counts (total activity or MVPA). 
Interestingly, those born extremely preterm had a self-perception of inferior exercise 
capability and reported increased difficulty in breathing during exercise when compared to 
term-born peers. 
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Kilbride et al. followed up a cohort of ELBW graduates of neonatal intensive care (mean 
gestational age 26 weeks’ gestation at birth) between 9 and 15 years of age in order to 
assess exercise tolerance and lung function in this otherwise asymptomatic group of 
children, comparing them with a term-born control group (Kilbride et al., 2003). In terms of 
PA outcomes, parents perceived their ELBW children as less active physically than the term 
controls using a simple 5-point scale (‘inactive’ to ‘very active’). Lung function was reported 
to be significantly reduced in the ELBW children, however, the majority of the difference 
was accounted for by ELBW children who had BPD/CLD in infancy. Additionally, ELBW 
children had reduced oxygen consumption (independent of BPD/CLD status) during 
exercise. This most likely reflected reduced fitness rather than cardiorespiratory 
dysfunction, but could represent other physiological limitations not yet described. 
Interestingly, a small proportion of BPD/CLD children were excluded from the exercise 
challenge analysis as their effort was considered sub-maximal. One possible reason for this 
diminished effort could be exercise-induced bronchoconstriction, which the authors 
acknowledged was not measured in their study.  
One of the most well-characterised extremely preterm-born cohorts is that described by 
the Norwegian group who examined the exercise capacity of two cohorts of extremely 
preterm children aged 10 years (born in the 1990s) and 18 years (born in the 1980s) using 
an incremental treadmill test (Clemm et al., 2012). The study team did not find differences 
in peak V̇O2 or anaerobic threshold in spite of reduced FEV1 in the preterm group although 
distance covered was on average 10% lower over the course of the test when compared to 
term controls. Conversely, leisure time PA reported via self-completed questionnaire was 
significantly reduced in the preterm-born group. When the 10 year old cohort was recently 
followed up at 18 years of age, there were small reductions in exercise capacity with 
decrements in mean peak V̇O2 and treadmill distance covered when compared to term 
controls (Clemm et al., 2015).  However, these differences were largely explained by male 
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gender and individuals with minor disabilities. Lung function expressed as predicted FEV1 
was also lower in the extremely preterm group but this was interestingly not related to 
exercise capacity. The study also found that leisure-time physical exercise was lower in the 
preterm group when reported in hours per week. Higher levels of exercise correlated with 
higher peak V̇O2 in both the preterm and term groups suggesting that they both have 
similar training potential. Furthermore, longitudinal analysis demonstrated that capacity at 
10 years of age was reported to predict capacity at age 18 years in terms of peak V̇O2 as 
well as treadmill distance covered suggesting tracking of exercise capacity over time. There 
was no changes in leisure time physical exercise, which remained lower in the preterm 
group.  
Rogers and colleagues investigated differences in PA as well as aerobic capacity, flexibility 
and muscle strength in 17-year olds born with ELBW stating that “establishing early, 
adequate levels of fitness and activity may be particularly important in former tiny infants, 
who may be at risk of early onset adult disease” (Rogers et al., 2005). PA was measured 
using questionnaire-based data on sports and activity participation and aerobic fitness was 
measured using a graded stepping test. ELBW teenagers were noted to have reduced 
aerobic fitness capacity, participated in less sport and reported reduced levels of PA. The 
authors acknowledge that it is difficult to know if reduced exercise tolerance is a result of 
detraining through lack of activity or as a result of preterm birth (i.e. subclinical 
cardiorespiratory compromise) - an area that needs further evaluation. If the former, the 
authors speculate that this may be due to physical limitations, which may be physiological 
or perceived, and followed by a subsequent decision not to participate by the child 
themselves or through parental intervention. However, by 17 years of age, these 
individuals are likely to have freed themselves from obligatory participation (e.g. physical 
education lessons or other organised sport) and therefore may represent a lifestyle choice. 
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In summary, although some studies show only modest differences in exercise capacity in 
terms of peak volume of oxygen consumption (V̇O2), preterm-born children have different 
breathing patterns, using increased ventilatory reserve to maintain similar oxygen uptake 
at maximal or peak exercise (V̇O2) as term-born children. Furthermore, they exhibit 
increased rates of exercise-induced bronchoconstriction which are reversible following 
administration of salbutamol (Joshi et al., 2013). Other studies have shown a difference in 
peak V̇O2, as well as reduced anaerobic threshold, lower peak workload and increased 
residual volume in preterm-born children (Welsh et al., 2010, Kilbride et al., 2003, Smith et 
al., 2008) especially in those with BPD/CLD. Together these deficits suggest that airflow 
obstruction, reduced lung compliance, and gas trapping which may all be results of injury to 
the developing lung in the postnatal period. Moreover, the reduced DLCO reported in some 
studies further indicates disruption in alveolar and pulmonary microvascular development 
in preterm-born children which may be secondary to neonatal lung injury. 
1.7.2.2 In Adults 
Svedenkrans and colleagues recently reported on the exercise capacity of preterm-born 
adults aged between 18-26 years who enrolled for military service in Sweden (Svedenkrans 
et al., 2013) and noted reduced performance on cycle ergometry including after correction 
for birthweight. Indeed, the effect was dose-dependent with a decline in exercise capacity 
for each week of decrease in gestational age at birth (Figure 1-11). The authors suggest that 
fewer alveoli, reduced capillary density and smaller airways as sources of the deficit in 
exercise capacity but also cite cardiovascular, neurological and body composition 
limitations as possible contributing factors. 
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Figure 1-11 Adjusted results expressed as least squared means for maximal exercise 
capacity (Watt) in relation to gestational age. Reproduced from Svedenkrans et al. PLoS 
ONE. 2013:e80869 under the Creative Commons Attribution (CC BY) licence. 
 
These findings correlate well with outcomes from other large cohort studies based in 
Scandinavia. Two previous studies have used data from the Helsinki study of VLBW adults 
established in the late 1970s which assessed frequency of conditioning leisure time PA 
using questionnaire-based data (Kajantie et al., 2010, Kaseva et al., 2012). Compared with 
term controls, VLBW adults participated in lower frequency, duration and intensity of 
conditioning PA (defined as exercise to maintain physical condition or competitive training) 
which was not explained by confounders including height, parental education, lean mass 
and percentage body fat. Notwithstanding, there is some evidence that body composition 
may be an additional factor. For example, in the study by Kaseva et al. VLBW participants 
had lower lean body mass. In contrast, in a study of young adults, there was no difference 
in lean body weight when preterm-born subjects with and without BPD/CLD, and term born 
subjects were compared (Landry et al., 2016). However, preterm-born subjects with 
BPD/CLD had reduced total active energy expenditure and spent more time sedentary; 
additionally, all preterm-born groups (irrespective of neonatal history) had increased 
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prevalence of bronchial hyper-responsiveness.  Of note, follow up of the Helsinki cohort did 
not find evidence of differences in objective measures of total activity, MVPA, or time 
spent sedentary using accelerometry when compared to term controls (Kaseva et al., 
2015). 
A further Finnish cohort study demonstrated that extremely preterm-born 23-year olds 
perceived themselves to be less physically fit that term controls (Tikanmaki et al., 2016). 
This study excluded participants with cerebral palsy and other physical disabilities. The 
authors could not show any differences in cardiorespiratory fitness when measured by a 
submaximal step test and suggest that any associations are mediated through percentage 
body fat and PA. Instead the authors noted that reduced self-perceived fitness may be 
related to decrements in muscle strength. Saigal reported on a cohort of young adults also 
born in the 1970-80s (aged approximately 23 years) who were followed-up longitudinally 
after admission to the neonatal unit as a result of ELBW (Saigal et al., 2007). Information on 
PA and other measures (functional limitations, healthcare usage) were collected using 
questionnaires. ELBW young adults had significantly lower scores in measures of physical 
self-efficacy, perceived physical ability, and reported less participation in sports and 
strenuous activity when compared with term-born controls. They also reported higher 
rates of asthma and functional limitations including visual deficits and dexterity.  
Another follow-up study of the Norwegian cohort by Clemm and colleagues reported that 
peak V̇O2 and distance completed during treadmill testing was reduced by 10% in those 
born extremely preterm when compared to term-born peers at 25 years of age. There were 
no differences between the groups in terms of self-reported leisure time PA although this 
did correlate with improved exercise performance (Clemm et al., 2014); furthermore, 
exercise capacity was not related to FEV1 or a history of BPD/CLD. When combining results 
of this study with those from the previous analysis at 18 years of age, participants born 
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extremely preterm were less physically active, thus suggesting a detraining effect is 
responsible for reduced exercise capacity. This idea was shared by Vrijlandt and colleagues 
whose cohort of preterm-born young adults self-reported fewer hours of exercise per week 
at approximately 19 years of age (Vrijlandt et al., 2006). 
Of note in regards to the studies presented in this section is the limited information of data 
presented on contemporary graduates of modern neonatal care. Preterm infants born in 
the late 1970s and 1980s were subject to prolonged invasive mechanical ventilation and 
high levels of oxygen supplementation. Commercially available exogenous surfactant, 
which significantly reduces the incidence of respiratory distress syndrome and allows rapid 
step-down to more gentle forms of ventilation, only become available in the 1990s 
following extensive clinical trials during the 1980s (Halliday, 2008). However, 
simultaneously, the survival rate at the extremes of viable gestation had markedly 
improved such that rates of BPD/CLD have remained largely the same (Costeloe et al., 
2012). Thus, it would be of great interest to compare and contrast the respiratory 
outcomes, as they relate to levels of physical activity, in preterm-born children who were 
born in the early era and modern eras of surfactant use.  
 
 Summary of introduction 
In this chapter, I have presented background information relating to foetal growth and 
development of the respiratory system; preterm birth and neonatal outcomes; low 
birthweight, and infant growth. The current evidence in regards to how these factors 
impact upon respiratory health in childhood, and beyond, have been reviewed. I have then 
presented the literature in relation to the impact of preterm birth on physical activity, a 
potential mediator of respiratory health through the life course. 
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In compiling the data included within this chapter, I have identified general paucity of data 
which specifically relates to preterm-born children, especially in regards to foetal and infant 
growth patterns and how these relate to later respiratory outcomes. There is growing 
evidence that the aetiology of lung disease in preterm-born children is different to those 
born at term, thus it is important to specifically investigate such factors and how they 
impact on the respiratory health in this vulnerable population. This is especially so given 
the rise in preterm birth rates worldwide. Chapters 2 and 3 of this thesis will address the 
effect of foetal growth, and then infant weight gain on later respiratory symptoms. 
Physical activity is an important mediator of health and disease. Preterm-born children may 
be at risk of reduced PA secondary to decrements in lung function and impaired exercise 
capacity. The evidence presented in this introduction identifies a lack of data in regards to 
levels of physical activity in preterm-born children, especially those born in the surfactant 
era, and how this relates to markers of respiratory health; namely, lung function, and 
incidence of respiratory symptoms.  Moreover, the majority of the existing studies do not 
focus on preterm birth as a primary exposure, and rely on questionnaire data as opposed 
to objective measures of PA such as accelerometers. Chapters 4 and 5 of this thesis will 
investigate the levels of objectively measured physical activity in preterm-born children. 
Below, I describe the cohort studies from which data for my analyses were obtained, 
before outlining the research questions and aims to address my specific hypotheses 
presented in each chapter.  
 
 Cohort studies 
 Respiratory and Neurological Outcomes of Preterms Study (RANOPS) 
The RANOPS study was lead by Dr Martin Edwards and Professor Sailesh Kotecha from the 
Department of Child Heath at Cardiff University. The design of the study was a cross-
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sectional questionnaire survey of children between 1-10 years of age with a history of 
preterm birth, and matched term-born controls (born in the same locality, gender, and 
day). Ethical approval for the survey was obtained from the Wales Research Ethics 
Committee (REC ref 13/WA/0155). In 2013, local principal investigators representing each 
of the health boards in Wales mailed out an invitation to participate on behalf of the 
research team in Cardiff (Appendix 1), along with the study questionnaire which included a 
section to obtain consent for use of the provided data. Optional consent was also obtained 
for database linkage, and to be contacted regarding queries/future research studies. The 
respiratory content of the questionnaire, which is the focus of this thesis, was based 
around the Liverpool Respiratory Questionnaire (Powell et al., 2002) for children <5 years 
of age (Appendix 2), and the ISAAC questionnaire (Asher et al., 1995) for children ≥5 years 
of age (Appendix 3). Both questionnaires are designed to be parent-completed. In total, 
26,722 were mailed out with a final response rate of 7,149 (26.7%). Longitudinal follow-up 
of RANOPS in now under way.  
 
 Avon Longitudinal Study of Parents and Children (ALSPAC) 
The ALSPAC cohort, branded for participants as ‘Children of the 90s’, was established by 
Professor Jean Golding at Bristol University as a response to the WHO call for longitudinal 
studies to determine the prevalence and antecedents of ill health (Golding et al., 2001). 
Initially focused on pregnant mothers, the primary aim was to collect observational data via 
self-completed questionnaires which could be linked to other information obtained from 
health records. Enrolment took place between 1990-1992 with the aim to recruit 
participants when they attended for their dating antenatal ultrasound scan (although 
enrolment was open throughout pregnancy and beyond). At the end of the pregnancy 
recruitment phase, 14,541 participants had been enrolled, with further numbers added 
during subsequent recruitment campaigns (Boyd et al., 2013). Over the first 6 years, follow-
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up was based on postal questionnaires; however, a 10% sample of ALSPAC (‘Child in Focus’) 
were observed during frequent clinic visits, before the whole cohort at-large attended for 
their first clinic visit between 7-8 years of age. Follow-up has continued to this day with 
clinics completed at 11, 15, and 18 years of age, with data collection at the age 24 clinic 
currently ongoing.   
 Millennium Cohort Study (MCS) 
The MCS was commissioned by the Economic and Social Research Council and 
administered by the Centre for Longitudinal Studies at University College London. Branded 
as ‘Child of the New Century’, the survey followed-up approximately 19,000 families of 
children born between 2000-2002. To improve the representativeness of the data in 
comparison to the UK’s previous birth cohorts, MCS was designed to over-sample from 
geographic areas with high levels of child poverty, with high ethic minority populations, and 
from the devolved nations of the UK.  This was particularly to investigate social and 
economic circumstances at birth and in early childhood, and the potential life 
disadvantages/advantages this may confer (Hansen K., 2012). The first ‘sweep’ was 
performed when children were aged approximately 9 months by a team of field workers 
and focused on the circumstances of pregnancy and birth. These data were linked to birth 
records to verify the information collected in the family’s home. Further sweeps have been 
performed at the ages of 3, 5, 7 and 11. Data collection for the survey at 14 years of age 
has recently been completed and further follow-up at age 17 is planned.   
 Research questions and aims 
 Associations between foetal size, growth trajectory, and childhood respiratory 
symptoms in preterm-born and term-born children 
In this first study, my principal question was:  
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‘Does foetal size, or growth trajectory, predict increased incidence of respiratory symptoms 
in preterm-born children?’ 
 The specific aims of the study were to: 
I. investigate whether anthropometric data obtained from first and second trimester 
foetal ultrasound scans were related to increased respiratory symptoms in 
childhood 
II. investigate if altered growth trajectory, calculated from change in foetal biometric 
measurement between first and second trimester scans, and between second 
trimester scans and birthweight, are related to increased respiratory symptoms in 
childhood 
Data for this study were obtained from the Respiratory and Neurological Outcomes of 
Preterms Study (RANOPS).  Foetal ultrasound reports were obtained from the national 
radiology database via anonymous database linkage performed by the NHS Wales 
Informatics Service (NWIS).  
 
 Associations between weight gain and childhood respiratory symptoms in 
preterm-born and term-born children 
The research question for my second study was:  
‘Following preterm birth, is weight gain in infancy associated with increased respiratory 
symptoms later in childhood? What are the important factors mediating this relationship?’ 
My specific aims were: 
I. To investigate if weight gain between birth and nine months of age was associated 
with increased respiratory symptoms in childhood. 
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II. To investigate if weight gain between birth and 24 months of age was associated 
with increased respiratory symptoms in childhood. 
III. To investigate if degree of prematurity influenced the effect of weight gain on 
respiratory symptoms in childhood. 
IV. To explore if early life factors mediate the relationship between infant weight gain 
and childhood respiratory symptoms. 
Data for this study were obtained from the RANOPS cohort. Weight data were obtained 
from the national child health database via anonymous database linkage performed by 
NWIS.  
 
 Physical activity in preterm-born 11-year old children born in the 1990s 
The research question for this study was:  
‘What are the levels of objectively measured physical activity in preterm-born children 
when compared to term-born controls?  Are levels of physical activity related to the 
decrements in lung function observed in these children?’  
 
The specific aims were: 
I. To investigate the levels of total physical activity, moderate to vigorous physical 
activity, and sedentary behaviour in preterm-born children and compare these to 
term-born controls. 
II. To investigate if measure of lung function are correlated to levels of physical 
activity. 
Data were obtained from the Avon Longitudinal Study of Parents and Children (ALSPAC).  
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 Physical activity and sedentary behaviour in preterm-born 7-year old children 
born in the 2000s 
The research question for this final chapter was:  
‘What are the levels of objectively measured physical activity and sedentary behaviour in 
preterm-born children compared to those born at term? Do current respiratory symptoms 
and family history mediate these relationships?’  
The specific aims were: 
I. To compare the levels of physical activity and sedentary behaviour in preterm-born 
children to those of children born at term. 
II. To investigate whether respiratory symptoms and family history of atopy mediate 
any observed relationships between preterm-birth and physical activity. 
Data were obtained from the Millennium Cohort Study (MCS). 
 
 
 
 
2 Association of foetal size and growth trajectory with respiratory 
symptoms in preterm-born and term-born children 
 
 Overview 
Preterm-born children (<37 weeks’ gestational age) are at an increased risk of respiratory 
symptoms, hospital admissions, and reduced lung function in childhood and beyond (Been 
et al., 2014, Kotecha et al., 2013, Edwards et al., 2016, Sonnenschein-van der Voort et al., 
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2012). Increasing evidence suggests that these risks persist in to adulthood potentially 
developing in to early-onset COPD (Bush, 2008, Kotecha et al., 2013). 
As presented in the Introduction to this thesis, there has been sustained interest in both 
antenatal and postnatal growth patterns in children, and how these relate to risk of 
childhood respiratory disease, most commonly asthma. Historically, birthweight has been 
used a proxy for foetal wellbeing and has been related to outcomes both in child and 
adulthood (Barker et al., 1991, Lawlor et al., 2005, Kotecha et al., 2015). However, it is 
increasingly recognised that birthweight is a result of many months of development during 
which the infant may be exposed to adverse intrauterine conditions including nutritional 
deficits, placental dysfunction, and maternal smoking (Duijts, 2012, Turner, 2012, 
Henderson and Warner, 2012). Foetal adaptations to this adversity may affect the 
development of organ systems (Gluckman et al., 2008), such as the respiratory system, 
which continues to develop throughout gestation (Kotecha, 2000). Dysregulation of lung 
growth may be further compounded by preterm birth (Joshi and Kotecha, 2007) and 
pulmonary inflammation associated with neonatal respiratory distress (Chakraborty et al., 
2010). To date, the few studies investigating growth patterns in utero and their association 
with later childhood respiratory disease have reported inconsistent results (Pike et al., 
2010, Turner et al., 2011, Turner et al., 2010, Sonnenschein-van der Voort et al., 2012). 
Moreover, none of these studies have been conducted in preterm-born children- a 
vulnerable population at-risk of long term respiratory morbidity. Little is known about the 
influence of foetal size and growth trajectory on the later risk of increased respiratory 
symptoms in the preterm-born population. Investigating this relationship may help to 
disentangle the interaction between foetal growth, birthweight, gestational age and risk of 
respiratory symptoms in childhood.  
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 Aims and Hypothesis 
The aim of this study was to (a) investigate whether differences in foetal size and growth 
trajectory are important factors in predicting increased respiratory symptoms in both 
preterm and term-born children; (b) investigate whether anthropometric data obtained 
from first and second trimester foetal ultrasound scans were related to increased 
respiratory symptoms in childhood; and (c) investigate if altered growth trajectory, 
calculated from change in foetal biometric measurement between first and second 
trimester scans, and between second trimester scans and birthweight, are related to 
increased respiratory symptoms in childhood. 
The specific hypotheses are: 
a) That reduced foetal size in the first or second trimester of pregnancy will be 
associated with increased respiratory symptoms in childhood 
b) That changes in growth trajectory during gestation will be associated with 
increased respiratory symptoms. Specifically 
i. Growth faltering between the 1st trimester and 2nd trimester would be 
associated with increased respiratory symptoms  
ii. Growth faltering between the 2nd trimester and birth would be associated 
with increased respiratory symptoms 
 Methods 
 The Respiratory and Neurological Outcomes of Preterms Study (RANOPS) 
Respiratory outcome data from RANOPS, a cross-sectional population study of preterm-
born children, were used (Edwards et al., 2015a, Edwards et al., 2016). In 2013, our group 
sent Liverpool Respiratory Symptom Questionnaires (if <5 years of age) or a modified ISAAC 
Questionnaire (if over ≥5 years of age), to all identifiable live-born preterm (<37 weeks’ 
gestation) surviving children born in Wales aged between 1 and 10 years, and term controls 
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(born same gender, day and locality), n=26,722. In total 7,149/26,722 (26.7%) were 
returned, of which 4283 were born preterm and 2,866 were born at term. Both 
questionnaires have been validated (Asher et al., 1995) (Powell et al., 2002) and use of such 
questionnaires is widely accepted in epidemiological studies. Ethical approval for the 
survey was obtained from the Research Ethics Committee and parents gave consent by 
returning completed questionnaires (REC ref 13/WA/0155). 
 
 Perinatal data 
Demographic data, including gestation, birthweight, singleton or multiple birth and Wales 
index of multiple deprivation (WIMD, a measure of socio-economic status) were available 
from national healthcare databases via the NHS Wales Informatics Service (NWIS). Children 
were divided into four groups based on gestational age at birth: 25-32, 33-34, 35-36 weeks’ 
gestation and term controls (37-43 weeks’ gestation). This approach is similar to studies on 
lung function (Kotecha et al., 2012) and that of others as it represents specific stages in lung 
development (Joshi and Kotecha, 2007) and children most at risk of lung disease (Boyle et 
al., 2012, Greenough, 2012). Intrauterine growth restriction (IUGR) was defined as <10th 
centile for standardised birthweight corrected for gestation and gender using the LMS 
method (Medical Research Council, UK) as previously used in studies of growth and lung 
function (Ong, 2000, Kotecha et al., 2010). The LMS method uses a reference population to 
construct smoothed growth curves which can be applied to external datasets to derive 
percentiles and/or z-scores (Cole, 1990).  
 
 Foetal anthropometric data 
Questionnaire responders had the option to give consent to healthcare database linkage 
for further study. Access to the national system for radiology imaging and reporting was 
possible for 4 of 7 Health Boards in Wales through NWIS (Aneurin Bevan, Abertawe, Hywel 
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Dda, Betsi Cadwalder). The remaining Health Boards (Cardiff and Vale, Powys, Cwm Taff) 
used differing systems which could not be linked. For each questionnaire responder giving 
consent for database linkage, a unique anonymous identifier originally generated for 
RANOPS by NWIS was returned to the information analyst. Using this ID the mother of the 
child was identified along with their date of birth, NHS number and Hospital number. The 
date of birth of the child, and the number born (i.e. singleton or multiple) were used to 
identify the correct pregnancy and extract the antenatal scan reports from the radiology 
database. All scan reports were anonymised using the RANOPS ID only prior to 
transmission back to the research team. 
Scan reports were provided in a text-based format and therefore foetal measurements 
(crown rump length, head circumference, femur length) were extracted using C++ coding, 
which identified strings of characters following the name of the measurement (CRL, HC, FL 
and variants). C++ script was prepared by Dr W John Watkins. The extracted data file was 
checked in its entirety for accuracy against the original data file and cleaned where 
appropriate.  
Gestation (in completed weeks) at the time of the scan was abstracted from the reports 
where possible, or, if missing, was calculated from the difference between gestation at 
birth and date of scan. The growth charts of Robinson (CRL) and Chitty (HC and FL) were 
used to create z-scores, adjusted for gestational age at the time of measurement, using the 
published equations (Loughna et al., 2009, Robinson and Fleming, 1975):  
CRL z − score =
(GA − 23.73)2
67.234
 
HC z − score = −109.7 + 15.16GA − 0.002388GA3  
FL z − score = −32.43 + 3.416GA − 0.0004791GA3 
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The CRL z-score for 1st trimester scans closest to 12 weeks’ gestation (10-13 weeks’ 
gestation inclusive, and within ±3.5SD of mean CRL measurement) was identified for each 
child. For second trimester scans, the HC and FL z-scores closest to 20 weeks’ gestation (17-
23 weeks’ gestation inclusive, and within ±3.5SD of mean HC or FL measurement) were 
identified. The available data are presented graphically below (CRL, Figure 2-1; FL, Figure 
2-2; and HC, Figure 2-3). 
 
Figure 2-1 CRL data plotted according to Robinson & Fleming 1975. Lines represent the 
97th, 90th, 50th, 10th, and 3rd centiles. A total of 2297/2581 CRL measurements are 
represented in the chart (284 were excluded for being greater than ±3.5SD from the 
mean CRL at a given gestational age). Measurements used in the analysis were limited to 
10-13 weeks (70-91 days), as represented by the dotted lines. Use of CRL measurements 
are not recommended after 13 weeks of gestation as measurement error increases 
beyond this point. 
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Figure 2-2 Femur length data plotted according to Chitty and Loughna et al. 2009. Lines 
represent the 97th, 90th, 50th, 10th, and 3rd centiles. A total of 5956/6230 FL measurements 
are represented in the chart (274 were excluded for being greater than ±3.5SD from the 
mean FL at a given gestational age). Measurements used in the analysis were limited to 
17-23 weeks, as represented by the dotted lines. 
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Figure 2-3 Head circumference plotted according to Chitty & Loughna et al. 2009. Lines 
represent the 97th, 90th, 50th, 10th, and 3rd centiles. A total of 6240/6402 HC 
measurements are represented in the chart (162 were excluded for being greater than 
±3.5SD from the mean HC at a given gestational age). Measurements used in the analysis 
were limited to 17-23 weeks, as represented by the dotted lines. 
 
 
Growth acceleration was defined as an increase in foetal measurement of >0.67SD and 
growth deceleration was defined as a decrease of >0.67SD between each time point (1st-2nd 
trimester and 2nd trimester to birthweight). A difference of 0.67 was chosen as this reflects 
the difference between centile lines drawn on the standard growth chart (e.g. 2nd, 9th, 25th, 
50th, 75th, 91st and 98th centiles), is used clinically to assess growth change (Ong, 2000) and 
effects on later respiratory health (Kotecha et al., 2010).  
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 Respiratory outcome data 
Respiratory outcomes were taken from the RANOPS questionnaire data and included 
wheeze-ever, recent wheeze (last 3 months for <5 years of age; last 12 months for ≥5 years 
of age), use of inhalers, hospital admissions for chest-related problems, and doctor-
diagnosed asthma (≥5 years of age only). All outcomes were dichotomous (Edwards et al., 
2015a, Edwards et al., 2016). 
 Statistical Analysis 
Not all cases had valid CRL, HC or FL measurements. Therefore, the number of participants 
included in each comparison of foetal measurement varied. In order to determine if this 
introduced selection bias, differences in demographics were compared to the whole 
dataset. Chi-squared tests were used to investigate the differences in categorical 
demographic data. Normality of continuous data was checked by visually inspecting Q-Q 
plots. Independent sample t-tests were used for continuous variables which were normally 
distributed. 
Univariate logistic regression models were used to investigate the association between 
foetal size in the first trimester (CRL) and size in the 2nd trimester (HC and FL) with 
childhood respiratory outcomes. Further models were then used to investigate change in 
growth between (a) 1st and 2nd trimester (CRL to HC and CRL to FL); (b) between 1st 
trimester and birth (CRL to BW); (c) between 2nd trimester and birth (HC to BW and FL to 
BW), and risk of childhood respiratory outcomes. ‘No change’ was set as the reference 
category. Inclusion was limited to singletons as it was not possible to consistently ascertain 
from the scan reports the correct measurements in the case of multiple pregnancies. 
Furthermore, growth in multiple pregnancies may differ from that of singletons.  The 
analyses were further stratified by age (<5 or ≥5 years) as some respiratory outcomes are 
reported differently in these two groups. Gestational age, birthweight, IUGR, gender, 
maternal smoking in pregnancy, current maternal smoking, family history of atopy, 
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caesarean delivery, breastfeeding, ethnicity and Welsh index of multiple deprivation were 
then included in adjusted multivariable models if they had a p-value <0.10 for ‘wheeze-
ever’, which was the primary outcome for all analyses. A level of p<0.05 was set for 
statistical significance. All modelling was conducted independently for preterm-born and 
term-born participants using SPSS (version 20. SPSS Inc. Chicago, IL; US). 
 Results 
 Data availability 
Figure 2-4 outlines the data available for this study. 4362/5012 (87%) questionnaire 
responders from the four LHBs consented to further healthcare database linkage. After 
removal of 13 duplicate IDs, sufficient information was available to identify 4295/4349 
(99%) of mothers. After exclusion of multiple pregnancies (n=436), ultrasound scans for 
3125 mothers were identified, of which 1486 infants were preterm-born (394 multiple 
pregnancies excluded) and 1203 were born at term (42 multiple pregnancies excluded). In 
total, 615 CRL, 1,196 HC and 1,326 FL measurements were available for analysis in the 
preterm group, 509 CRL, 1,141 HC and 1,326 FL measurements were available in the term 
group. When compared to the whole dataset, there were no differences in demographics 
when alternative foetal measurements were used in the analysis (Table 2-1). Therefore, 
additional selection bias was not introduced by using participants depending upon the 
availability of a particular biometric measurement.  
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Figure 2-4 Process for acquisition of foetal anthropometric data 
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Table 2-1 Demographics of participants in RANOPS who had valid foetal anthropometry 
data 
PRETERM Before 
exclusions 
N=1880 
CRL-BW 
analysis 
N=615 
HC-BW 
analysis 
N=1196 
FL-BW 
 Analysis 
N=1326 
Gestational age, weeks 
Mean (SD) 
33.7 
(2.77) 
33.9 
(2.62) 
33.8 
(2.72) 
33.8 
(2.72) 
Birthweight, kg 
Mean (SD) 
2.25 
(0.70) 
2.32 
(0.70) 
2.31 
(0.72) 
2.31 
(0.72) 
Male (%) 1,036/1880 
(55) 
332/615 
(54) 
672/1,196 
(56) 
753/1,326 
(58) 
WIMD rank 
median (IQR) 
942 
(936) 
963 
(822) 
934 
(819) 
935 
(819) 
Age, years 
Mean (SD) 
4.67 
(2.89) 
4.32 
(2.65) 
4.62 
(2.74) 
4.62 
(2.75) 
Mother smoke in 
pregnancy (%) 
275/1880 
(14.6) 
91/615 
(14.8) 
181/1,196 
(15.7) 
209/1,326 
(15.6) 
Maternal age, years 
Mean (SD) 
29.9/1880 
(6.37) 
29.7 
(5.94) 
29.5 
(6.30) 
29.5 
(6.28) 
≥5 years of age (%) 918/1880 
(48.8) 
347/615 
(43.6) 
514/1,196 
(43.0) 
689/1,326 
(52.0) 
IUGR (%) 
 
222/1880 
(11.8) 
53/717 
(8.6) 
117/1,196 
(9.8) 
129/1,326 
(9.7) 
Family history of atopy 512/1880 
(27.2) 
173/615 
(28.1) 
351/1196 
(29.3) 
376/1326 
(28.4) 
 
 
TERM Before 
exclusions 
N=1245 
CRL-BW 
analysis 
N=509 
HC-BW 
analysis 
N=1141 
FL-BW 
 Analysis 
N=1118 
Gestational age, weeks 
Mean (SD) 
39.6 
(1.28) 
39.6 
(1.23) 
39.6 
(1.24) 
39.7 
(1.21) 
Birthweight, kg 
Mean (SD) 
3.45 
(0.50) 
3.47 
(0.49) 
3.48 
(0.48) 
3.48 
(0.48) 
Male (%) 692/1245 
(55.6) 
275/509 
(54.0) 
627/1141 
(55.0) 
612/1118 
(54.7) 
WIMD rank 
median (IQR) 
1009 
(825) 
988 
(814) 
1006 
(493) 
1000 
(812) 
Age, years 4.74 4.41 4.6 4.62 
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Mean (SD) (2.82) (2.74) (2.78) (2.79) 
Mother smoke in 
pregnancy (%) 
165/1245 
(13.3) 
62/509 
(12.2) 
149/1092 
(13.1) 
146/1118 
(0.34) 
Maternal age, years 
Mean (SD) 
30.3 
(5.7) 
30.3 
(5.7) 
30.2 
(5.7) 
30.2 
(5.74) 
≥5 years of age (%) 634/1245 
(50.9) 
238/509 
(46.8) 
560/1141 
(49.1) 
553/1118 
(49.5) 
IUGR (%) 
 
73/1245 
(5.9) 
24/509 
(4.7) 
62/1141 
(5.4) 
57/1118 
(5.1) 
Family history of atopy 327/1245 
(26.3) 
133/509 
(26.1) 
307/1141 
(26.9) 
301/1118 
(26.9) 
 
 Results: Preterm-born children 
 
First trimester CRL size at 12 weeks’ and 2nd trimester HC or FL at 20 weeks’ gestation were 
not associated with later respiratory outcomes including wheeze-ever, recent wheeze, 
hospital admission for respiratory problems, inhaler use or doctor-diagnosed asthma. The 
results were unchanged when preschool and school-aged children were analysed 
separately (Table 2-2). Gestational age, gender, current maternal smoking, family history of 
asthma/atopy, breastfeeding, WIMD and whether the child was aged <5 or ≥5 years were 
all significantly associated with wheeze-ever in univariate analysis as shown in Table 2-3. 
These covariates were thus included in the adjusted models. When a change of ±0.67 of z-
score was used to define growth trajectory, both accelerated and decelerated growth from 
1st trimester CRL to birthweight was associated with increased odds of wheeze-ever 
(Acceleration: OR 1.82; 95% CI 1.16, 2.86; deceleration: OR 1.27; 95% CI 0.87, 1.86) when 
compared to those with unchanged trajectory. However, only growth acceleration was 
statistically significant (Table 2-4). In the adjusted model, the odds of wheeze-ever 
increased to 2.21 (95% CI 1.25, 2.32) for growth acceleration and 1.32 (95% CI 0.89, 1.94) 
for deceleration, with the latter noted to not be statistically significant. 
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Table 2-2 Association between foetal size variables and respiratory outcomes in preterm-born childhood. Data are Odds ratios (95% confidence intervals) 
Size variables 
 
Wheeze-ever Wheeze last 12 
months 
Wheeze last 3 
months 
Inhaler use Hospital admission Doctor-diagnosed 
asthma 
All        
Crown-rump 
length N=615 
0.97 
(0.87, 1.08) 
- - 
1.02 
(0.89, 1.16) 
1.12 
(0.92, 1.36) 
- 
Head 
circumference N=1196 
0.95 
(0.85, 1.05) 
- - 
1.03 
(0.91, 1.17) 
1.05 
(0.88, 1.27) 
- 
Femur  
length 
N=1327 
0.96 
(0.87, 1.07) 
- - 
1.05 
(0.92, 1.18) 
1.04  
(0.87, 1.24) 
- 
Under 5        
Crown-rump 
length N=347 
1.02 
(0.87, 1.20) 
- 
1.09 
(0.92, 1.30) 
0.99 
(0.83, 1.19) 
1.10  
(0.87, 1.39) 
- 
Head 
circumference N=680 
0.99 
(0.86, 1.15) 
- 
1.03 
(0.88, 1.19) 
1.04 
(0.88, 1.22) 
1.09 
(0.89, 1.34) 
- 
Femur  
length 
N=688 
0.96 
(0.83, 1.12) 
- 
1.02 
(0.88, 1.20) 
1.08  
(0.91, 1.28) 
0.98 
(0.78, 1.21) 
- 
Over 5        
Crown-rump 
length N=268 
0.93 
(0.80, 1.08) 
0.86 
(0.73, 1.03) 
- 
1.05 
(0.87, 1.27) 
1.50 
(0.88, 2.56) 
1.04 
(0.87, 1.24) 
Head 
circumference N=516 
0.91 
(0.77, 1.08) 
1.04 
(0.86, 1.26) 
- 
1.05 
(0.85, 1.29) 
1.10 
(0.69, 1.74) 
0.90 
(0.74, 1.11) 
Femur  
length 
N=638 
0.93 
(0.81, 1.08) 
1.03 
(0.87, 1.21) 
- 
0.99 
(0.82, 1.19) 
1.07 
(0.72, 1.57) 
0.96  
(0.81, 1.15) 
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Table 2-3 Univariate associations between potential confounders of the association between foetal growth trajectory and respiratory outcomes in 
preterm-born children. 
 
Wheeze-ever 
Recent 
Wheeze 
Wheeze last 
12 months§ 
Wheeze last 3 
months† Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma§ 
Gestational age        
≤32 weeks 2.12** 
(1.69, 2.65) 
1.69** 
(1.33, 2.13) 
1.54* 
(1.08, 2.19) 
1.79** 
(1.31, 2.47) 
2.03** 
(1.58, 2.61) 
2.41** 
(1.67, 3.48) 
1.59* 
(1.10, 2.31) 
33-34 weeks 1.21 
(0.94, 1.52) 
1.13 
(0.87, 1.45) 
1.15  
(0.79, 1.69) 
1.09 
(0.77, 1.53) 
0.93 
(0.70, 1.25) 
1.25 
(0.81, 1.94) 
0.81 
(0.52, 1.26) 
35-36 weeks Ref 
 
Ref Ref 
 
Ref 
 
Ref 
 
Ref 
 
Ref 
 
SD Birthweight 0.96 
(0.89, 1.04) 
0.95 
(0.87, 1.04 
0.88 
(0.78, 1.00) 
1.02 
(0.91, 1.14) 
0.91* 
(0.83, 1.00) 
0.98 
(0.85, 1.13) 
0.91 
(0.80, 1.04) 
IUGR (<10th centile 
for SD birthweight) 
 
 
     
Yes 1.20 
(0.91, 1.60) 
1.15 
(0.85, 1.56 
1.47 
(0.95, 2.26) 
0.94 
(0.61, 1.42) 
1.05 
(0.75, 1.48) 
0.65 
(0.52, 1.49) 
1.13 
(0.70, 1.84) 
No Ref 
 
Ref Ref 
 
Ref 
 
Ref 
 
Ref 
 
Ref 
 
Gender        
Male 1.19 
(1.00, 1.43) 
1.19 
(0.98, 1.46) 
1.28 
(0.95, 1.74) 
1.15 
(0.88, 1.51) 
1.14 
(0.92, 1.43) 
1.62* 
(1.15, 2.27) 
1.41* 
(1.01, 1.96) 
Female Ref 
 
Ref Ref 
 
Ref 
 
Ref 
 
Ref 
 
Ref 
 
Maternal smoking -
pregnancy 
 
 
     
Yes 1.08 
(0.83, 1.30) 
1.14 
(0.86, 1.49) 
1.26 
(0.85, 1.87) 
1.06 
(0.72, 1.60) 
1.00 
(0.74, 1.37) 
1.03 
(0.67, 1.63) 
1.10 
(0.71, 1.69) 
No Ref Ref Ref Ref Ref Ref Ref 
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Maternal smoking-
current 
 
 
     
Yes 1.34* 
(1.07, 1.69) 
1.40* 
(1.10, 1.79) 
1.27 
(0.89, 1.82) 
1.58 
(1.13, 2.21) 
1.25 
(0.95, 1.63) 
1.37 
(0.94, 2.01) 
1.25 
(0.85, 1.84) 
No Ref 
 
Ref Ref 
 
Ref 
 
Ref 
 
Ref 
 
Ref 
 
Family history of 
asthma/atopy 
 
 
     
Yes 2.01** 
(1.63, 2.47) 
2.44** 
1.97, 3.02) 
2.77** 
(2.00, 3.84 
2.12** 
(1.59, 2.81) 
2.01 
(0.60, 2.54) 
1.84** 
(1.32, 2.57) 
2.10 
(1.48, 2.99) 
No Ref 
 
Ref Ref 
 
Ref 
 
Ref 
 
Ref 
 
Ref 
 
Delivery by 
caesarean section 
 
 
     
Yes 1.03 
(0.81, 1.31) 
1.01 
(0.78, 1.32) 
1.03 
(0.68, 1.57) 
0.96 
(0.68, 1.37) 
1.05 
(0.79, 1.41) 
0.94 
(0.62, 1.43) 
0.98 
(0.63, 1.51) 
No 
 
Ref Ref Ref 
 
Ref 
 
Ref 
 
Ref 
 
Ref 
 
Breastfeeding        
Yes 1.24* 
(1.04, 1.49) 
1.27 
(1.04, 1.54) 
1.19 
(0.88, 1.60) 
1.40* 
(1.07, 1.83) 
1.30* 
(1.04, 1.62) 
1.36 
(0.98, 1.89) 
0.90 
(0.65, 1.24) 
No Ref Ref Ref 
 
Ref 
 
Ref 
 
Ref 
 
Ref 
 
Ethnicity        
Non-white 0.72 
(0.46, 1.15) 
0.66 
(0.38, 1.13) 
1.40 
(0.63, 3.15) 
0.36* 
(0.17, 0.79) 
0.66 
(0.35, 1.23) 
0.88 
(0.38, 2.07) 
0.66 
(0.23, 1.92) 
White 
 
Ref Ref Ref 
 
Ref 
 
Ref 
 
Ref 
 
Ref 
 
WIMD quintile        
1-lowest 1.52* 
(1.11, 2.07) 
1.52* 
(1.08, 2.14) 
1.48 
(0.89, 2.45) 
1.51 
(0.95, 2.40) 
1.27 
(0.87, 1.84) 
1.83* 
(1.04, 3.22) 
0.78 
(0.45, 1.35) 
2 1.10 1.25 1.36 1.14 0.96 1.35 1.08 
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(0.82, 1.47) (0.90, 1.72) (0.85, 2.19) (0.73, 1.78) (0.67, 1.68) (0.77, 2.36) (0.67, 1.74) 
3 1.27 
(0.96, 1.70) 
1.08 
(0.78, 1.49) 
1.00 
(0.61, 1.67) 
1.06 
(0.69, 1.63) 
1.12 
(0.79, 1.59) 
1.57 
(0.91, 2.69) 
0.67 
(0.40, 1.14) 
4 1.07 
(0.79, 1.44) 
1.15 
(0.82, 1.60) 
1.29 
(0.80, 2.09) 
1.03 
(0.65, 1.64) 
1.11 
(0.77, 1.59) 
0.97 
(0.53, 1.78) 
0.86 
(0.52, 1.42) 
5-highest Ref 
 
Ref Ref 
 
Ref 
 
Ref 
 
Ref 
 
Ref 
 
Age <5/≥5 years        
>5 0.56** 
(0.50, 0.68) 
0.69** 
(0.56, 0.84) 
- - 0.65** 
(0.52, 0.81) 
0.23** 
(0.15, 0.34) 
- 
≤5 Ref 
 
Ref - 
 
- Ref 
 
Ref 
 
- 
 
*p<0.05; **p<0.001; §children >5 years of age only; †children ≤5 years of age only 
SD= standard deviation IUGR= intrauterine growth restriction WIMD=Wales index of multiple deprivation 
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Table 2-4 Association between 1st trimester to birthweight growth trajectory and respiratory symptoms in preterm-born children. Data are Odds ratios 
(95% confidence intervals) 
1st Trimester CRL to birthweight Wheeze-ever 
Recent 
Wheeze 
Wheeze last 
12 months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
All 
measurements 
N=615 
Deceleration 
N= 306 
1.27 
(0.87, 1.86) 
1.01 
(0.67, 1.54) 
- - 
0.70 
(0.45, 1.11) 
0.75 
(0.37, 1.49) 
- 
Acceleration 
N=142 
1.82* 
(1.16, 2.86) 
1.35 
(0.83, 2.18) 
- - 
1.29 
(0.78, 2.14) 
1.29 
(0.61, 2.71) 
- 
No change  
N=167 
Ref Ref - - Ref Ref - 
All 
measurements 
N=615 
(adjusted)†† 
Deceleration 
N= 306 
1.32 
(0.89, 1.94) 
1.00 
(0.65, 1.54) 
- - 
0.71 
(0.45, 1.13) 
0.80 
(0.39, 1.64) 
- 
Acceleration 
N=142 
2.21* 
(1.25, 2.32) 
1.42 
(0.86, 2.34) 
- - 
1.35 
(0.81, 2.26) 
1.70 
(0.78, 3.70) 
- 
No change  
N=167 
Ref Ref - - Ref Ref - 
Under 5 
N=347 
Deceleration 
N=176 
1.45 
(0.89, 2.38) 
- - 
0.95 
(0.56, 1.61) 
0.67 
(0.38, 1.18) 
0.87 
(0.41, 1.83) 
- 
Acceleration 
N=70 
2.58* 
(1.35, 4.90) 
- 
- 1.60 
(0.85, 3.02) 
1.28 
(0.66, 2.47) 
1.54 
(0.67, 3.57) 
- 
No change  
N=101 
Ref - - Ref Ref Ref - 
Under 5 
N=347 
(adjusted)†† 
Deceleration 
N=176 
1.53 
(0.92, 2.53) 
- - 
0.95 
(0.55, 1.64) 
0.67 
(0.37, 1.21) 
0.92 
(0.43, 1.96) 
- 
Acceleration 
N=70 
2.80* 
(1.45, 5.46) 
- 
- 1.72 
(0.89, 3.32) 
1.39 
(0.70, 2.77) 
1.68 
(0.71, 3.98) 
- 
No change  
N=101 
Ref - - Ref Ref Ref - 
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Over 5 
N=268 
Deceleration 
N=130 
1.09 
(0.60, 2.00) 
- 
1.15 
(0.58, 2.28) 
- 
0.79 
(0.37, 1.69) 
0.25 
(0.02, 2.79) 
1.35 
(0.64, 2.85) 
Acceleration 
N=72 
1.50 
(0.74, 2.86) 
- 
1.20 
(0.56, 2.58) 
- 
1.46 
(0.66, 3.26) 
1.39 
(0.23, 8.60) 
1.85 
(0.83, 4.15) 
No change  
N=66 
Ref - Ref - Ref Ref Ref 
Over 5 
N=268 
(adjusted) ‡ 
Deceleration 
N=130 
1.06 
(0.57, 1.97) 
- 
1.08 
(0.54, 2.20) 
- 
0.74 
(0.34, 1.61) 
0.25 
(0.02, 2.88) 
1.25 
(0.58, 2.67) 
Acceleration 
N=72 
1.35 
(0.68, 2.71) 
- 
1.09 
(0.49, 2.40) 
- 
1.34 
(0.59, 3.03) 
1.26 
(0.19, 8.27) 
1.66 
(0.73, 3.78) 
No change  
N=66 
Ref - Ref - Ref Ref Ref 
*p<0.05 
†adjusted for gestational age, gender, current maternal smoking, family history of atopy, breastfeeding, WIMD and child ≤5 or >5 years of age 
‡adjusted for gestational age, gender, current maternal smoking, family history of atopy, breastfeeding and WIMD 
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First trimester CRL to second trimester HC growth deceleration was associated with 
increased odds of wheeze-ever (OR 1.43; 95% CI 0.92, 2.22), inhaler use (OR 1.47; 95% CI 
0.88, 2.45), and hospital admission (OR 2.79; 95% CI 1.18, 6.62) but only hospital admission 
reached statistical significance (Table 2-5). In the adjusted model the odds of wheeze-ever 
(OR 1.59; 95%CI 1.01, 2.51), inhaler use (OR 1.60; 95% CI 0.94, 2.70) and hospital admission 
(OR 3.84; 95% CI 1.56, 9.51) all increased, with wheeze-ever and hospital admission, but 
not inhaler use, being statistically significant. There were no associations with 1st Trimester 
CRL to 2nd trimester FL growth (Table 2-6). 
When a change of ±0.67 of z-score was used to define growth trajectory, accelerated 
growth from 2nd Trimester HC to birthweight was associated with increased odds of 
wheeze-ever (OR 1.49; 95% CI 1.09, 2.04). This increased in the adjusted model to an OR of 
1.60 (95%CI 1.15, 2.22). Growth deceleration was also associated with increased odds of 
wheeze-ever, but this was not statistically significant in the adjusted model (OR 1.24; 95% 
CI 0.95, 1.62); these results appeared to be attributable to the <5 years age group where 
both deceleration and acceleration were significant for wheeze-ever (OR 1.55; 95%CI 1.09, 
2.21 and OR 2.00; 95%CI 1.27, 3.15 respectively in the adjusted model).  
In the ≥5 years age group, growth deceleration was significantly associated with decreased 
odds of doctor-diagnosed asthma (OR 0.59; 95% CI 0.35, 0.97). However, this was in the 
absence of association with any other outcome and was not statistically significant in the 
adjusted model. The odds of hospital admission also appeared to be associated with 
growth acceleration (OR 4.22 95% CI 1.02, 17.52), but the wide range of the upper 
confidence interval suggests this finding may be spurious (Table 2-7). Both growth 
deceleration (OR 1.38; 95% CI 0.97, 1.95) and acceleration (OR 1.37; 95% CI 0.88, 2.12) 
between 2nd Trimester FL and birthweight tended to be associated with wheeze-ever but 
were not statistically significant (Table 2-8).
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Table 2-5 Association between 1st trimester (CRL) to 2nd Trimester (HC) growth trajectory and respiratory symptoms in preterm-born children. Data are 
Odds ratios (95% confidence intervals) 
1st Trimester CRL to 2nd trimester HC Wheeze-ever 
Recent 
Wheeze 
Wheeze last 
12 months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
All 
measurements 
N= 527 
Deceleration 
N= 151 
1.43 
(0.92, 2.22) 
1.22 
(0.76, 1.95) 
- - 
1.47 
(0.88, 2.45) 
2.79* 
(1.18, 6.62) 
- 
Acceleration 
N= 203 
1.14 
(0.76, 1.72) 
1.04 
(0.66, 1.62) 
- - 
1.05 
(0.64, 1.73) 
2.38* 
(1.03, 5.52) 
- 
No change  
N= 173 
Ref Ref - - Ref Ref - 
All 
measurements 
N= 527 
(adjusted)† 
Deceleration 
N= 151 
1.59* 
(1.01, 2.51) 
1.29 
(0.79, 2.11) 
- - 
1.60 
(0.94, 2.70) 
3.84* 
(1.56, 9.51) 
- 
Acceleration 
N= 203 
1.07 
(0.70, 1.62) 
0.94 
(0.59, 1.50) 
- - 
1.00 
(0.60, 1.66) 
2.57* 
(1.08, 6.09) 
- 
No change  
N= 173 
Ref Ref - - Ref Ref - 
Under 5 
N= 327 
Deceleration 
N=85 
1.46 
(0.52, 2.60) 
- - 
1.43 
(0.78, 2.60) 
1.52 
(0.80, 2.89) 
2.53* 
(1.01, 6.37) 
- 
Acceleration 
N=131 
1.11 
(0.67, 1.84) 
- 
- 1.04 
(0.60, 1.80) 
1.10 
(0.58, 1.94) 
2.32 
(0.98, 5.50) 
- 
No change  
N=111 
Ref - - Ref Ref Ref - 
Under 5 
N= 327 
(adjusted) ‡ 
Deceleration 
N=85 
1.61 
(0.88, 2.93) 
- - 
1.53 
(0.82, 2.85) 
1.65 
(0.84, 3.23) 
2.97* 
(1.15, 7.71) 
- 
Acceleration 
N=131 
1.09 
(0.64, 1.83) 
- 
- 1.01 
(0.57, 1.78) 
1.04 
(0.57, 1.98) 
2.51* 
(1.04, 6.06) 
- 
No change  
N=111 
Ref - - Ref Ref Ref - 
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Over 5 
N= 200 
Deceleration 
N=66 
1.60 
(0.79, 3.23) 
- 
1.00 
(0.45, 2.20) 
- 
1.48 
(0.63, 3.51) 
Not computed 
 
1.87 
(0.81, 4.35) 
Acceleration 
N=72 
1.21 
(0.60, 2.43) 
- 
1.03 
(0.48, 2.23 
- 
1.02 
(0.42, 2.48) 
Not computed 1.12 
(0.47, 2.68) 
No change  
N=62 
Ref - Ref - Ref Ref Ref 
Over 5 
N= 200 
(adjusted) ‡ 
Deceleration 
N=66 
1.65 
(0.80, 3.40) 
- 
0.91 
(0.40, 2.11) 
- 
1.46 
(0.61, 3.53) 
Not computed 
 
1.82 
(0.77, 4.34) 
Acceleration 
N=72 
1.10 
(0.53, 2.27) 
- 
0.82 
(0.36, 1.90) 
- 
0.85 
(0.34, 2.13) 
Not computed 0.95 
(0.38, 2.38) 
No change  
N=62 
Ref - Ref - Ref Ref Ref 
*p<0.05 
†adjusted for gestational age, gender, current maternal smoking, family history of atopy, breastfeeding, WIMD and child ≤5 or >5 years of age 
‡adjusted for gestational age, gender, current maternal smoking, family history of atopy, breastfeeding and WIMD 
 
 
 
  
73 | P a g e  
 
Table 2-6 Association between 1st trimester (CRL) to 2nd trimester (FL) growth trajectory and respiratory symptoms in preterm-born children. Data are 
Odds ratios (95% confidence intervals) 
1st Trimester CRL to 2nd trimester FL Wheeze-ever 
Recent 
Wheeze 
Wheeze last 
12 months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
All 
measurements 
N= 582 
Deceleration 
N= 154 
1.10 
(0.72, 1.67) 
0.88 
(0.56, 1.39) 
- - 
0.76 
(0.47, 1.25) 
1.18 
(0.56, 2.50) 
- 
Acceleration 
N= 223 
1.27 
(0.87, 1.86) 
1.01 
(0.67, 1.52) 
- - 
0.79 
(0.51, 1.23) 
1.23 
(0.62, 2.42) 
- 
No change  
N= 205 
Ref Ref - - Ref Ref - 
All 
measurements 
N= 582 
(adjusted)† 
Deceleration 
N= 154 
1.24 
(0.80, 1.82) 
0.97 
(0.60, 1.55) 
- - 
0.83 
(0.50, 1.39) 
1.74 
(0.78, 3.88) 
- 
Acceleration 
N= 223 
1.34 
(0.91, 1.98) 
1.06 
(0.70, 1.61) 
- - 
0.82 
(0.52, 1.29) 
1.39 
(0.69, 2.81) 
- 
No change  
N= 205 
Ref Ref - - Ref Ref - 
Under 5 
N= 334 
Deceleration 
N=76 
1.27 
(0.71, 2.26) 
- - 
1.13 
(0.62, 2.05) 
0.83 
(0.43, 1.59) 
1.28 
(0.55, 2.94) 
- 
Acceleration 
N=130 
1.06 
(0.65, 1.73) 
- 
- 0.91 
(0.54, 1.54) 
0.87 
(0.50, 1.51) 
1.29 
(0.62, 2.67) 
- 
No change  
N=128 
Ref - - Ref Ref Ref - 
Under 5 
N= 334 
(adjusted) ‡ 
Deceleration 
N=76 
1.37 
(0.75, 2.50) 
- - 
1.24 
(0.66, 2.32) 
1.01 
(0.50, 2.01) 
1.56 
(0.64, 3.76) 
- 
Acceleration 
N=130 
1.11 
(0.67, 1.84) 
- 
- 0.99 
(0.58, 1.70) 
0.95 
(0.54, 1.70) 
1.40 
(0.67, 2.94) 
- 
No change  
N=128 
Ref - - Ref Ref Ref - 
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Over 5 
N=248 
Deceleration 
N=78 
1.15 
(0.60, 2.20) 
- 
0.70 
(0.34, 1.45) 
- 
0.73 
(0.34, 1.56) 
3.04 
(0.31, 30) 
0.98 
(0.47, 2.07) 
Acceleration 
N=93 
1.77 
(0.96, 3.27) 
- 
1.19 
(0.62, 2.30) 
- 
0.68 
(0.33, 1.43) 
1.67 
(0.15, 18.8) 
1.21 
(0.60, 2.42) 
No change  
N=77 
Ref - Ref - Ref Ref Ref 
Over 5 
N=248 
(adjusted) ‡ 
Deceleration 
N=78 
1.13 
(0.58, 2.19) 
- 
0.71 
(0.34, 1.52) 
- 
0.73 
(0.33, 1.60) 
3.57 
(0.35, 37.0) 
0.98 
(0.46, 2.10) 
Acceleration 
N=93 
1.76 
(0.94, 2.30) 
- 
1.20 
(0.61, 2.36) 
- 
0.67 
(0.32, 1.42) 
1.74 
(0.15, 20.2) 
1.21 
(0.59, 2.47) 
No change  
N=77 
Ref - Ref - Ref Ref Ref 
*p<0.05 
†adjusted for gestational age, gender, current maternal smoking, family history of atopy, breastfeeding, WIMD and child ≤5 or >5 years of age 
‡adjusted for gestational age, gender, current maternal smoking, family history of atopy, breastfeeding and WIMD 
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Table 2-7 Association between 2nd trimester (HC) to birthweight growth trajectory and respiratory symptoms in preterm-born children. Data are Odds 
ratios (95% confidence intervals) 
2nd Trimester HC to birthweight Wheeze-ever 
Recent 
Wheeze 
Wheeze last 
12 months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
All 
measurements 
N=1196 
Deceleration 
N=486 
1.12 
(0.87, 1.45) 
0.89 
(0.68, 1.18) 
- - 
0.88 
(0.65. 1.19) 
0.85  
(0.55, 1.33) 
- 
Acceleration 
N=238 
1.49* 
(1.09, 2.04) 
1.30 
(0.94, 1.80) 
- - 
1.15 
(0.80, 1.64) 
1.27 
(0.77, 2.09) 
- 
No change  
N=472 
Ref Ref - - Ref Ref - 
All 
measurements 
N=1196 
(adjusted)† 
Deceleration 
N=486 
1.24 
(0.95, 1.62) 
0.94 
(0.74, 1.26) 
- - 
0.95 
(0.70, 1.31) 
0.92 
(0.58, 1.46) 
- 
Acceleration 
N=238 
1.60* 
(1.15, 2.22) 
1.39 
(0.99, 1.96) 
- - 
1.22 
(0.84, 1.77) 
1.39 
(0.23, 2.34) 
- 
No change  
N=472 
Ref Ref - - Ref Ref - 
Under 5 
N=682 
Deceleration 
N=282 
1.41* 
(1.01, 1.98) 
- - 
1.03 
(0.73, 1.48) 
1.02 
(0.69, 1.50) 
0.72 
(0.44, 1.17) 
- 
Acceleration 
N =130 
1.99* 
(1.28, 3.09) 
- 
- 1.42 
(0.92, 2.19) 
1.27  
(0.80, 2.03) 
1.11 
(0.63, 1.94) 
- 
No change  
N=270 
Ref - - Ref Ref Ref - 
Under 5 
N=682 
(adjusted) ‡ 
Deceleration 
N=282 
1.55* 
(1.09, 2.21) 
- - 
1.07 
(0.74, 1.55) 
1.12 
(0.75, 1.66) 
0.79 
(0.48, 1.30) 
- 
Acceleration 
N =130 
2.00* 
(1.27, 3.15) 
- 
- 1.43 
(0.92, 2.24) 
1.35 
(0.84, 2.17) 
1.16 
(0.65, 2.06) 
- 
No change  
N=270 
Ref - - Ref Ref Ref - 
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Over 5 
N=514 
Deceleration 
N=204 
0.82 
(0.55, 1.22) 
- 
0.70 
(0.45, 1.10) 
- 
0.66 
(0.40, 1.10) 
2.36 
(0.60, 9.25) 
0.59* 
(0.35, 0.97) 
Acceleration 
N=108 
1.11 
(0.70, 1.77) 
- 
1.17 
(0.70, 1.94) 
- 
1.00 
(0.57, 1.77) 
3.90 
(0.96, 15.9) 
1.19 
(0.69, 2.04) 
No change  
N=202 
Ref - Ref - Ref Ref Ref 
Over 5 
N=514 
(adjusted) ‡ 
Deceleration 
N=204 
0.92 
(0.61, 1.39) 
- 
0.78 
(0.48, 1.25) 
- 
0.75 
(0.44, 1.28) 
2.51 
(0.63, 9.97) 
0.63 
(0.37, 1.06) 
Acceleration 
N=108 
1.17 
(0.72, 1.91) 
- 
1.31 
(0.76, 2.25) 
- 
1.04 
(0.57, 1.90) 
4.22* 
(1.02, 17.51) 
1.28 
(0.73, 2.25) 
No change  
N=202 
Ref - Ref - Ref Ref Ref 
*p<0.05 
†adjusted for gestational age, gender, current maternal smoking, family history of atopy, breastfeeding, WIMD and child ≤5 or >5 years of age 
‡adjusted for gestational age, gender, current maternal smoking, family history of atopy, breastfeeding and WIMD 
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Table 2-8 Association between 2nd trimester (FL) to birthweight growth trajectory and respiratory symptoms in preterm-born children. Data are Odds 
ratios (95% confidence intervals) 
2nd Trimester FL to birthweight Wheeze-ever 
Recent 
Wheeze 
Wheeze last 
12 months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
All 
measurements 
N=1326 
Deceleration 
N=594 
0.97  
(0.77, 1.24) 
0.83 
(0.64, 1.08) 
- - 
0.78  
(0.58, 1.03) 
1.00 
(0.66, 1.53) 
- 
Acceleration 
N=228 
1.17  
(0.86, 1.61) 
1.28 
(0.92, 1.77) 
- - 
1.28 
(0.90, 1.81) 
1.46 
(0.89, 2.42) 
- 
No change  
N=504 
Ref Ref - - Ref Ref - 
All 
measurements 
N=1326 
(adjusted)† 
Deceleration 
N=594 
1.06 
(0.82, 1.35) 
0.86 
(0.66, 1.13) 
- - 
0.83 
(0.62, 1.11) 
1.17 
(0.76, 1.81) 
 
Acceleration 
N=228 
1.17 
(0.84, 1.61) 
1.32 
(0.94, 1.84) 
- - 
1.30 
(0.91, 1.87) 
1.46 
(0.87, 2.44) 
 
No change  
N=504 
Ref Ref - - Ref Ref - 
Under 5 
N=689 
Deceleration 
N=286 
1.25 
(0.89, 1.75) 
- - 
1.02 
(0.72, 1.44) 
0.86  
(0.59, 1.26) 
0.95 
(0.59, 1.54) 
- 
Acceleration 
N=129 
1.35 
(0.88, 2.08) 
- 
- 1.34 
(0.87, 2.06) 
1.17 
(0.74, 1.86) 
1.31 
(0.74, 2.30) 
- 
No change  
N=274 
Ref - - Ref Ref Ref - 
Under 5 
N=689 
(adjusted) ‡ 
Deceleration 
N=286 
1.38 
(0.97, 1.95) 
- - 
1.08 
(0.75, 1.56) 
0.94 
(0.64, 1.40) 
1.04 
(0.64, 1.69) 
- 
Acceleration 
N=129 
1.37 
(0.88, 2.12) 
- 
- 1.41 
(0.90, 2.19) 
1.24 
(0.78, 1.99) 
1.34 
(0.76, 2.38) 
- 
No change  
N=274 
Ref - - Ref Ref Ref - 
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Over 5 
N=637 
Deceleration 
N=308 
0.80 
(0.57, 1.13) 
- 
0.69 
(0.47, 1.01) 
- 
0.71 
(0.46, 1.10) 
1.98 
(0.70, 5.64) 
0.67 
(0.45, 1.10) 
Acceleration 
N=99 
0.97 
(0.61, 1.55) 
- 
1.20 
(0.72, 1.97) 
- 
1.42 
(0.83, 2.43) 
2.39 
(0.68, 8.46) 
1.06 
(0.63, 1.81) 
No change  
N=230 
Ref - Ref - Ref Ref Ref 
Over 5 
N=637 
(adjusted)‡ 
Deceleration 
N=308 
0.81 
(0.57, 1.16) 
- 
0.64* 
(0.45, 0.99) 
- 
0.67 
(0.43, 1.05) 
0.70 
(0.45, 1.10) 
0.63 
(0.37, 1.06) 
Acceleration 
N=99 
0.92 
(0.59, 1.56) 
- 
1.21 
(0.72, 2.04) 
- 
1.34 
(0.77, 2.34) 
1.41 
(0.81, 2.45) 
1.28 
(0.73, 2.25) 
No change  
N=230 
Ref - Ref - Ref Ref Ref 
*p<0.05 
†adjusted for gestational age, gender, current maternal smoking, family history of atopy, breastfeeding, WIMD and child ≤5 or >5 years of age 
‡adjusted for gestational age, gender, current maternal smoking, family history of atopy, breastfeeding and WIMD 
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 Outcomes in term-born children 
In common with the results from the preterm-born group, there were no associations 
between foetal size variables and childhood respiratory outcomes in term-born children 
(Table 2-9). Results of the univariate modelling to identify potential confounders are shown 
in Table 2-10. Gestational age, gender, family history of asthma/atopy and delivery by 
caesarean section were significant independent variables and were thus included in the 
adjusted model.  
When a change of ±0.67SD of z-score was used to define growth trajectory between 1st 
trimester CRL and BW, growth acceleration was significantly associated with increased 
inhaler usage (OR 2.13; 95% CI 1.02, 4.70) but not with wheeze-ever or recent wheeze. In 
the <5 years age group, acceleration was significantly associated with wheeze in the last 3 
months (OR 2.38; 95% CI 1.06, 5.36), whereas deceleration was associated with inhaler use 
only (OR 2.51; 95% CI 1.03, 6.14). These results were not robust to the inclusion of 
covariates in the adjusted model as the effect size was attenuated and was no longer 
statistically significant. In the ≥5 years group, deceleration was negatively associated with 
wheeze-ever (OR 0.48 95%CI 0.24, 0.94), however this was not significant in the adjusted 
model (Table 2-11). 
First trimester CRL to 2nd trimester HC growth did not appear to be associated with any 
respiratory outcome (Table 2-12). On the other hand, 1st Trimester CRL to 2nd trimester FL 
growth deceleration was associated with increased odds ratios for wheeze-ever (OR 2.56; 
95%CI 1.23, 5.33) and inhaler use (OR 4.89; 95% CI 1.48, 16.1) in the ≥5 age group. This was 
supported by a (non-significant) association of growth deceleration with wheeze in the last 
12 months (OR 2.23, 95%CI 0.90, 5.51) (Table 2-13). 
Regarding 2nd to 3rd trimester growth change (HC to BW), there were no consistent 
associations aside from decreased odds of inhaler use for growth deceleration in the over 5 
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age group (OR 0.50; 95% CI 0.27, 0.95) (Table 2-14). Similarly, there were no associations 
when FL was used as the measure of 2nd trimester growth (Table 2-15).  
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Table 2-9 Association between foetal size variables and respiratory outcomes in term-born childhood. Data are Odds ratios (95% confidence intervals) 
Size variables 
 
Wheeze-ever Wheeze last 12 
months 
Wheeze last 3 
months 
Inhaler use Hospital admission Doctor-diagnosed 
asthma 
All        
Crown-rump 
length 
N= 509 
0.99 
(0.88, 1.12) 
- - 
1.04 
(0.88, 1.23) 
1.10 
(0.83, 1.44) 
- 
Head 
circumference 
N= 1007 
1.07 
(0.95, 1.21) 
- - 
0.94 
(0.80, 1.13) 
1.07 
(0.79, 1.45) 
- 
Femur  
length 
N= 1118 
1.00 
(0.88, 1.13) 
- - 
0.92 
(0.77, 1.09) 
0.91 
(0.67, 1.22) 
- 
Under 5        
Crown-rump 
length 
N= 271 
0.98 
(0.83, 1.16) 
- 
 1.03 
(0.82, 1.29) 
1.18 
(0.86, 1.60) 
- 
Head 
circumference 
N= 561 
1.05 
(0.89, 1.24) 
- 
0.99 
(0.80, 1.21) 
0.86 
(0.67, 1.10) 
1.12 
(0.78, 1.90) 
- 
Femur  
length 
N=565 
0.94 
(0.79, 1.12) 
- 
0.93 
(0.74, 1.15) 
0.79 
(0.61, 1.03) 
0.85 
(0.59, 1.25) 
- 
Over 5        
Crown-rump 
length 
N= 238 
1.02 
(0.86, 1.22) 
0.99 
(0.80, 1.22) 
- 
1.07 
(0.84, 1.36) 
0.89 
(0.43, 1.84) 
0.96 
(0.77, 1.19) 
Head 
circumference 
N= 446 
1.08 
(0.90, 1.31) 
1.17 
(0.93, 1.46) 
- 
1.05 
(0.80, 1.37) 
0.88 
(0.48, 1.60) 
1.01 
(0.80, 1.27) 
Femur  
length 
N= 553 
1.02 
(0.85, 1.21) 
1.07 
(0.87, 1.32) 
- 
1.03 
(0.81, 1.32) 
0.90 
(0.52, 1.55) 
1.00 
(0.80, 1.24) 
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Table 2-10 Univariate associations between potential confounders of the association between foetal growth trajectory and respiratory outcomes in 
term-born children. 
 
Wheeze-ever 
Recent 
wheeze 
Wheeze last 
12 months§ 
Wheeze last 
3 months† Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma§ 
Gestational age 0.85 * 
(0.78, 0.93) 
0.89* 
(0.77, 0.96) 
0.82* 
(0.70, 0.96) 
0.89 
(0.78, 1.04) 
0.83* 
(0.73, 0.94) 
0.92 
(0.74, 1.15) 
0.82* 
(0.69, 0.97) 
SD Birthweight 0.99 
(0.89, 1.12) 
1.00 
(0.87, 1.16) 
0.60 
(0.69, 1.07) 
1.16 
(0.94, 1.42) 
0.94 
(0.79, 1.12) 
0.77 
(0.57, 1.06) 
0.88 
(0.70, 1.11) 
IUGR (<10th centile 
for SD BW) 
 
 
     
Yes 1.29 
(0.80, 2.09) 
1.72* 
(1.01, 2.93) 
3.17* 
(1.54, 6.55) 
0.89 
(0.38, 2.07) 
1.69 
(0.92, 3.11) 
1.93 
(0.74, 5.03) 
2.24* 
(1.12, 5.24) 
No Re Ref Re Ref Ref Re Re 
Gender        
Male 1.39* 
(1.10, 1.76) 
1.38* 
(1.03, 1.85) 
1.59* 
(1.04, 2.43) 
1.24 
(0.80, 1.81) 
1.36 
(0.96, 1.91) 
1.63 
(0.88, 3.00) 
1.61* 
(1.03, 2.52) 
Female Ref Ref Ref Ref Ref Ref Ref 
Maternal smoking -
pregnancy 
 
 
     
Yes 1.37 
(0.98, 1.91) 
1.67* 
(1.14, 2.45) 
1.34 
(0.77, 2.33) 
2.11* 
(1.24, 3.59) 
1.74* 
(1.13, 2.68) 
1.33 
(0.61, 2.88) 
1.24 
(0.69, 2.23) 
No Ref Ref Ref Ref Ref Ref Ref 
Maternal smoking-
current 
 
 
     
Yes 1.31 
(0.95, 1.79) 
1.60 
(1.09,  
1.16 
(0.67, 2.01) 
2.07* 
(1.26, 3.41) 
1.18 
(0.75, 1.84) 
0.95 
(0.42, 2.12) 
0.81 
(0.43, 1.52) 
No Ref Ref Ref Ref Ref Ref Ref 
Family history of 
asthma/atopy 
 
 
     
Yes 2.29** 
(1.78, 2.96) 
2.41** 
(1.79, 3.25) 
3.47** 
(2.25, 5.33) 
1.70* 
(1.12, 2.59) 
2.42** 
(1.71, 3.41) 
1.72 
(0.95, 3.14) 
3.51** 
(2.24, 5.50) 
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No Ref Ref Ref Ref Ref Ref Ref 
Delivery by 
Caesarean section 
 
 
     
Yes 1.54* 
(1.11, 2.13) 
1.27 
(0.86, 1.88) 
1.87* 
(1.06, 2.28) 
0.89 
(0.52, 1.54) 
1.48 
(0.96, 2.26) 
1.58 
(0.73, 3.43) 
1.98* 
(1.09, 3.59) 
No Ref Ref Ref Ref Ref Ref Ref 
Breastfeeding        
Yes 1.10 
(0.87, 1.40) 
0.98 
(0.73, 1.30) 
0.76 
(0.50, 1.15) 
1.26 
(0.85, 1.89) 
1.15 
(0.82, 1.61) 
1.69 
(0.94, 3.02) 
1.15 
(0.75, 1.77) 
No Ref Ref Ref Ref Ref Ref Ref 
Ethnicity        
Non-white 1.27 
(0.72, 2.24) 
1.82 
(0.98, 3.38) 
3.10* 
(1.37, 7.04) 
0.97 
(0.36, 2.63) 
0.55 
(0.20, 1.54) 
2.73* 
(1.03, 7.22) 
1.00 
(0.34, 2.97) 
White Ref Ref Ref Ref Ref Ref Ref 
WIMD quintile        
1 1.09 
(0.72, 1.63) 
1.18 
(0.70, 1.97) 
0.84 
(0.39, 1.82) 
1.51 
(0.73, 3.12) 
1.01 
(0.57, 1.79) 
0.77 
(0.34, 1.74) 
0.77 
(0.34, 1.74) 
2 1.16 
(0.79, 1.69) 
1.31 
(0.82, 2.11) 
1.30 
(0.67, 2.53) 
1.32 
(0.67, 2.63) 
0.92 
(0.54, 1.57) 
1.64 
(0.84, 3.21) 
1.64 
(0.84, 3.21) 
3 1.18 
(0.82, 1.69) 
1.63 
(1.04, 2.54) 
1.59 
(0.88, 2.88) 
1.67 
(0.85, 3.27) 
1.14 
(0.70, 1.88) 
1.48 
(0.80, 2.77) 
1.48 
(0.80, 2.77) 
4 0.83 
(0.57, 1.21) 
0.83 
(0.51, 1.34) 
0.44 
(0.40, 1.49) 
0.89 
(0.43, 1.84) 
0.66 
(0.38, 1.14) 
0.58 
(0.78, 1.21) 
0.58 
(0.28, 1.21) 
5 Ref Ref Ref Ref Ref Ref Ref 
Age <5/≥ 5 years        
>5 0.56** 
(0.44, 0.70) 
0.87 
(0.65, 1.16) 
- - 0.88 
(0.63, 1.23) 
0.38 
(0.20, 0.72) 
- 
<5 Ref Ref - - Ref Ref - 
*p<0.05; **p<0.001; §children > 5 years of age only; †children ≤5 years of age only 
SD= standard deviation IUGR=intrauterine growth restriction WIMD=Welsh index of multiple deprivation 
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Table 2-11 Association between 1st trimester to birthweight growth trajectory and respiratory symptoms in term-born children. Data are Odds ratios 
(95% confidence intervals) 
1st Trimester CRL to birthweight Wheeze-ever 
Recent 
Wheeze 
Wheeze last 
12 months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
All 
measurements 
N=509 
Deceleration 
N= 240 
0.79 
(0.52, 1.22) 
1.35 
(0.78, 2.35) 
- - 
1.70 
(0.87, 3.32) 
1.46 
(0.45, 4.74) 
- 
Acceleration 
N=131 
0.80 
(0.49, 1.31) 
1.70 
(0.93) 
- - 
2.05 
(0.99, 4.24) 
2.47 
(0.74, 8.23) 
- 
No change  
N=138 
Ref Ref - - Ref Ref - 
All 
measurements 
N=509 
(adjusted)† 
Deceleration 
N= 240 
0.87 
(0.56, 1.35) 
1.15 
(0.61, 2.16) 
- - 
1.85 
(0.94, 3.66) 
1.56 
(0.47, 5.18) 
- 
Acceleration 
N=131 
0.86 
(0.52, 1.43) 
1.36 
(0.67, 2.78) 
- - 
2.13* 
(1.02, 4.70) 
2.74 
(0.80, 9.43) 
- 
No change  
N=138 
Ref Ref - - Ref Ref - 
Under 5 
N=271 
Deceleration 
N=125 
1.21 
(0.69, 2.12) 
- - 
1.90 
(0.91, 4.0) 
2.51* 
(1.03, 6.14) 
2.26 
(0.60, 8.48) 
- 
Acceleration 
N=65 
0.96 
(0.50, 1.85) 
- - 
2.38* 
(1.06, 5.36) 
2.39 
(0.88, 6.48) 
3.14 
(0.78, 12.7) 
- 
No change  
N=81 
Ref - - Ref Ref Ref - 
Under 5 
N=271 
(adjusted) ‡ 
Deceleration 
N=125 
1.18 
(0.67, 2.10) 
- - 
1.96 
(0.93, 4.15) 
2.47 
(1.00, 6.12) 
2.20 
(0.58, 8.40) 
- 
Acceleration 
N=65 
0.89 
(0.45, 1.75) 
- - 
2.26 
(0.99, 5.18) 
2.22 
(0.80, 6.12) 
2.96 
(0.72, 12.2) 
- 
No change  
N=81 
Ref - - Ref Ref Ref - 
85 | P a g e  
 
Over 5 
N=238 
Deceleration 
N=115 
0.48* 
(0.24, 0.94) 
- 
0.87 
(0.37, 2.04) 
- 
0.99 
(0.35, 2.79) 
Not computed 
0.68 
(0.29, 1.57) 
Acceleration 
N=66 
0.69 
(0.33, 1.15) 
- 
1.15 
(0.46, 2.87) 
- 
1.70 
(0.59, 4.93) 
1.75 
(0.16, 19.8) 
0.84 
(0.33, 2.11) 
No change  
N=57 
Ref - Ref - Ref Ref Ref 
Over 5 
N=238 
(adjusted) ‡ 
Deceleration 
N=115 
0.54 
(0.27, 1.09) 
- 
1.03 
(0.42, 2.50) 
- 
1.05 
(0.36, 3.04) 
Not computed 
0.76 
(0.32, 1.81) 
Acceleration 
N=66 
0.75 
(0.35, 1.63) 
- 
1.20 
(0.45, 3.16) 
- 
1.74 
(0.58, 5.23) 
1.54 
(0.13, 18.4) 
0.95 
(0.37, 2.48) 
No change  
N=57 
Ref - Ref - Ref Ref Ref 
*p<0.05 
†Adjusted for gestational age, gender, family history of atopy and delivery by caesarean section, ≤5 or >5 years of age 
‡Adjusted for gestational age, gender, family history of atopy and delivery by caesarean section 
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Table 2-12 Association between 1st trimester to 2nd Trimester (HC) growth trajectory and respiratory symptoms in term-born children. Data are Odds 
ratios (95% confidence intervals) 
1st Trimester CRL to 2nd trimester HC Wheeze-ever 
Recent 
Wheeze 
Wheeze last 
12 months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
All 
measurements 
N= 442 
Deceleration 
N= 116 
0.89 
(0.55, 1.42) 
1.02 
(0.59, 1.77) 
- - 
1.40 
(0.74, 2.63) 
0.51 
(0.14, 1.94) 
- 
Acceleration 
N= 143 
1.03 
(0.66, 1.60) 
0.71 
(0.41, 1.24) 
- - 
0.91 
(0.48, 1.74) 
1.30 
(0.50, 3.36) 
- 
No change  
N= 183 
Ref Ref - - Ref Ref - 
All 
measurements 
N= 442 
(adjusted)† 
Deceleration 
N= 116 
0.84 
(0.51, 1.37) 
0.83 
(0.42, 1.62) 
- - 
1.34 
(0.71, 2.55) 
0.48 
(0.12, 1.87) 
- 
Acceleration 
N= 143 
0.98 
(0.62, 1.55) 
0.57 
(0.30, 1.11) 
- - 
0.87 
(0.45, 1.69) 
1.24 
(0.47, 3.30) 
- 
No change  
N= 183 
Ref Ref - - Ref Ref - 
Under 5 
N= 262 
Deceleration 
N=64 
0.66 
(0.35, 1.23) 
- - 
1.06 
(0.53, 2.14) 
1.26 
(0.56, 2.85) 
0.36 
(0.08, 1.73) 
- 
Acceleration 
N=88 
0.92 
(0.53, 1.61) 
- - 
0.60 
(0.30, 1.21) 
0.86 
(0.39, 1.92) 
0.97 
(0.35, 2.72) 
- 
No change  
N=110 
Ref - - Ref Ref Ref - 
Under 5 
N= 262 
(adjusted) ‡ 
Deceleration 
N=64 
0.54 
(0.28, 1.04) 
- - 
0.94 
(0.46, 1.93) 
1.07 
(0.46, 2.46) 
0.30 
(0.06, 1.51) 
- 
Acceleration 
N=88 
0.88 
(0.49, 1.57) 
- - 
0.59 
(0.29, 1.20) 
0.83 
(0.37, 1.87) 
0.92 
(0.32, 2.66) 
- 
No change  
N=110 
Ref - - Ref Ref Ref - 
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Over 5 
N= 180 
Deceleration 
N=52 
1.45 
(0.69, 3.07) 
- 
1.03 
(0.41, 2.48) 
- 
1.70 
(0.61, 4.75) 
Not computed 
1.53 
(0.62, 3.73) 
Acceleration 
N=55 
1.22 
(0.58, 2.58) 
- 
0.94 
(0.38, 2.30) 
- 
1.00 
(0.32, 3.05) 
Not computed 
1.00 
(0.39, 2.56) 
No change  
N=73 
Ref - Ref - Ref Ref Ref 
Over 5 
N= 180 
(adjusted) ‡ 
Deceleration 
N=52 
1.48 
(0.68, 3.20) 
- 
0.96 
(0.37, 2.49) 
- 
1.67 
(0.59, 4.83) 
Not computed 
1.71 
(0.68, 4.29) 
Acceleration 
N=55 
1.17 
(0.54, 2.51) 
- 
0.81 
(0.32, 2.09) 
- 
0.93 
(0.30, 2.91) 
Not computed 
0.98 
(0.37, 2.56) 
No change  
N=73 
Ref - Ref - Ref Ref Ref 
†Adjusted for gestational age, gender, family history of atopy and delivery by caesarean section, ≤5 or >5 years of age 
‡Adjusted for gestational age, gender, family history of atopy and delivery by caesarean section 
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Table 2-13 Association between 1st trimester to 2nd trimester (FL) growth trajectory and respiratory symptoms in term-born children. Data are Odds 
ratios (95% confidence intervals) 
1st Trimester CRL to 2nd trimester FL 
Wheeze-ever 
Recent 
wheeze 
Wheeze last 
12 months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
All 
measurements 
N= 499 
Deceleration 
N= 136 
1.18 
(0.75, 1.84) 
1.72* 
(1.01, 2.93) 
- - 
1.95* 
(1.04, 3.67) 
0.81 
(0.29, 2.28) 
- 
Acceleration 
N= 178 
0.93 
(0.61, 1.41) 
0.97 
(0.57, 1.67) 
- - 
1.29 
(0.68, 2.42) 
0.72 
(0.27, 1.93) 
- 
No change 
N= 185 
Ref Ref - - Ref Ref - 
All 
measurements 
N= 499 
(adjusted)† 
Deceleration 
N= 136 
1.31 
(0.81, 2.10) 
1.62 
(0.85, 3.09) 
- - 
2.14* 
(1.12, 4.09) 
0.89 
(0.30, 2.60) 
- 
Acceleration 
N= 178 
1.02 
(0.66, 1.59) 
0.93 
(0.49, 1.74) 
- - 
1.41 
(0.74, 2.69) 
0.78 
(0.28, 2.17) 
- 
No change 
N= 185 
Ref Ref - - Ref Ref - 
Under 5 
N= 265 
Catch down 
N=66 
0.74 
(0.40, 1.38) 
- -  
1.35 
(0.60, 3.02) 
0.87 
(0.28, 2.70) 
- 
Acceleration 
N=95 
0.74 
(0.42, 1.29) 
- -  
0.87 
(0.40, 1.92) 
0.71 
(0.24, 2.08) 
- 
No change 
N=104 
Ref - - Ref Ref Ref - 
Under 5 
N= 265 
(adjusted) ‡ 
Catch down 
N=66 
0.76 
(0.40, 1.44) 
- - 
1.74 
(0.85, 3.54) 
1.43 
(0.62, 3.28) 
0.83 
(0.26, 2.67) 
- 
Acceleration 
N=95 
0.86 
(0.48, 1.53) 
- - 
0.86 
(0.42, 1.77) 
1.06 
(0.47, 2.41) 
0.76 
(0.25, 2.30) 
- 
No change 
N=104 
Ref - - Ref Ref Ref - 
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Over 5 
N=234 
Deceleration 
N=70 
2.48* 
(1.12, 5.02) 
- 
2.10 
(0.89, 5.00) 
- 
4.39* 
(1.36, 14.17) 
1.16 
(0.07, 18.89) 
0.46 
(0.19, 1.13) 
Acceleration 
N=83 
1.42 
(0.70, 2.89) 
- 
1.44 
(0.60, 3.46) 
- 
2.94 
(0.90, 9.65) 
0.98 
(0.06, 15.87) 
0.67 
(0.27, 1.67) 
No change 
N=81 
Ref - Ref - Ref Ref Ref 
Over 5 
N=234 
(adjusted) ‡ 
Deceleration 
N=70 
2.56* 
(1.23, 5.33) 
- 
2.23 
(0.90, 5.51) 
- 
4.89* 
(1.48, 16.1) 
1.24 
(0.08, 20.7) 
2.42 
(0.96, 6.09) 
Acceleration 
N=83 
1.37 
(0.66, 2.84) 
- 
1.36 
(0.55, 3.40) 
- 
3.05 
(0.91, 10.2) 
1.06 
(0.06, 17.8) 
1.48 
(0.58, 3.75) 
No change 
N=81 
Ref - Ref - Ref Ref Ref 
†Adjusted for gestational age, gender, family history of atopy and delivery by caesarean section, ≤5 or >5 years of age 
‡Adjusted for gestational age, gender, family history of atopy and delivery by caesarean section 
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Table 2-14 Association between 2nd trimester (HC) to birthweight growth trajectory and respiratory symptoms in term-born children. Data are Odds 
ratios (95% confidence intervals) 
2nd Trimester HC to birthweight Wheeze-ever 
Recent 
Wheeze 
Wheeze last 
12 months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
All 
measurements 
N=1141 
Deceleration 
N=378 
0.96 
(0.73, 1.26) 
0.98 
(0.70, 1.37) 
- - 
0.86 
(0.59, 1.27) 
0.96 
(0.49, 1.90) 
- 
Acceleration 
N=192 
1.16 
(0.83, 1.62) 
1.12 
(0.74, 1.69) 
- - 
0.81 
(0.49, 1.33) 
1.37 
(0.64, 2.95) 
- 
No change  
N=571 
Ref Ref - - Ref Ref - 
All 
measurements 
N=1141 
(adjusted)† 
Deceleration 
N=378 
0.95 
(0.72, 1.51) 
0.84 
(0.54, 1.31) 
- - 
0.86 
(0.58, 1.27) 
0.90 
(0.45, 1.80) 
- 
Acceleration 
N=192 
1.06 
(0.75, 1.51) 
0.67 
(0.38, 1.21) 
- - 
0.73 
(0.44, 1.23) 
1.26 
(0.58, 2.74) 
- 
No change  
N=571 
Ref Ref - - Ref Ref - 
Under 5 
N=581 
Deceleration 
N=200 
0.97 
(0.67, 1.40) 
- - 
1.11 
(0.71, 1.74) 
1.23 
(0.73, 2.07) 
0.81 
(0.36, 1.80) 
- 
Acceleration 
N=103 
0.96 
(0.61, 1.51) 
- - 
0.80 
(0.44, 1.46) 
0.80 
(0.39, 1.65) 
1.12 
(0.45, 2.78) 
- 
No change  
N=278 
Ref - - Ref Ref Ref - 
Under 5 
N=581 
(adjusted) ‡ 
Deceleration 
N=200 
1.01 
(0.69, 1.46) 
- -  
1.29 
(0.76, 2.20) 
0.78 
(0.35, 1.75) 
- 
Acceleration 
N=103 
0.96 
(0.60, 1.53) 
- -  
0.79 
(0.38, 1.64) 
1.11 
(0.44, 2.78) 
- 
No change  
N=278 
Ref - - Ref Ref Ref - 
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Over 5 
N=560 
Deceleration 
N=178 
0.90 
(0.60, 1.36) 
- 
0.81 
(0.49, 1.36) 
- 
0.54 
(0.29, 1.00) 
1.32 
(0.36, 5.00) 
0.83 
(0.50, 1.39) 
Acceleration 
N=89 
1.40 
(0.85, 2.30) 
- 
1.56 
(0.88, 2.75) 
- 
0.82 
(0.40, 1.67) 
2.01 
(0.47, 8.60) 
0.91 
(0.48, 1.73) 
No change  
N=293 
Ref - Ref - Ref Ref Ref 
Over 5 
N=560 
(adjusted) ‡ 
Deceleration 
N=178 
0.87 
(0.57, 1.34) 
- 
0.80 
(0.47, 1.36) 
- 
0.50* 
(0.27, 0.95) 
1.34 
(0.35, 5.14) 
0.77 
(0.45, 1.33) 
Acceleration 
N=89 
1.17 
(0.70, 1.97) 
- 
1.38 
(0.76, 2.51) 
- 
0.66 
(0.32, 1.40) 
1.77 
(0.40, 7.89) 
0.73 
(0.36, 1.44) 
No change  
N=293 Ref - Ref - Ref Ref Ref 
*p<0.05 
†Adjusted for gestational age, gender, family history of atopy and delivery by caesarean section, ≤5 or >5 years of age 
‡Adjusted for gestational age, gender, family history of atopy and delivery by caesarean section 
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Table 2-15 Association between 2nd trimester (FL) to birthweight growth trajectory and respiratory symptoms in term-born children. Data are Odds 
ratios (95% confidence intervals) 
2nd Trimester FL to birthweight Wheeze-ever 
Recent 
Wheeze 
Wheeze last 
12 months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
All 
measurements 
N= 1118 
Deceleration 
N= 466 
0.95 
(0.73, 1.24) 
1.15 
(0.82, 1.60) 
- - 
1.10 
(0.75, 1.61) 
1.00 
(0.51, 1.94) 
- 
Acceleration 
N= 188 
0.94 
(0.66, 1.34) 
1.20 
(0.78, 1.84) 
- - 
1.05 
(0.63, 1.74) 
1.25 
(0.55, 2.83) 
- 
No change  
N= 464 
Ref Ref - - Ref Ref - 
All 
measurements 
N= 1118 
(adjusted)† 
Deceleration 
N= 466 
1.03 
(0.78, 1.36) 
1.16 
(0.75, 1.80) 
- - 
1.19 
(0.80, 1.77) 
1.07 
(0.54, 2.10) 
- 
Acceleration 
N= 188 
0.96 
(0.66, 1.37) 
1.07 
(0.60, 1.90) 
- - 
1.10 
(0.65, 1.83) 
1.28 
(0.56, 2.95) 
- 
No change  
N= 464 
Ref Ref - - Ref Ref - 
Under 5 
N= 565 
Deceleration 
N=221 
0.97 
(0.67, 1.40) 
- - 
1.19 
(0.76, 1.87) 
1.12 
(0.67, 1.89) 
1.03 
(0.47, 2.24) 
- 
Acceleration 
N=100 
0.70 
(0.43, 1.13) 
- - 
0.86 
(0.47, 1.58) 
0.63 
(0.29, 1.38) 
1.05 
(0.39, 2.81) 
- 
No change  
N=244 
Ref - - Ref Ref Ref - 
Under 5 
N= 565 
(adjusted) ‡ 
Deceleration 
N=221 
0.98 
(0.68, 1.43) 
- - 
1.25 
(0.79, 1.97) 
1.15 
(0.68, 1.96) 
1.03 
(0.47, 2.25) 
- 
Acceleration 
N=100 
0.70 
(0.43, 1.14) 
- - 
0.86 
(0.45, 1.56) 
0.67 
(0.29, 1.40) 
1.09 
(0.40, 2.97) 
- 
No change  
N=244 
Ref - - Ref Ref Ref - 
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Over 5 
N=553 
Deceleration 
N=245 
0.99 
(0.67, 1.48) 
- 
1.13 
(0.69, 1.86) 
- 
1.10 
(0.62, 1.95) 
1.13 
(0.30, 4.24) 
0.75 
(0.46, 1.23) 
Acceleration 
N=88 
1.36 
(0.81, 2.30) 
- 
1.72 
(0.93, 3.16) 
- 
1.68 
(0.83, 3.38) 
1.91 
(0.42, 8.70) 
0.85 
(0.44, 1.66) 
No change  
N=220 
Ref - Ref - Ref Ref Ref 
Over 5 
N=553 
(adjusted) ‡ 
Deceleration 
N=245 
1.12 
(0.74, 1.70) 
- 
1.29 
(0.77, 2.17) 
- 
1.24 
(0.69, 2.25) 
1.27 
(0.33, 4.88) 
0.82 
(0.49, 1.38) 
Acceleration 
N=88 
1.40 
(0.82, 2.41) 
- 
1.82 
(0.96, 3.44) 
- 
1.77 
(0.86, 3.63) 
1.96 
(0.43, 9.01) 
0.87 
(0.43, 1.74) 
No change  
N=220 
Ref - Ref - Ref Ref Ref 
†Adjusted for gestational age, gender, family history of atopy and delivery by caesarean section, ≤5 or >5 years of age 
‡Adjusted for gestational age, gender, family history of atopy and delivery by caesarean section 
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 Discussion 
In this chapter, I have suggested that foetal growth patterns are potentially important 
factors in predicting the risk of increased wheeze in preterm and term born children. 
Previous studies in term-born cohorts have used birthweight as proxy for foetal growth, 
and examined associations with respiratory symptoms and lung function, with mixed 
results in children and adults (Kotecha et al., 2015, Lawlor et al., 2005). By assessing growth 
over specific periods of gestation, I have attempted to define the impact of growth 
trajectory in during key periods of development. In contrast to my hypotheses, I noted that 
both growth acceleration, and deceleration, were associated with increased risk of 
respiratory symptoms in preterm-born, and term-born children. The results are 
summarised in Table 2-16 and Table 2-17 below which indicate the direction of growth 
change for a given period of gestation and the OR associated with the outcome: 
Table 2-16: Summary of results in relation to growth change during foetal life and 
associations with increased respiratory symptoms in preterm-born children (p<0.05) 
Preterm-born children Wheeze-ever Hospital admission 
1st trimester- birth 
CRL-BW 
(Table 2-4) 
Whole group ↑OR 2.21 n/s 
<5 years of age ↑OR 2.80 n/s 
≥5 years of age n/s n/s 
1st-2nd trimester 
CRL-HC 
(Table 2-5) 
Whole group ↓OR 1.59 ↑OR2.57; ↓OR3.84 
<5 years of age n/s ↑OR2.51; ↓OR2.97 
≥5 years of age n/s Not computed 
1st-2nd trimester 
CRL-FL 
(Table 2-6) 
Whole group n/s n/s 
<5 years of age n/s n/s 
≥5 years of age n/s n/s 
2nd trimester- birth 
HC-BW 
(Table 2-7) 
Whole group ↑ OR1.60 n/s 
<5 years of age ↑OR2.00   ↓OR1.55 n/s 
≥5 years of age n/s ↑OR4.22 
2nd trimester- birth 
FL-BW 
(Table 2-8) 
Whole group n/s n/s 
<5 years of age n/s n/s 
≥5 years of age n/s n/s 
↑= growth acceleration significantly associated with respiratory outcome 
↓= growth deceleration significantly associated with respiratory outcome 
n/s= not statistically significant 
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Table 2-17 Summary of results in relation to growth change during foetal life and 
associations with increased respiratory symptoms in term-born children (p<0.05) 
Term-born children Wheeze-ever Inhaler use 
1st trimester- birth 
CRL-BW 
(Table 2-11) 
Whole group n/s ↑ OR2.13 
<5 years of age n/s n/s 
≥5 years of age n/s n/s 
1st-2nd trimester 
CRL-HC 
(Table 2-12) 
Whole group n/s n/s 
<5 years of age n/s n/s 
≥5 years of age n/s n/s 
1st-2nd trimester 
CRL-FL 
(Table 2-13) 
Whole group n/s n/s 
<5 years of age n/s n/s 
≥5 years of age ↓OR2.56 ↓OR4.89 
2nd trimester- birth 
HC-BW 
(Table 2-14) 
Whole group n/s n/s 
<5 years of age n/s n/s 
≥5 years of age n/s n/s 
2nd trimester- birth 
FL-BW 
(Table 2-15) 
Whole group n/s n/s 
<5 years of age n/s n/s 
≥5 years of age n/s n/s 
↑= growth acceleration significantly associated with respiratory outcome 
↓= growth deceleration significantly associated with respiratory outcome 
n/s= not statistically significant 
 
To date, three other groups have investigated similar hypotheses to this study- all of which 
were conducted in term-born cohorts, and present varying results. In common with my 
study, investigators from the Generation R cohort did not identify any association with 
measures of foetal size and childhood respiratory outcomes at four years of age 
(Sonnenschein-van der Voort et al., 2012). In contrast, Turner and colleagues reported a 4% 
decrease in the odds of wheeze-ever and 5% decrease in asthma ever per millimetre 
increase in CRL in 5-year old children. Increases in BD and FL were associated with 
decreases in doctor-confirmed asthma of 12% and 10% respectively (Turner et al., 2010). 
Furthermore, improvements in lung function were also identified for increases in first 
trimester CRL and BD. Although asthma is difficult to diagnose in children under 5 years of 
age as wheezy symptoms can be transient in this age group, when the cohort was followed 
up at age 10, increases in first trimester CRL and second trimester BD were still associated 
with a 6% and 13% reduction in risk of recent and active wheeze respectively and increased 
CRL and BD was also associated with increased FEV1 (Turner et al., 2011).    
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Although it was not possible to classify children by atopic status in my study, the data 
presented in this chapter somewhat complement that of Pike et al. who reported that a 
reduction in the relative risk of non-atopic wheeze was related to an increase in head 
circumference only (RR 0.90 95% CI 0.81, 0.90 per SD increase in HC growth velocity) 
between the 1st and 2nd trimesters in 3-year old children (Pike et al., 2010). I similarly 
observed that growth faltering between approximately 10-20 weeks’ gestation was 
associated with increased odds of wheeze-ever, recent wheeze, inhaler use and hospital 
admission (OR 1.59, 1.29, 1.60 and 3.84 respectively) in preterm-born children 
(acknowledging that recent wheeze, nor inhaler use, met the criteria for statistical 
significance). Further observations from the Southampton group suggested that foetal 
abdominal growth acceleration between the 1st and 2nd trimesters was associated with an 
increase in atopy (RR 1.46; 95% CI 1.11, 1.93 per SD of increase in growth velocity) and 
atopic wheeze (RR 1.32 95% CI 0.94, 1.85); an increase in growth velocity during the 2nd to 
3rd trimester (19-34 weeks) was associated with a decreased risk of atopy (RR 0.80; 95%CI 
0.68 0.95) and atopic wheeze (RR 0.8; 95% CI 0.65, 1.00).  
In my study, when growth trajectories for both between the 1st trimester to birth and 
between the 2nd trimester and birth were investigated, both growth acceleration and 
deceleration were associated with increased odds of wheeze-ever, predominantly in 
preterm-born children aged less than five years. One can speculate that when compared to 
a normal pattern of growth, both growth acceleration and deceleration may have 
deleterious effects on early respiratory health. This concept is supported by the recent 
systematic review presented by Alkandari and colleagues who noted that accelerated 
growth was associated with both advantageous and disadvantageous effects on respiratory 
outcomes (Alkandari et al., 2015).   
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The mechanisms of how change in growth rate impacts upon the developing organs are not 
yet known. However, timing of insults which prompt growth change are likely to be of 
significant importance. The main structures of the respiratory system are established in the 
first and early second trimester, whereas the majority of differentiation and maturation 
occurs between the 2nd trimester and birth (Larsen, 1998). One possibility is that structural 
and mechanical deficits are established early in gestation that later manifest as airway 
obstruction due to smaller airways. For example, the data presented by Turner in term-
born children demonstrated increased respiratory symptoms for children with persistently 
low 1st-2nd trimester growth (wheeze-ever OR 3.31; 1.82, 6.02) (Turner et al., 2010). My 
data in term-born children similarly noted increased odds ratios for wheeze-ever, wheeze 
in the last 12 months, and inhaler use in children ≥5 years of age when growth deceleration 
was expressed as a >0.67SD decrease between 1st trimester CRL and 2nd trimester FL z-
scores.  
In the Southampton cohort, early growth faltering was associated with non-atopic wheeze, 
and atopic wheeze was related to growth faltering in the 3rd trimester (Pike et al., 2010). 
The authors suggest that the latter may be an effect of altered immunological status. These 
associations are consistent with the “developmental origins of health and disease” and that 
of a predictive adaptive response, where adverse intrauterine conditions induce a 
developmental mismatch with the postnatal environment (Pike et al., 2008). In contrast, 
co-workers from the Generation R cohort did not find any associations between 2nd to 3rd 
trimester growth trajectory and asthma symptoms over the first four years of life 
(Sonnenschein-van der Voort et al., 2012) in term-born children.  
Finally, an interesting contribution from my data noted that the effect of growth trajectory 
change was most evident in children aged under five. Thus, this could represent part of an 
‘early wheeze’ phenotype which may in part may be due to altered response to infections 
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as a result of dysregulated lung growth (Barker et al., 2013). These finding may be 
especially pertinent to the RANOPS preterm-born cohort as the risk of both chronic airway 
obstruction and inflammation are substantially increased due to the immaturity of the 
airways, trauma caused by perinatal respiratory disease, and propensity to being born 
small for gestational age.  
 
 Strengths and limitations 
The main strength of this study is the use of contemporary cohort of preterm-born children 
which was specifically designed to investigate associations with respiratory symptoms in 
childhood. Validated questionnaires were used, allowing comparison with other studies. 
Moreover, I was able to link to national databases to obtain additional information on birth 
outcomes and socio-economic status.  
Database access also facilitated collection of antenatal ultrasound data for the majority of 
the cohort and allowed investigations of foetal growth measures rather than using 
birthweight as a proxy for foetal wellbeing. Although the data were obtained 
retrospectively and each scan was performed by a qualified ultrasonographer, it is 
acknowledged that prospective data obtained as part of a research protocol may have 
improved the accuracy of the results (Royston and Altman, 1995); however, some findings 
were comparable with other studies. Unfortunately, under the standard scanning protocols 
within units in Wales, no single measurement is performed both in the first and second 
trimester scans. Third trimester scans are not routine, therefore abdominal circumference, 
which is used to assess in utero growth restriction, was only available in a minority of cases. 
The available measurements were compared under the assumption that they reflect similar 
levels of growth. Also, data on head circumference and length at birth were not available, 
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as a nationwide neonatal database did not exist at that time; thus, birthweight was used as 
a measure of 3rd trimester growth to compare with antenatal measurements. 
Finally, in common with all cohort studies, residual confounding by unmeasured covariates 
cannot be ruled out. In the cohort at large, non-responders to the questionnaire were of 
lower socio-economic status (Edwards et al., 2016). However, given that infants born into 
such conditions are more likely to be born preterm, IUGR and have been exposed to a less 
favourable intrauterine growth environment (e.g. tobacco smoke) one would expect 
inclusion of these children to strengthen rather than weaken the associations I have 
presented.  
 
 
 Summary and conclusions 
In this chapter I have presented data on foetal growth trajectory and potential associations 
with respiratory health in preterm-born children and demonstrated that change in 
trajectory may be a determinant of later lung disease. Mine is the first study to specifically 
assess this in children born preterm. Consistent with the “Developmental Origins of Health 
and Disease” hypothesis, the timing of growth change is likely to be an important factor in 
terms of influencing lung development. Future prospective studies might focus on the 
collection on serial measurements of the foetus during pregnancy to allow more detailed 
comparisons of anthropometry and the relationship with birth outcomes such as 
prematurity and IUGR, and with later health outcomes in childhood and beyond. Initiatives 
such as the GROW software, which builds in maternal parameters such as height and 
weight to produce and ‘individualised’ foetal growth trajectory, provide valuable tools to 
assess foetal wellbeing and timing of growth change (Figueras and Gardosi, 2011).           
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3 Associations between infant weight gain and childhood 
respiratory symptoms in preterm-born and term-born children 
 
 Overview 
In the previous chapter, potential links between foetal growth and respiratory health in 
childhood were identified, especially in preterm-born children. However, data are not 
consistent between studies, and in addition, some data suggest that postnatal growth, 
commonly weight gain, results in increased respiratory symptoms in childhood and beyond. 
Recent studies have focused on the term-born population (Claudia et al., 2015, Magnus et 
al., 2015, Popovic et al., 2016, van der Gugten et al., 2012, Flexeder et al., 2012). A meta-
analysis of 147,000 children included 7,384 preterm-born children from several European 
cohorts, and noted an association between greater weight gain in infancy and increased 
childhood asthma (Sonnenschein-van der Voort et al., 2014). A further exploration of 
24,938 children, 2,053 of whom were born preterm, noted an association between 
gestational age, infant weight gain in the first year of life, and measures of lung function 
(den Dekker et al., 2016). However, both studies included preterm-born subjects who were 
recruited in largely term-born cohorts, suggesting selection bias. Moreover, previous 
studies have reported only associations and have not explored the important early-life 
factors that may influence the effect of foetal growth trajectories and postnatal weight gain 
on respiratory outcomes. In this chapter I use data from the RANOPS cohort which was 
specifically designed to investigate preterm-born children and key factors associated with 
their respiratory disease.  
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 Aims and Hypothesis 
In this study, I investigated postnatal weight gain and the association with the risk of 
respiratory symptoms in preterm and term-born children. Furthermore, multiple regression 
analysis and mediation analysis were conducted to establish if early-life factors may be 
important in the association between infant weight gain and childhood respiratory 
symptoms. 
My hypotheses were: 
 Infant weight gain was associated with increased respiratory symptoms in preterm- 
and term-born children. 
 There would be a ‘dose dependent’ effect of gestational age on the association 
between rapid infant weight gain and later respiratory outcomes. 
 The effect of weight gain on respiratory health would be mediated by gestational 
age; other important factors may be identified. 
 
 Methods 
 The Respiratory and Neurological Outcomes of Preterms Study (RANOPS) 
Respiratory outcome data from RANOPS, a cross-sectional population study of preterm-
born children, were used. In 2013, all identifiable live-born preterm (<37 weeks’ gestation) 
surviving children born in Wales aged between 1 and 10 years, and term controls (born 
same gender, day and locality) were sent the Liverpool Respiratory Symptom Questionnaire 
(if <5 years of age) or a modified ISAAC Questionnaire (if ≥5 years of age), n=13,361.  
(Edwards et al., 2015a, Edwards et al., 2016). Both questionnaires have been validated 
previously (Asher et al., 1995) (Powell et al., 2002) and use of such questionnaires is widely 
accepted in epidemiological studies. Ethical approval for the survey was obtained from the 
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Research Ethics Committee and parents gave consent by virtue of returning completed 
questionnaires. 
 
 Perinatal data 
Demographic data, including gestation, birthweight, singleton or multiple birth and Wales 
index of multiple deprivation (WIMD, a measure of socio-economic status) were available 
from NWIS. For the preterm analysis, children were divided into four groups based on 
gestational age at birth: 25-32, 33-34, 35-36 weeks’ gestation. This approach is similar to 
studies on lung function (Kotecha et al., 2012) and that of others as it represents specific 
stages in lung development (Joshi and Kotecha, 2007) and children most at risk of lung 
disease (Boyle et al., 2012, Greenough, 2012). Gestational age in term-born children was 
defined as ‘early-term’ (37-38 weeks’ gestation) and Term (≥39 weeks), as early-term 
children have also been noted to have increased respiratory symptoms (Edwards et al., 
2015a). Intrauterine growth restriction (IUGR) was defined as <10th centile for 
standardised birthweight corrected for gestation and gender using the LMS method 
(Medical Research Council, UK) (Ong, 2000, Kotecha et al., 2010).  
 
 Infant weight data 
Postnatal weight data obtained from clinic and community appointments were provided by 
NWIS. The closest available weight measurement to 9 months (limited to a range of 6 to 12 
months) and 24 months of age (limited to a range of 18 to 28 months) was identified for 
each participant. Birthweight, weight at 9 months and weight at 24 months of age were 
then standardised for gestational age (birthweight), age at time of measurement (postnatal 
weight) and gender using the LMS method (Medical Research Council, UK) to produce z-
scores. Participants with birthweight or postnatal weight outside ±3.5 SD or with unknown 
gestational age were excluded. 
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Infant weight gain between birth and 9 months of age, and between birth and 24 months 
of age was defined by dichotomising the population into those who demonstrated an 
increase of >0.67SD in weight and those who did not. A change of >0.67 was chosen as this 
reflects the difference between centile lines drawn on the standard growth chart (e.g. 2nd, 
9th, 25th, 50th, 75th, 91st and 98th centiles) and is used clinically to assess growth (Ong, 
2000). However, the use of ‘centile crossing’ as measure of change in growth velocity in 
longitudinal data is sometimes criticised. In order to validate my results, the method of 
Royston was used to calculate measures of conditional growth velocity between birth and 
nine months of age (Royston, 1995). With this method, the measures of growth velocity are 
independent from initial size and are corrected for regression to the mean (Royston and 
Altman, 1995) (Figure 3-1).  
 
Figure 3-1: Example of conditional measures of humerus length in two foetuses. The 
reference curves represent the 3rd, 10th, 50th, 90th and 97th centiles. Foetus ‘A’ is on the 3rd 
cross-sectional centile for humerus length at 20 weeks of gestation, and grows to be on 
the 1st cross-sectional centile at 24 weeks. The foetus is small at both timepoints, 
however, conditional to the measurement of length at 20 weeks, is placed on the 
conditional 8th centile which reflects adequate growth. Foetus ‘B’ is on the 75th cross- 
sectional centile for length at 28 weeks, and 13th centile at 32 weeks. Obtaining the 
measure of conditional growth notes this foetus is on the 1st conditional centile, which 
may indicate more concern in regards to growth trajectory than the crossing of cross-
sectional centiles. Reproduced with permission from Royston and Altman. Ultrasound 
Obstet Gynecol. 1995 Nov;6(5):307-12.   
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Multilevel models using all available weight data for preterm-born (n= 11,581) and term-
born children (n= 9,163) were used to derive regression equations to predict expected 
weight at 9 months (Figure 3-2). Multilevel models are advantageous as they allow 
consideration to be given to within-subject regression slopes whilst taking in to account 
missing data in longitudinal data sets (Rabe-Hesketh and Skrondal, 2012). Level one of the 
hierarchical model used all available weight data, and level two consisted of each 
individual’s study ID. Multilevel modelling was performed in Stata (Version 12, StataCorp, 
Texas USA). The resulting regression equation and constants from the model were applied 
to the dataset to calculate the conditional growth velocity using Royston’s published 
equations. A separate model was run for the preterm group and for the term group due to 
the difference in growth patterns of preterm-born children. 
 
Figure 3-2 Example of available weight data in preterm-born children for use in multilevel modelling 
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 Respiratory outcomes 
Respiratory outcomes were extracted from the RANOPS questionnaire which included 
wheeze-ever, recent wheeze (last 3 months for <5 years of age; last 12 months for ≥5 years 
of age), use of inhalers, hospital admissions for chest-related reasons, and doctor-
diagnosed asthma (≥5 years of age only). All outcomes were dichotomous (Edwards et al., 
2015a, Edwards et al., 2016). 
 
 Statistical analysis 
Chi-squared tests were used to investigate the differences in categorical demographic data 
between weight gain groups (>0.67SD weight gain or not). Normality of continuous data 
was checked by visually inspecting Q-Q plots. Independent sample t-tests were used for 
continuous variables which were normally distributed. WIMD score was subsequently 
converted into quintiles for use in statistical models.  
First, univariate logistic regression models were used to investigate the association 
between infant weight gain at both 9 months and 2 years of age with childhood respiratory 
outcomes. ‘No change’ was set as the reference category. Confounders were then included 
in adjusted multivariable models if they had a p-value <0.10 for associations with ‘wheeze-
ever’, which was the primary outcome for all analyses. Both the univariate and 
multivariable models were initially conducted using all available data (<5 and ≥5 years of 
age combined). The ‘Recent Wheeze’ outcome was a combined outcome of ‘wheeze in the 
last 3 months’ (<5 years of age) and ‘wheeze in the last year’ (≥5 years of age). Modelling 
was then conducted with the data separated into the <5 and ≥5 years age groups.  In order 
to validate the results, the analyses were repeated using the measure of conditional 
growth at 9 months of age.  
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Second, to assess if the relationship between weight gain and ‘wheeze-ever’ was mediated 
via gestational age and or via significant covariates, mediation analysis was performed 
using structural equation modelling (Mplus version 7, Muthen and Muthen, Los Angeles, 
California USA). Mediation analysis explores how the relationship between an exposure 
and an outcome can be explained by their relationship with a third variable (or more). 
Mediation is said to occur if inclusion of the mediating variable(s) reduces the strength of 
the relationship (direct effect) between the exposure and outcome (Figure 3-3). However, 
use of bootstrapping to produce robust 95% confidence intervals for the indirect effect of 
the mediator is the favoured way to interpret if mediation has occurred, as the distribution 
of the indirect effect is often not close to normal (Field, 2013). Bootstrapping is a technique 
that does not rely on assumptions of normality (it is non-parametric) and repeatedly 
samples from within the dataset (1000 samples in my analysis) in order to derive 
confidence intervals for the indirect effect (Muthen et al., 2016). All potential mediators 
were entered in parallel (Muthen et al., 2016). Modelling was conducted independently for 
both the preterm and term-born groups.  
 
Figure 3-3 Diagram representing the relationship between a mediating variable and the 
exposure and outcome of interest, for comparison with relationships with confounders 
and covariates. The direct effect is the effect of the exposure on the outcome, adjusted 
for the mediator (and any other variables in the model, as per a standard regression). The 
indirect effect is the effect of the exposure on the outcome via the mediating variable.  
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Finally, I considered the cohort as a whole study population (including preterm and term 
groups) and used interaction terms to investigate the combined effects of gestation groups 
and infant weight gain when defined as >0.67SD increase between birthweight and weight 
at 9 months using logistic regression. Term-born children with ‘no change’ for weight gain 
were used as the control category. Both univariate, and multivariable modelling including 
covariates with a p-value <0.10 as described above, were performed. This was then 
repeated to include ‘early term’ as an additional gestational group. All modelling was 
performed using SPSS (version 20, IBM, Chicago IL, USA). Statistical significance was set at 
p<0.05 for all analyses described above. 
 
 Results 
 Data availability 
Following exclusions for missing birthweight (n=193), missing weight at 9 months, and 
weight z-score ±3.5 SD (n=1,132), 5,824/7,149 (81%) participants had valid data; 3,425 
participants were born preterm and 2,399 were born at term. At 24 months of age, 
3,094/7,149 (43%) participants had valid data following exclusions for missing weight data, 
or weight z-score ±3.5 SD; 1,819 were born preterm and 1,275 born at term.   
 Demographics 
Demographics of preterm and term-born children with, and without, >0.67SD weight gain 
at 9 months of age and at 24 months of age are presented in Table 3-1 and Table 3-2, 
respectively. In the preterm-born group, children of lower birthweight, whose mothers 
smoked during pregnancy, were of the lowest WIMD quintile, and whose mothers currently 
smoke, were more likely to exhibit weight gain of >0.67SD between birth and 9 months of 
age. Children born IUGR, by caesarean section, and as one of a multiple birth were also 
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significantly more likely to have infant weight gain. In term-born children, lower 
birthweight, maternal smoking in pregnancy and current maternal smoking, multiple birth, 
and IUGR were associated with infant weight gain at 9 months. 
 
Table 3-1 Demographics of participants included in the infant weight gain analysis at 9 
months of age 
Postnatal weight data at age 9 
months 
 
Preterm 
N = 3425 
Term 
N= 2399 
 
 
No change 
N=2,661 
>0.67SD 
N=764 
No change 
N=1765 
>0.67SD 
N=634  
Birthweight, kg**‡ 
Mean (SD) 
 
2.30 
(0.66) 
2.11 
(2.11) 
3.55 
(0.48) 
3.21 
(0.45) 
Gender (%) † 
Male 
1,447 
(54.4) 
436 
(57.1) 
909 
(51.5) 
366 
(57.7) 
Female 
1,214 
(45.6) 
328 
(42.9) 
856 
(48.5) 
268 
(42.3) 
WIMD quintiles (%)* 
1(most) 
454 
(17.1) 
151 
(19.8) 
256 
(14.5) 
105 
(16.6) 
 
2 
533 
(20.0) 
165 
(21.6) 
323 
(18.3) 
127 
(20.0) 
 
3 
560 
(21.0) 
171 
(22.4) 
377 
(21.4) 
142 
(22.4) 
 
4 
556 
(20.9) 
126 
(16.5) 
373 
(21.1) 
134 
(21.1) 
 
5 (least) 
558 
(21.0) 
151 
(19.8) 
436 
(24.7) 
126 
(19.9) 
Maternal smoking: 
pregnancy (%) **‡ 
Yes 
307 
(11.5) 
146 
(19.1) 
159 
(9.0) 
95 
(15.0) 
 
No 
2,354 
(88.5) 
618 
(80.9) 
1606 
(91.0) 
539 
(85.0) 
Maternal smoking: 
Current (%) **‡ 
Yes 
411 
(15.4) 
179 
(23.4) 
181 
(10.3) 
119 
(18.8) 
 
No 
2,250 
(84.6) 
585 
(76.6) 
1584 
(89.7) 
515 
(81.2) 
Maternal age, years 
Mean (SD) 
 
30.4 
(5.9) 
29.6 
(6.0) 
30.6 
(5.6) 
29.9 
(5.7) 
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Singletons (%)*† 
Multiple 
558 
(21.0) 
119 
(26.0) 
18 
(1.00) 
15 
(2.4) 
 
Singleton 
2,103 
(79.0) 
565 
(74.0) 
1747 
(99.0) 
619 
(97.6) 
Caesarean delivery 
(%)* 
Yes 
1,204/3,232 
(48.0) 
390/3,232 
(53.8) 
440/2250 
(26.6) 
169/2250 
(28.4) 
 
No 
1,303/3,232 
(52.0) 
335/3,232 
(46.2) 
1214/2250 
(73.4) 
427/2250 
(71.6) 
IUGR (%) **‡ 
Yes 
183 
(6.9) 
193 
(25.3) 
57 
(3.2) 
97 
(15.3) 
 
No 
2,478 
(93.1) 
571 
(74.7) 
1708 
(96.8) 
537 
(84.7) 
Breastfeeding 
Yes 
1,415 
(53.2) 
376 
(49.2) 
1093 
(61.9) 
376 
(59.3) 
 
No 
1,246 
(46.8) 
388 
(50.8) 
672 
(38.1) 
258 
(40.7) 
Family history of 
asthma/atopy 
Yes 
675 
(25.4) 
215 
(28.1) 
457 
(25.9) 
145 
(22.9) 
 
No 
1,986 
(74.6) 
549 
(71.9) 
1308 
(74.1) 
489 
(77.1) 
Weight at 9m, kg  
Mean (SD) **‡ 
 
7.97 
(1.14) 
9.04 
(1.19) 
8.53 
(1.05) 
9.61 
(1.34) 
Preterm *p<0.05, **p<0.001; Term †p<0.05, ‡p<0.001 
Denominators are given for categorical variables with missing data 
 
At 24 months of age in the preterm-born group, children of lower birthweight, whose 
mothers smoked during pregnancy, of lowest WIMD quintile, and whose mothers currently 
smoke, were more likely to exhibit weight gain >0.67SD between birth and 24 months of 
age (Table 3-2). Children born IUGR, by caesarean section, and as one of a multiple birth 
were also significantly more likely to have infant weight gain. In term-born children, lower 
birthweight, gender, maternal smoking in pregnancy, current maternal smoking, and IUGR 
were associated with infant weight gain at 24 months of age. 
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Table 3-2 Demographics of participants included in the infant weight gain analysis at 24 
months of age 
Postnatal weight data at age 24 
months 
 
Preterm 
N = 1819 
Term 
N= 1275 
 
 
No change 
N=1253 
>0.67SD 
N=566 
No change 
N=871 
>0.67SD 
N=404  
Birthweight, kg**‡ 
Mean (SD) 
 
2.29 
(0.66) 
2.09 
(0.55) 
3.54 
(0.47) 
3.28 
(0.47) 
Gender (%) † 
Male 
684 
(54.6) 
298 
(52.7) 
446 
(51.2) 
228 
(56.4) 
Female 
569 
(45.4) 
268 
(47.3) 
425 
(48.8) 
176 
(43.6) 
WIMD quintiles (%) 
1(most) 
171 
(13.6) 
92 
(16.3) 
98 
(11.3) 
51 
(12.6) 
 
2 
238 
(19.0) 
120 
(21.2) 
145 
(16.6) 
72 
(17.8) 
 
3 
274 
(21.9) 
128 
(22.6) 
208 
(23.9) 
89 
(22.0) 
 
4 
288 
(23.0) 
97 
(17.1) 
207 
(23.8) 
85 
(21.0) 
 
5 (least) 
282 
(22.5) 
129 
(22.8) 
213 
(24.5) 
107 
(26.5) 
Maternal smoking: 
pregnancy (%)*† 
Yes 
140 
(11.2) 
94 
(16.6) 
76 
(8.7) 
54 
(13.4) 
 
No 
1113 
(88.8) 
472 
(83.4) 
795 
(91.3) 
350 
(86.6) 
Maternal smoking: 
Current (%)*† 
Yes 
184 
(14.7) 
121 
(21.4) 
90 
(10.3) 
61 
(15.1) 
 
No 
1069 
(85.3) 
445 
(78.6) 
781 
(89.7) 
343 
(84.9) 
Maternal age, years 
Mean (SD) 
 
30.6 
(5.80) 
30.1 
(5.78) 
31.1 
(5.51) 
30.2 
(5.75) 
Singletons (%)* 
Multiple 
268 
(21.4) 
148 
(26.1) 
12 
(1.4) 
9 
(2.2) 
 
Singleton 
985 
(78.6) 
418 
(73.9) 
859 
(98.6) 
395 
(97.8) 
Caesarean delivery 
(%)* 
Yes 
543/1,693 
(46.6) 
278/1,693 
(52.7) 
242/1,195 
(29.7) 
98/1,195 
(25.7) 
 
No 
622/1,693 
(53.4) 
250/1,693 
(47.3) 
572/1,195 
(70.3) 
283/1,195 
(74.3) 
IUGR (%) **‡ Yes 76 132 23 59 
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(6.1) (23.3) (2.6) (14.6) 
 
No 
1177 
(93.9) 
434 
(76.7) 
848 
(97.4) 
345 
(85.4) 
Breastfeeding 
Yes 
691 
(55.1) 
310 
(54.8) 
575 
(66.0) 
261 
(64.6) 
 
No 
562 
(44.9) 
256 
(45.2) 
296 
(34.0) 
143 
(35.4) 
Family history of 
asthma/atopy 
Yes 
314 
(25.1) 
132 
(23.3) 
217 
(24.9) 
105 
(26.0) 
 
No 
939 
(74.9) 
434 
(76.7) 
654 
(75.1) 
299 
(74.0) 
Weight at 24m, kg**‡  
Mean (SD) 
 
11.60 
(1.48) 
13.03 
(1.64) 
12.1 
(1.35) 
13.70 
(1.58) 
Preterm *p<0.05, **p<0.001; Term †p<0.05, ‡p<0.001 
Denominators are given for categorical variables with missing data 
 
 Outcomes in preterm-born children 
3.5.3.1 Univariate analysis 
Results of the univariate analyses are shown in Table 3-3. Lower gestation, male gender, 
maternal smoking in pregnancy, current maternal smoking, family history of asthma/atopy 
and lower WIMD quintile were associated with increased wheeze-ever at p<0.10 (of which 
all were significant at p<0.05 aside from maternal smoking in pregnancy. Breastfeeding, 
non-white ethnicity and being ≥5 years of age were significantly associated with decreased 
wheeze-ever (all p<0.10 and thus entered in to the fully adjusted model). 
 
3.5.3.2 Using >0.67SD change in weight as primary exposure 
A >0.67SD increase in weight between birth and 9 months of age was significantly 
associated with wheeze-ever in preterm-born children (OR 1.21; 95% CI 1.03, 1.42). In the 
fully adjusted model, the association remained after inclusion of covariates (which had 
p<0.10 in univariate analysis). When the cohort was split into those aged <5 years and 
those aged over 5, wheeze-ever was significant in the fully adjusted model in the ≥5 years 
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age group only (OR 1.37; 95% CI 1.06, 1.77); wheeze in the last 12 months showed a similar 
but non-significant effect (OR 1.25; 95% CI 0.93, 1.68), Table 3-4. 
When weight gain was defined as >0.67SDS change between birthweight and 24 months of 
age, there were no significant associations with later respiratory symptoms. However, the 
largest effect was in the ≥5 years age group (wheeze-ever OR 1.27; 95% CI 0.96, 1.67); this 
attenuated in the fully adjusted model (OR 1.13; 95% CI 0.83, 1.55), Table 3-5.
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Table 3-3 Univariate associations between potential confounders with weight gain and respiratory outcomes in preterm-born children 
Preterm only 
Wheeze-ever Recent Wheeze 
Wheeze last 12 
months§ 
Wheeze last 3 
months† Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma§ 
Gestation        
≤32 weeks 1.83** 
(1.54, 2.18) 
1.56** 
(1.30, 1.87) 
1.52** 
(1.16, 2.00) 
1.57** 
(1.22, 2.01) 
1.79** 
(1.46, 2.19) 
2.03** 
(1.50, 2.74) 
1.70** 
(1.28, 2.25) 
33-34 weeks 1.20* 
(1.01, 1.42) 
1.15 
(0.95, 1.39) 
1.02 
(0.77, 1.36) 
1.24 
(0.96, 1.60) 
1.03 
(0.83, 1.28) 
1.41* 
(1.02, 1.96) 
0.97 
(0.91, 1.31) 
35-36 weeks Ref Ref Ref Ref Ref Ref Ref 
Birthweight SDS        
 0.97 
(0.93, 1.02) 
0.97 
(0.92, 1.02) 
0.96 
(0.88, 1.03) 
0.98 
(0.91, 1.04) 
0.97 
(0.92, 1.03) 
0.93 
(0.85, 1.01) 
0.97 
(0.90, 1.06) 
IUGR        
Yes 1.02 
(0.82, 1.26) 
1.08 
(0.85, 1.37) 
1.22 
(0.86, 1.73) 
0.97 
(0.70, 1.34) 
0.98 
(0.75, 1.29) 
1.11 
(0.75, 1.65) 
1.04 
(0.72, 1.52) 
No Ref Ref Ref Ref Ref Ref Ref 
Gender        
Male 1.38** 
(1.22, 1.56) 
1.32** 
(1.15, 1.52) 
1.37* 
(1.11, 1.69) 
1.32* 
(1.10, 1.59) 
1.34** 
(1.14, 1.57) 
1.38* 
(1.10, 1.74) 
1.33* 
(1.06, 1.67) 
Female Ref Ref Ref Ref Ref Ref Ref 
Maternal smoking -
pregnancy 
       
Yes 1.17‡ 
(0.98, 1.40) 
1.25* 
(1.03, 1.51) 
1.43* 
(1.09, 1.89) 
1.17 
(0.89, 1.54) 
1.08 
(0.86, 1.35) 
0.85 
(0.60, 1.20) 
1.14 
(0.85, 1.55) 
No Ref Ref Ref Ref Ref Ref Ref 
Maternal smoking-current        
Yes 1.26* 
(1.08, 1.48) 
1.20* 
(1.20, 1.43) 
1.02 
(0.78, 1.33) 
1.44* 
(1.13, 1.82) 
1.14 
(0.94, 1.40) 
1.05 
(0.78, 1.40) 
1.08 
(0.82, 1.43) 
No Ref Ref Ref Ref Ref Ref Ref 
Family history of Asthma/ 
Atopy 
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Yes 2.07** 
(1.79, 2.40) 
2.24** 
(1.93, 2.60) 
2.33** 
(1.85, 2.93) 
2.07** 
(1.70, 2.52) 
2.09** 
(1.78, 2.47) 
1.76** 
(1.36, 2.19) 
3.03** 
(2.38, 3.86) 
No Ref Ref Ref Ref Ref Ref Ref 
Delivery by C/S        
Yes 1.12 
(0.98, 1.27) 
1.15 
(0.99, 1.32) 
1.08 
(0.87, 1.34) 
1.56 
(0.96, 1.40) 
1.12 
(0.94, 1.30) 
1.43* 
(1.13, 1.80) 
1.09 
(0.87, 1.38) 
No Ref Ref Ref Ref Ref Ref Ref 
Breastfeeding        
Yes 0.83* 
(0.73, 0.94) 
0.81* 
(0.71, 0.93) 
0.85 
(0.69, 1.04) 
0.74* 
(0.62, 0.89) 
0.76* 
(0.65, 0.89) 
0.80* 
(0.63, 1.00) 
0.98 
(0.79, 1.23) 
No Ref Ref Ref Ref Ref Ref Ref 
Ethnicity        
Non-white 0.71* 
(0.54, 0.94) 
0.91 
(0.67, 1.24) 
1.57 
(0.99, 2.47) 
0.59* 
(0.39, 0.90) 
0.72 
(0.49, 1.04) 
0.94 
(0.57, 1.55)  
1.29 
(0.79, 2.11) 
White Ref Ref Ref Ref Ref Ref Ref 
WIMD quintile        
lowest- 1 1.44** 
(1.18, 1.75) 
1.74** 
(1.39, 2.16) 
2.06** 
(1.46, 2.92) 
1.46* 
(1.09, 1.95) 
1.44* 
(1.13, 1.84) 
1.42 
(0.99, 2.03) 
1.46 
(1.01, 2.09) 
2 1.16 
(0.96, 1.41) 
1.30* 
(1.04, 1.61) 
1.72* 
(1.23, 2.40) 
1.03 
(0.77, 1.38) 
1.08 
(0.85, 1.40) 
1.30 
(0.92, 1.86) 
1.57* 
(1.11, 2.20) 
3 1.23* 
(1.02, 1.49) 
1.36** 
(1.09, 1.69) 
1.59* 
(1.13, 2.34) 
1.17 
(0.88, 1.57) 
1.23 
(0.96, 1.56) 
1.09 
(0.76, 1.58) 
1.13 
(0.79, 1.62) 
4 1.17 
(0.97, 1.42) 
1.30* 
(1.04, 1.63) 
1.53* 
(1.09, 2.15) 
1.18 
(0.87, 1.59) 
1.16 
(0.91, 1.49) 
1.13 
(0.78, 1.64) 
1.29 
(0.91, 1.83) 
highest- 5 Ref Ref Ref Ref Ref Ref Ref 
Age <5/≥5 years        
>5 0.60** 
(0.53, 0.68) 
0.59** 
(0.51, 0.68) 
- - 0.65** 
(0.55, 0.76) 
0.18** 
(0.13, 0.24) 
- 
<5 Ref Ref - - Ref Ref - 
§Children ≥5 years of age only; †children <5 years of age only 
‡p<0.10, *p<0.05; **p<0.001 
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Table 3-4 Associations between rapid weight gain from birth to 9 months of age and respiratory outcomes in preterm-born children 
All 
 
Wheeze-ever Recent Wheeze 
Wheeze last 12 
months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
Univariate         
>0.67 
 
N=764 1.21* 
(1.03, 1.42) 
1.19 
(0.99, 1.42) 
- - 1.08 
(0.88, 1.32) 
1.03 
(0.76, 1.40) 
- 
No change N= 2661 Ref Ref - - Ref Ref - 
Fully adjusted†         
>0.67 
 
N= 684 1.22* 
(1.02, 1.45) 
1.15 
(0.95, 1.40) 
- - 
1.07 
(0.86, 1.33) 
1.01 
(0.79, 1.53) 
- 
No change  N= 2358 Ref Ref - - Ref Ref - 
<5         
Univariate         
>0.67 
 
N= 378 1.10 
(0.87, 1.38) 
- - 1.11 
(0.87, 1.42) 
1.06 
(0.81, 1.39) 
1.07 
(0.76, 1.51) 
- 
No change  N= 1314 Ref - - Ref Ref Ref - 
Fully adjusted‡         
>0.67 
 
N= 353 1.11 
(0.86, 1.42) 
- - 1.11 
(0.85, 1.44) 
1.11 
(0.83, 1.49) 
1.13 
(0.79, 1.62) 
- 
No change N= 1231 Ref - - Ref Ref Ref - 
≥5         
Univariate         
>0.67 N= 386 1.33* 
(1.06, 1.67) 
- 1.28 
(0.99, 1.67) 
- 1.10 
(0.81, 1.48) 
0.87 
(0.38, 1.82) 
1.24 
(0.94, 1.63) 
No change N= 1347 Ref - Ref - Ref Ref Ref 
Fully adjusted‡         
>0.67 N= 331 1.37* 
(1.06, 1.77) 
- 1.25 
(0.93, 1.68) 
- 1.03 
(0.74, 1.44) 
1.01 
(0.45, 2.29) 
1.21 
(0.89, 1.64) 
No change N= 1127 Ref - Ref - Ref Ref Ref 
†Adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking (current), family history of asthma/atopy, breastfeeding at birth, ethnicity, WIMD, <5/≥5 years of age 
†Adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking (current), family history of asthma/atopy, breastfeeding at birth, ethnicity, WIMD 
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Table 3-5 Associations between weight gain from birth to 24 months of age and respiratory outcomes in preterm-born children 
All 
 
Wheeze-ever Recent Wheeze 
Wheeze last 12 
months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
Univariate         
>0.67 
 
N=566 1.14 
(0.94, 1.39) 
1.09 
(0.87, 1.36) 
- - 
1.08 
(0.85, 1.39) 
1.18 
(0.80, 1.73) 
- 
No change N= 1253 Ref Ref - - Ref Ref - 
Fully adjusted†         
>0.67 
 
N= 501 1.12 
(0.89, 1.39) 
1.16 
(0.91, 1.48) 
- - 
1.14 
(0.87, 1.50) 
1.14 
(0.87, 1.50) 
- 
No change  N= 1080 Ref Ref - - Ref Ref - 
<5         
Univariate         
>0.67 
 
N= 258 1.05 
(0.78, 1.41) 
- - 
1.10 
(0.81, 1.49) 
1.07 
(0.76, 1.50) 
1.24 
(0.79, 1.92) 
- 
No change  N= 603 Ref - - Ref Ref Ref - 
Fully adjusted‡         
>0.67 
 
N= 240 1.12 
(0.81, 1.54) 
- - 
1.19 
(0.85, 1.66) 
1.19 
(0.81, 1.73) 
1.34 
(0.84, 2.15) 
- 
No change N= 551 Ref - - Ref Ref Ref - 
≥5         
Univariate         
>0.67 N= 308 1.27 
(0.96, 1.67) 
- 
1.12 
(0.81, 1.56) 
- 
1.13 
(0.79, 1.62) 
1.21 
(0.50, 2.92) 
1.19 
(0.85, 1.66) 
No change N= 650 Ref - Ref - Ref Ref Ref 
Fully adjusted‡         
>0.67 N= 261 1.13 
(0.83, 1.55) 
- 
1.11 
(0.76, 1.61) 
- 
1.09 
(0.73, 1.63) 
1.09 
(0.40, 2.99) 
1.14 
(0.78, 1.65) 
No change N=529 Ref - Ref - Ref Ref Ref 
†Adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking (current), family history of asthma/atopy, breastfeeding at birth, ethnicity, WIMD, <5/≥5 years of age 
†Adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking (current), family history of asthma/atopy, breastfeeding at birth, ethnicity, WIMD 
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3.5.3.3 Using conditional growth change in weight as primary exposure 
Using the continuous measure of conditional growth, weight gain between birth and 9 
months of age was associated with increased odds of wheeze-ever (OR 1.30; 95% CI 1.14, 
1.49), recent wheeze (OR 1.21; 95% CI 1.05, 1.41) and inhaler use (OR 1.27; 95% CI 1.08, 
1.51) in the univariate model. Adjusting for covariates attenuated these results however 
wheeze-ever still remained statistically significant (OR 1.17; 95% CI 1.01, 1.37) and was 
similar to the result when weight gain was defined as >0.67SD change (OR1.22; 95% CI 
1.02, 1.45). Considering the <5 years age group, weight gain was associated with increased 
wheeze in the last 3 months (OR 1.24; 95% CI 1.01, 1.53) and inhaler use (OR 1.32; 95% CI 
1.05, 1.66) in the univariate model, however both effects attenuated in the adjusted model 
(OR 1.15; 95% CI 0.92, 1.45 and OR 1.13; 95% CI 0.87, 1.45 for wheeze in the last 3 months 
and inhaler use, respectively). In the ≥5 years age group, weight gain was significantly 
associated with wheeze-ever (OR 1.50; 95% CI 1.24, 1.82) and doctor-diagnosed asthma 
(OR 1.44; 95% CI 1.14, 1.82); after adjustment, both remained statistically significant 
(wheeze-ever OR 1.26; 95% CI 1.02, 1.57. Doctor-diagnosed asthma OR 1.33 95% CI 1.02, 
1.75) (Table 3-6).  
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Table 3-6 Associations between conditional weight gain from birth to 9 months of age and respiratory outcomes in preterm-born children 
All Wheeze-ever 
Recent 
Wheeze 
Wheeze last 12 
months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-diagnosed 
asthma 
Univariate Conditional 
growth 
N= 3425 
1.30** 
(1.14, 1.49) 
1.21* 
(1.05, 1.41) 
- - 
1.27* 
(1.08, 1.51) 
1.11 
(0.86, 1.43) 
- 
Fully 
adjusted† 
Conditional 
growth 
N=3042  
1.17* 
(1.01, 1.37) 
1.09 
(0.93, 1.29) 
- - 
1.12 
(0.93, 1.36) 
0.98 
(0.73, 1.31) 
- 
Age <5 years        
Univariate Conditional 
growth 
N= 1692 
1.08 
(0.97, 1.33) 
- - 
1.24* 
(1.01, 1.53) 
1.32* 
(1.05, 1.66) 
1.20 
(0.90, 1.60) 
- 
Fully 
adjusted‡ 
Conditional 
growth 
N=1584 
1.08 
(0.87, 1.33) 
- - 
1.15 
(0.92, 1.45) 
1.13 
(0.87, 1.45) 
1.10 
(0.81, 1.49) 
- 
Age ≥5 years        
Univariate Conditional 
growth 
N=1733 
1.50** 
(1.24, 1.82) 
- 
1.22 
(0.98, 1.53) 
- 
1.25 
(0.98, 1.61) 
0.98 
(0.52, 1.84) 
1.44* 
(1.14, 1.82) 
Fully 
adjusted‡ 
Conditional 
growth 
N= 1458 
1.26* 
(1.02, 1.57) 
- 
1.08 
(0.83, 1.39) 
- 
1.10 
(0.83, 1.47) 
0.84 
(0.42, 1.66) 
1.33* 
(1.02, 1.75) 
*p<0.05; **p<0.001 
†Adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking (current), family history of asthma/atopy, breastfeeding at birth, ethnicity, WIMD, <5/≥5 
‡ Adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking (current), family history of asthma/atopy, breastfeeding at birth, ethnicity, WIMD 
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3.5.3.4 Mediation analysis 
Results of the mediation analysis for preterm-born children are summarised in Table 3-7 
and Figure 3-4. Gestational age, maternal smoking in pregnancy, current maternal smoking 
and breastfeeding all had significant univariate associations with weight gain whereas male 
gender, being ≥5 years of age, ethnicity and family history of asthma/atopy did not; all of 
these factors were significant predictors (p<0.05) of wheeze-ever except for maternal 
smoking in pregnancy.   Of the above covariates, bootstrapped confidence intervals for 
specific indirect effects did not include zero for gestational age and current maternal 
smoking, indicating strong evidence that weight gain influenced wheeze-ever via 
gestational age and current maternal smoking. Moreover, the size of the direct effect 
(B=0.07, p=0.22) diminished relative to the adjusted regression model presented in Table 3-
4 (B=0.19, p=0.03), further indicating the mediating effect of these two factors. 
Table 3-7 Results of mediation analysis on the effect of infant weight gain from birth to 9 
months of age on wheeze-ever in preterm-born children 
>0.67SDS weight gain b SE 95% CI p 
Univariate associations     
Gestation on weight gain -0.22 
 
0.05 -0.31, -0.13 <0.001 
Maternal smoking on 
weight gain 
0.29 
 
0.06 0.17, 0.41 <0.001 
Direct effect*     
Wheeze-ever on Weight 
gain 
0.07 
 
0.06 -0.04, 0.18 0.22 
Specific indirect effects     
Wheeze-ever on weight 
gain via gestation 
-0.04 0.01 -0.06, -0.02† ‡<0.001 
Wheeze-ever on weight 
gain via current maternal 
smoking 
0.03 0.01 0.01, 0.18† ‡0.02 
*adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking 
(current), family history of asthma/atopy, breastfeeding, ethnicity, WIMD, age 
under/over 5 years 
†bootstrapped confidence intervals (1000 samples) 
‡normal theory (sobel) test 
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Figure 3-4 Diagrammatic representation of mediation analysis results in preterm-born 
children (>0.67SD weight gain). Both the indirect effects of gestational age and current 
maternal smoking mediate the direct effect of rapid weight gain on wheeze-ever in 
preterm born children.  
 
 Outcomes in term-born children 
3.5.4.1 Univariate analysis 
Results of univariate analyses in term-born children are shown in Table 3-8. Gestation, male 
gender, current maternal smoking, family history of asthma/atopy and lower WIMD 
quintile were associated with increased odds of wheeze-ever at the p<0.10 level. Being ≥5 
years of age was associated with decreased odds of wheeze-ever. These covariates were 
therefore included in the adjusted model.
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Table 3-8 Univariate associations between potential confounders and respiratory outcomes in term-born children 
 
Wheeze-
ever 
Recent 
Wheeze 
Wheeze last 
12 months§ 
Wheeze last 
3 months† Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma§ 
Gestational age 0.88** 
(0.83, 0.93) 
0.87** 
(0.80, 0.94) 
0.88* 
(0.78, 0.98) 
0.86* 
(0.78, 0.96) 
0.81** 
(0.74, 0.89) 
0.85* 
(0.73, 0.998) 
0.87* 
(0.77, 0.98) 
Gestation        
37-38 weeks 1.51** 
(1.23, 1.87) 
1.71** 
(1.32, 2.20) 
1.77* 
(1.22, 2.55) 
1.66* 
(1.17, 2.35) 
1.92** 
(1.44, 2.55) 
0.94 
(0.51, 1.72) 
1.71* 
(1.15, 2.52) 
≥39 weeks Ref Ref Ref Ref Ref Ref Ref 
SDS Birthweight 0.97 
(0.89, 1.05) 
0.98 
(0.89, 1.09) 
0.94 
(0.81, 1.09) 
1.02 
(0.89, 1.17) 
0.95 
(0.84, 1.07) 
0.90 
(0.73, 1.11) 
1.00 
(0.85, 1.17) 
IUGR (<10th centile for 
SD BW) 
       
Yes 1.10 
(0.80, 1.48) 
1.34 
(0.93, 1.94) 
1.66 
(0.99, 2.80) 
1.09 
(0.67, 1.84) 
1.34 
(0.88, 2.05) 
0.92 
(0.40, 2.13) 
1.67 
(0.96, 2.90) 
No Ref Ref Ref Ref Ref Ref Ref 
Gender        
Male 1.45** 
(1.24, 1.70) 
1.39* 
(1.14, 1.70) 
1.35 
(1.01, 1.81) 
1.43* 
(1.09, 1.88) 
1.45* 
(1.15, 1.84) 
1.95* 
(1.27, 3.01) 
1.56* 
(1.13, 2.16) 
Female Ref Ref Ref Ref Ref Ref Ref 
Maternal smoking -
pregnancy 
       
Yes 1.15 
(0.90, 1.46) 
1.34* 
(1.001, 1.80) 
1.08 
(0.71, 1.66) 
1.75* 
(1.16, 2.64) 
1.31 
(0.93, 1.84) 
1.01 
(0.53, 1.91) 
1.12 
(0.71, 1.77) 
No Ref Ref Ref Ref Ref Ref Ref 
Maternal smoking-
current 
       
Yes 1.27* 
(1.02, 1.59) 
1.38** 
(1.05, 1.81) 
1.07 
(0.71, 1.62) 
1.75* 
(1.2, 2.53) 
1.00 
(0.71, 1.42) 
1.12 
(0.63, 1.99) 
0.81 
(0.50, 1.32) 
No Ref Ref Ref Ref Ref Ref Ref 
Family history of Atopy        
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Yes 1.94* 
(1.63, 2.31) 
2.15** 
(1.75, 2.65) 
2.32** 
(1.70, 3.16) 
1.98** 
(1.49, 2.63) 
2.13** 
1.67, 2.71) 
1.78* 
(1.17, 2.71) 
2.75** 
(1.98, 3.81) 
No Ref Ref Ref Ref Ref Ref Ref 
Delivery by C/S        
Yes 1.23* 
(1.01, 1.49) 
1.21 
(0.97, 1.51) 
1.28 
(0.91, 1.79) 
1.15 
(0.85, 1.55) 
1.13 
(0.87, 1.48) 
0.88 
(0.54, 1.42) 
1.22 
(0.85, 1.75) 
No Ref Ref Ref Ref Ref Ref Ref 
Breastfeeding        
Yes 0.87 
(0.74, 1.02) 
0.90 
(0.74, 1.10) 
1.06 
(0.79, 1.42) 
0.75* 
(0.57, 0.99) 
0.80 
(0.63, 1.01) 
0.65* 
(0.44, 0.98) 
0.81 
(0.59, 1.11) 
No Ref Ref Ref Ref Ref Ref Ref 
Ethnicity        
Non-white 1.06 
(0.74, 1.49) 
1.46 
(0.98, 2.17) 
1.99* 
(1.09, 3.64) 
1.14 
 (0.67, 1.92) 
1.18 
(0.72, 1.91) 
2.19* 
(1.44, 4.20) 
1.28 
(0.62, 2.65) 
White Ref Ref Ref Ref Ref Ref Ref 
WIMD quintile        
lowest- 1 1.29* 
(1.00, 1.66) 
1.28 
(0.92, 1.78) 
1.42 
(0.88, 2.30) 
1.13 
(0.71, 1.78) 
1.75* 
(0.21, 2.54)  
1.68 
(0.88, 3.18) 
1.83* 
(1.11, 3.03) 
2 1.23 
(0.97, 1.57) 
1.43* 
(1.05, 1.95) 
1.76* 
(1.12, 2.77) 
1.15 
(0.75, 1.76) 
1.36 
(1.03, 2.08) 
1.60 
(0.86, 2.96) 
1.96* 
(1.20, 3.20) 
3 1.26 
(1.002, 1.60) 
1.61* 
(1.20, 2.16) 
1.74* 
(1.14, 2.67) 
1.44 
(0.61, 1.48) 
1.46* 
(1.03, 2.08) 
1.24 
(0.66, 2.33) 
1.73* 
(1.08, 2.77) 
4 1.04 
(0.82, 1.32) 
1.001 
(0.73, 1.38) 
1.03 
(0.65, 1.64) 
0.95 
(0.61, 1.48) 
0.99 
(0.68, 1.47) 
0.90 
(0.46, 1.79) 
0.94 
(0.55, 1.58) 
highest- 5 Ref Ref Ref Ref Ref Ref Ref 
Age <5/≥ 5 years of age        
≥5 0.55** 
(0.47, 0.65) 
0.77* 
(0.63, 0.94) 
- - 0.91 
(0.72, 1.15) 
0.27** 
(0.17, 0.44) 
- 
<5 Ref Ref - - Ref Ref - 
§Children ≥5 years of age only; †children <5 years of age only 
‡p<0.10, *p<0.05; **p<0.001 
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3.5.4.2 Using >0.67SD change in weight as primary exposure 
Within the term-born group wheeze-ever (OR 1.37; 95%CI 1.13. 1.65), recent wheeze (OR 1.28; 
95%CI 1.01. 1.63) and inhaler use (OR 1.45; 95%CI 1.10. 1.89) were all significantly increased in 
children with weight gain >0.67 SDS between birth and 9 months of age (Table 3-9). These 
associations were strengthened in the final model after adjustment for covariates: wheeze-
ever (OR 1.43; 95%CI 1.17, 1.74), recent wheeze (OR 1.31; 95% CI 1.03, 1.67) and inhaler use 
(OR 1.51; 95% CI 1.15, 2.00). Results were similar when the data were separated into the <5 
years and ≥5 years age groups, however, the associations tended to be stronger in the ≥5 years 
age group (wheeze-ever OR 1.55; 95% CI 1.16, 2.06), in keeping with the analyses in preterm-
born children described earlier. Doctor-diagnosed asthma was also strongly related to weight 
gain in the ≥5 group (OR 2.00; 1.39, 2.92) in the fully adjusted model. 
When investigating the effect of >0.67 SD weight gain between birthweight and 24 months of 
age, results showed increased respiratory symptoms, hospital admissions and doctor-
diagnosed asthma for the whole preterm-born group (Table 3-10). However, few associations 
remained statistically significant in the adjusted model: inhaler use in the whole term-born 
population (OR 1.63, 95%CI 1.13, 2.35), and between weight gain and wheeze-ever in the ≥5 
years age group (OR 1.58; 95% CI 1.10, 2.30). There were no significant associations noted in 
the <5 years age group.  
3.5.4.3 Using conditional growth change in weight as primary exposure 
The alternative analyses of using a measure of conditional growth largely corroborated the 
results described above: weight gain between birth and 9 months of age was associated with 
increased odds of wheeze-ever, recent wheeze, inhaler use and hospital admission for chest-
related reasons in univariate analysis (Table 3-11). When covariates were included in the 
model, wheeze-ever (OR 1.25 95% CI 1.05, 1.50) and inhaler use (OR 1.58; 1.22, 2.05) 
remained statistically significant. In the ≥5 years age group, wheeze-ever was of borderline 
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significance (OR 1.31 95% CI 0.99, 1.72), whereas inhaler use (OR 1.62 95% CI 1.12, 2.37) and 
doctor-diagnosed asthma (OR 1.65 95% CI 1.15, 2.36) remained significant. Results in the <5 
years age group showed similar results; particularly, increased weight gain was associated with 
increased hospital admission (OR 1.82 95% CI 1.12, 2.93), although this was not statistically 
significant in the adjusted model (OR 1.59; 95% CI 0.94, 2.69). 
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Table 3-9 Associations between rapid weight gain from birth to 9 months of age and respiratory outcomes in term-born children 
 
 
All 
 
Wheeze-ever Recent Wheeze 
Wheeze last 12 
months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
Univariate         
>0.67 
 
N=634 1.37* 
(1.13, 1.65) 
1.28* 
(1.01, 1.63) 
- - 
1.45* 
(1.10, 1.89) 
1.47 
(0.90, 2.40) 
- 
No change N= 1765 Ref Ref - - Ref Ref - 
Fully adjusted†         
>0.67 
 
N=596 1.38** 
(1.13, 1.69) 
1.28 
(0.97, 1.65) 
- - 
1.53* 
(1.15, 2.04) 
1.46 
(0.87, 2.45) 
- 
No change  N= 1654 Ref Ref - - Ref Ref - 
<5         
Univariate         
>0.67 
 
N= 299 1.32* 
(1.03, 1.75) 
- - 
1.23 
(0.88, 1.71) 
1.34 
(0.91, 1.97) 
1.45 
(0.86, 2.70) 
- 
No change  N= 872 Ref - - Ref Ref Ref - 
Fully adjusted‡         
>0.67 
 
N=290 1.32* 
(1.00, 1.74) 
- - 
1.19 
(0.85, 1.68) 
1.39 
(0.93, 2.07) 
1.52 
(0.84, 2.75) 
- 
No change N= 849 Ref - - Ref Ref Ref - 
≥5         
Univariate         
>0.67 N= 335 1.45* 
(1.11, 1.91) - 
1.36 
(0.96, 1.91) - 
1.56* 
(1.07, 2.29) 
1.45 
(0.54, 3.98) 
1.78* 
(1.25, 2.53) 
No change N= 893 Ref - Ref - Ref Ref Ref 
Fully adjusted‡         
>0.67 N= 306 1.48* 
(1.10, 2.01) 
- 
1.43* 
(0.98, 2.07) 
- 
1.73* 
(1.15, 2.61) 
1.26 
(0.54, 3.84) 
2.02** 
(1.37, 2.98) 
No change N= 805 Ref - Ref - Ref Ref Ref 
†Adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking (current), family history of asthma/atopy, WIMD, caesarean section,<5/≥5 years of age 
‡Adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking (current), family history of asthma/atopy, WIMD, caesarean section,<5/≥5 years of age 
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Table 3-10 Associations between rapid weight gain from birth to 24 months of age and respiratory outcomes in term-born children 
All 
 
Wheeze-ever Recent Wheeze 
Wheeze last 12 
months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-
diagnosed 
asthma 
Univariate         
>0.67 
 
N=404 1.17 
(0.92, 1.50) 
0.94 
(0.69, 1.29) 
- - 
1.50* 
(1.06, 2.14) 
1.43 
(0.77, 2.66) 
- 
No change N= 871 Ref Ref - - Ref Ref - 
Fully adjusted†         
>0.67 
 
N=404 1.26 
(0.97, 1.63) 
0.99 
(0.71, 1.36) 
- - 
1.63* 
(1.13, 2.35) 
1.49 
(0.78, 2.85) 
- 
No change  N= 871 Ref Ref - - Ref Ref - 
<5         
Univariate         
>0.67 
 
N= 189 1.03 
(0.73, 1.46) 
- - 
0.98 
(0.64, 1.56) 
1.52 
(0.91, 2.51) 
1.29 
(0.61, 2.75) 
- 
No change  N= 437 Ref - - Ref Ref Ref - 
Fully adjusted‡         
>0.67 
 
N= 189 1.06 
(0.74, 1.52) 
- - 
0.96 
(0.61, 1.51) 
1.61 
(0.95, 2.74) 
1.33 
(0.60, 2.90) 
- 
No change N= 437 Ref - - Ref Ref Ref - 
≥5         
Univariate         
>0.67 N= 215 1.41 
(0.99, 2.01) 
- 
0.99 
(0.64, 1.56) 
- 
1.49 
(0.91, 2.44) 
2.05 
(0.65, 6.43) 
1.48 
(0.92, 2.37) 
No change N= 434 Ref - Ref - Ref Ref Ref 
Fully adjusted‡         
>0.67 N= 215 1.58* 
(1.10, 2.30) 
- 
1.05 
(0.66, 1.67) 
- 
1.67 
(1.00, 2.78) 
1.68 
(0.51, 5.12) 
1.63 
(1.00, 2.67) 
No change N= 434 Ref - Ref - Ref Ref Ref 
†Adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking (current), family history of asthma/atopy, WIMD, caesarean section,<5/≥5 years of age 
‡Adjusted for gestation, gender, maternal smoking (pregnancy), maternal smoking (current), family history of asthma/atopy, WIMD, caesarean section 
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Table 3-11 Associations between conditional weight gain from birth to 9 months of age and respiratory outcomes in term-born children 
All Wheeze-ever 
Recent 
Wheeze 
Wheeze last 12 
months 
Wheeze last 3 
months Inhaler use 
Hospital 
admission 
Doctor-diagnosed 
asthma 
Univariate Conditional 
growth 
N= 2250 
1.41** 
(1.20, 1.65) 
1.33* 
(1.09, 1.63) 
- - 
1.68** 
(1.33, 2.11) 
1.56* 
(1.03, 2.39) 
- 
Fully 
adjusted† 
Conditional 
growth 
N=2399  
1.25* 
(1.05, 1.50) 
1.20 
(0.96, 1.51) 
- - 
1.58** 
(1.22, 2.05) 
1.46 
(0.91, 2.34) 
- 
Age <5 years        
Univariate Conditional 
growth 
N=1171  
1.41* 
(1.13, 1.75) 
- - 
1.37* 
(1.04, 1.80) 
1.69* 
(1.21, 2.23) 
1.82* 
(1.12, 2.93) 
- 
Fully  
adjusted‡ 
Conditional 
growth 
N=1139 
1.21 
(0.95, 1.54) 
- - 
1.16 
(0.86, 1.57) 
1.55* 
(1.09, 2.20) 
1.59 
(0.94, 2.69) 
- 
Age ≥5 years        
Univariate Conditional 
growth 
N=1228  
1.43* 
(1.13, 1.82) 
- 
1.29 
(0.96, 1.74) 
- 
1.67* 
(1.20, 2.32) 
0.95 
(0.38, 2.40) 
1.76* 
(1.23, 2.51) 
Fully 
adjusted‡ 
Conditional 
growth 
N= 1228 
1.31 
(0.99, 1.72) 
- 
1.26 
 (0.90, 1.77) 
- 
1.62* 
(1.12, 2.37) 
1.02 
(0.34, 3.04) 
1.65* 
(1.15, 2.36) 
*p<0.05; **p<0.001 
†Adjusted for gestation, gender, current maternal smoking, family history of asthma/atopy, WIMD, caesarean section, <5/≥5 years of age 
‡Adjusted for gestation, gender, current maternal smoking, family history of asthma/atopy, WIMD, caesarean section 
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3.5.4.4 Mediation analysis 
The results of the mediation analysis for term-born children are presented in Table 3-12 
and Figure 3-5. Gestational age, gender, maternal smoking, and WIMD all had significant 
univariate associations with weight gain whereas being aged <5 or ≥5 years, family history 
of asthma/atopy and birth by caesarean section did not. All of these factors were 
significant predictors of wheeze (p<0.05) with the exception of current maternal smoking 
and WIMD. Of the above covariates, bootstrapped confidence intervals did not include zero 
for male gender only, but did for the remaining variables entered in to the model. 
Therefore, gender was a significant mediator of the relationship between rapid infant 
weight gain and childhood wheeze. Early-term birth was not statistically significant as a 
mediator in the model (p=0.07). The direct effect of weight gain was reduced when 
compared to the final logistic regression model presented in Table 3-9 (B= 0.32 and B= 0.20 
respectively) indicating the mediating effect of gender. 
 
 
Table 3-12 Summary of mediation analysis in term-born children 
>0.67SDS weight gain b SE 95% CI p 
Univariate associations     
Gender on weight gain 0.16 
 
0.06 0.04, 0.27 0.03 
Direct effect*     
Wheeze-ever on Weight 
gain 
0.20 
 
0.06 0.07, 0.32 0.002 
Specific indirect effects     
Wheeze-ever on weight 
gain via gestation 
0.02 0.01 -0.05, -
0.004† 
0.07‡ 
Wheeze-ever on weight 
gain via gender 
0.02 0.01 0.01, 0.05† 0.02‡ 
*adjusted for gestation, gender, maternal smoking (current), family history of 
asthma/atopy, WIMD, caesarean section, age </≥ 5 years 
†bootstrapped confidence intervals (1000 samples) 
‡normal theory (sobel) test 
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Figure 3-5 Diagrammatic representation of mediation analysis result in term-born 
children 
 
 
 Outcome of combined analysis 
The results of the interaction analysis using data from the whole population are shown 
below in Table 3-13. Compared to term-born children who did not demonstrate weight 
gain of >0.67SD between birth and the age of 9 months, children born ≤32 weeks’ 
gestational age with infant weight gain >0.67SD had significantly increased odds of wheeze-
ever (OR 4.92; 95%CI 3.34, 7.27). Including significant covariates in the adjusted model 
increased the strength of the association (OR 5.04; 95% CI 3.36, 7.54); Figure 3-6 
demonstrates a clear trend of the effect of infant weight gain and gestation on the odds of 
wheeze-ever. 
When the term-born group was further subdivided, early-term birth with subsequent rapid 
postnatal weight gain was associated with increased odds of wheeze-ever when compared 
to the term born group without rapid weight gain (OR 2.25; 95% CI 1.48, 3.43). Of note, the 
magnitude of this effect was greater than the late preterm group, and marginally greater 
than the moderate preterm group (ORs 1.84, 2.20, respectively, Table 3-14 and Figure 3-7).  
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Table 3-13 Results of interaction analysis for odds of wheeze-ever. Each interaction term 
is compared with the reference group of term-born, no weight gain (OR 1.0). Including 
>0.67SD in the interaction with each gestational age group resulted in an increase in the 
odds ratio for wheeze-ever. The highest odds ratio for wheeze-ever was noted to be in 
the very preterm group who exhibited weight gain >0.67SD when compared to the 
reference group. 
Interaction (univariate) OR 95% CI p 
>0.67SD* Very preterm 4.92 3.34, 7.27 <0.001 
No weight gain* Very preterm 2.90 2.41, 3.50 <0.001 
>0.67SD* Moderate preterm 2.94 2.12, 4.07 <0.001 
No weight gain *Moderate preterm 1.89 1.56, 2.28 <0.001 
>0.67SD*Late preterm 1.83 1.49, 2.25 <0.001 
No weight gain *Late preterm 1.69 1.46, 1.96 <0.001 
>0.67SD*Term 1.37 1.13, 1.65 0.001 
No weight gain *Term 1.0 
  
    
Interaction (adjusted†)    
>0.67SD* Very preterm 5.04 3.36, 7.54 <0.001 
No weight gain * Very preterm 2.95 2.42, 3.58 <0.001 
>0.67SD* Moderate preterm 2.83 2.01, 2.98 <0.001 
No weight gain *Moderate preterm 2.01 1.65, 2.44 <0.001 
>0.67SD*Late preterm 1.70 1.37, 2.11 <0.001 
No weight gain *Late preterm 1.68 1.44, 1.95 <0.001 
>0.67SD*Term 1.36 1.11, 1.65 0.002 
No weight gain *Term 1.0   
†Adjusted for Gender, maternal smoking, family history of asthma, WIMD, 
aged >5 or  ≥5 years 
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Table 3-14 Results of interaction analysis for odds of wheeze-ever, including the 
additional ‘early term group’. Each interaction term is compared with the reference 
group of term-born, no weight gain (OR 1.0). The additional interaction between early-
term birth and >0.67SD weight gain was noted to be highly significant when compared to 
the reference group. 
Interaction (univariate) OR 95% CI p 
>0.67SDS* Very preterm 5.38 3.63, 7.97 <0.001 
No weight gain * Very preterm 3.17 2.613, 3.85 <0.001 
>0.67SDS* Moderate preterm 3.21 2.31, 4.47  <0.001 
No weight gain *Moderate preterm 2.06 1.70, 2.50  <0.001 
>0.67SDS*Late preterm 2.00 1.61, 2.47  <0.001 
No weight gain *Late preterm 1.85 1.58, 2.16  <0.001 
>0.67SDS*Early term 2.22 1.48, 3.33 <0.001 
No weight gain *Early term 1.52 1.19, 1.94 0.001 
>0.67SDS*Term 1.38 1.12, 1.70 0.003 
No weight gain *Term 1.0 
  
    
Interaction (adjusted†)    
>0.67SDS* Very preterm 5.52 3.67, 8.30 <0.001 
No weight gain * Very preterm 3.22 2.63, 3.95 <0.001 
>0.67SDS* Moderate preterm 3.10 2.20, 4.38 <0.001 
No weight gain *Moderate preterm 2.20 1.79, 2.70 <0.001 
>0.67SDS*Late preterm 1.87 1.49, 2.33 <0.001 
No weight gain *Late preterm 1.84 1.56, 2.16 <0.001 
>0.67SDS*Early term 2.25 1.48, 3.43 <0.001 
No weight gain *Early term 1.54 1.20, 1.98 0.001 
>0.67SDS*Term 1.37 1.10, 1.70 0.005 
No weight gain *Term 1.0   
†Adjusted for Gender, maternal smoking (current), family history of asthma, 
WIMD, aged >5 or ≥5 years 
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Figure 3-6 Graphical representation of interaction analysis (adjusted) presented in table 3-13. All ORs for wheeze-ever are compared to the reference category of Term-born, no change in 
weight gain between birth and 9 months of age. Error bars represent 95% confidence intervals for ORs. 
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Figure 3-7 Graphical representation of interaction analysis (adjusted), including the early-term group, presented in table 3-14. All ORs for wheeze-ever are compared to the reference category 
of Term-born, no change in weight gain between birth and 9 months of age. Error bars represent 95% confidence intervals for ORs.
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 Discussion 
In this chapter, I have reported increased wheeze-ever in childhood because of rapid 
weight gain, defined as >0.67SD change in the first year of life, after adjusting for 
confounding factors, in both preterm-born and term-born children. The odds ratios were 
1.22 (95% CI 1.02, 1.45) and 1.38 (95% CI 1.13, 1.69) respectively. Using the alternative 
method of conditional growth change yielded similar results (OR1.17 for preterm-born and 
1.25 for term-born children). Investigating rapid weight gain up until 2 years of age and the 
association with respiratory symptoms yielded results which were not statistically 
significant.  The interaction between birth at the extremes of prematurity (≤32 weeks’ 
gestation) and postnatal weight gain resulted in the poorest respiratory outcome when 
compared to the reference group of term-born children who did not exhibit rapid weight 
gain (OR 5.04; 95%CI 3.36, 7.5). The combination of early-term birth and rapid weight gain 
was also noted to be associated with increased wheeze-ever (OR 2.25; 95% CI 1.48, 3.43) 
compared to the reference group.  
Furthermore, using mediation analysis, I have identified important and modifiable factors 
influencing the relationship between weight gain and respiratory symptoms in preterm- 
born children. Although the majority of preterm births are spontaneous and not modifiable 
per se, the risk factors implicated in preterm birth (see introduction section 1.4.2) certainly 
are. Moreover, I also noted that current maternal smoking was another significant 
mediating factor indicating the continuing deleterious effects of environmental tobacco 
smoke on respiratory health in childhood. In term-born children, male gender was 
identified as a mediator of the association between rapid weight gain and increased 
respiratory symptoms. 
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A growing number of studies, but few in preterm-born cohorts, have investigated the 
association between early weight gain in infancy and respiratory health in childhood and 
adolescence, using variable definitions of weight gain and time at which the outcome is 
measured.  The recent study of the NINFEA cohort demonstrated that rapid growth, in 
terms of body size and growth velocity, was a significant predictor of increased wheeze 
during the first 18 months of life in term-born infants; these associations were 
independent, thus suggesting that the effects of being large and showing rapid growth 
potentially act through different mechanisms or have independent effects (Popovic et al., 
2016). Using the same measure of weight gain (>0.67SD) as presented in this chapter, two 
recent studies reported decrements in lung function and increased respiratory symptoms 
at age 5 when rapid postnatal growth was observed between birth and 3 months of age, 
the latter of which was independent of foetal growth (van der Gugten et al., 2012, 
Sonnenschein-van der Voort et al., 2012). Both the Southampton and Aberdeen groups 
noted that early childhood wheeze at age 3 was associated with excessive weight gain 
throughout the first year of life (Pike et al., 2010) (Turner et al., 2008).  
Other studies in term-born cohorts have investigated longer periods over which weight 
gain was defined. In a recent report, peak weight velocity in infancy between birth and 36 
months resulted in increased rates of asthma and recurrent lower respiratory tract 
infections at 3 years of age, and increased asthma at 7 years of age (Magnus et al., 2015). 
Similarly, Flexeder and colleagues investigated peak weight gain from birth to 24 months of 
age and reported increased risk of asthma at age 10 years of age (Flexeder et al., 2012) and 
a negative association with lung function, especially measures of flow, in adolescents 
(Claudia et al., 2015). Interestingly, lung function was not affected following administration 
of bronchodilator suggesting that the weight gain resulted in structural rather than 
functional changes to the airways (the salbutamol dose was limited to 200mcg due to side 
effects, thus larger doses may have been effective). Using data from eight European 
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cohorts, the study by Rzehak noted that risk of asthma at 6 years of age was increased in 
children with rapid weight gain up to 2 years; the population was characterised by 
increased incidence of low birthweight (Rzehak et al., 2013). 
These studies, along with my data, support the concept that rate of weight gain is an 
important factor in influencing later respiratory health, possibly because growth and 
development of the respiratory system does not match somatic growth. Thus, the airways 
may be small in comparison to lung capacity (dysanapsis). Further data on lung function 
complement this hypothesis, for example, term-born infants with decreased flow and 
respiratory compliance at birth were reported to have an increased risk of asthma at the 
age of 10 years (Haland et al., 2006).  Results from the ALSPAC cohort demonstrated 
increased FVC and forced FEV1, but lower FEV1/FVC ratio for children who exhibited rapid 
weight gain in infancy (Sonnenschein-van der Voort et al., 2015). When I performed a 
repeat analysis using the available weight data at 24 months, lesser associations with 
respiratory symptoms were noted. Methodological differences in calculating measures of 
weight gain may be responsible for differences in these results. However, one possibility is 
that the deleterious effects of early weight gain on respiratory health may be mitigated if 
‘catch-up growth’ occurs over a longer period of time, such as previous data suggesting 
that deficits in FEV1 present in IUGR term-born children are ameliorated by catch up growth 
by eight years of age (Kotecha et al., 2010).  
Similar to others (Sonnenschein-van der Voort et al., 2014), I observed an incremental 
increase in odds of wheeze-ever with decreasing gestational age with infant weight gain, 
when compared to a term-born control growth without weight gain (OR 5.04). An 
additional finding from my data presented evidence that birth at ‘early-term’, followed by 
rapid weight gain from birth to 9 months of age was also associated with increased odd of 
wheeze. I extended my investigation by identifying current maternal smoking, as well as 
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gestation, as mediators of the relationship between weight gain and wheeze in preterm-
born children. Passive smoking is associated with increased incidence of viral respiratory 
infections in early childhood and has long-term impacts on lung health (Narang and Bush, 
2012).  
Maternal smoking can be considered a proxy of socio-economic status and may represent 
higher rates of formula feeding (McAndrew et al., 2012). A recent study using data from 
the Millennium Cohort Study observed that increased prevalence of early transient and 
persistent/relapsing wheeze is socially patterned. Furthermore, the authors noted a dose-
dependent effect of smoking during pregnancy, which increased risk of wheezing, and 
breastfeeding, with ameliorated the risk (Taylor-Robinson et al., 2016). Although it was not 
identified as a significant mediator, lack of breastfeeding promoted weight gain, whereas 
breastfeeding was protective of childhood wheeze in my logistic regression analysis. Thus, 
nutrition may be key in balancing the beneficial effects of growth versus potential harm of 
excess weight gain in preterm-born infants. Exclusive breastfeeding ameliorated the 
association between postnatal weight gain and increased early transient wheeze in term-
born children in the study by Turner et al. (Turner et al., 2008). The recent report by Belfort 
and colleagues noted an association between asthma at the age of 8 years and postnatal 
growth in preterm infants when defined by increase in BMI up to 12 months of age (Belfort 
et al., 2016). This was not compensated for by increased linear growth, further indicating 
the potential developmental mismatch between somatic and organ growth which may 
promote later obesity and lung disease, possibly through the pro-inflammatory 
immunological effects of excess adipose tissue (Gishti et al., 2014).  
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 Strengths and limitations 
The main strength of my study is the use of contemporary cohort of preterm-born children 
that was specifically designed to investigate associations with respiratory symptoms in 
childhood. The use of validated respiratory questionnaires in the original RANOPS study, 
which are widely used in clinical epidemiology, allows comparison with other studies. 
Moreover, I was able to link to national databases to obtain additional information on birth 
and infant outcomes and socio-economic status. 
The postnatal weight data used were taken from the national child health databases; these 
originated from multiple sources including hospital clinics, community appointments and 
GP surgeries. There will be some variation due to differences between equipment and use 
by the operator (Bryant et al., 2015). However, the strength of these data are the number 
of points available, which allowed the use of multilevel modelling to construct 
“individualised” conditional growth standards which correct for regression to the mean. 
This more complex method resulted in similar results when compared to the primary 
analysis of >0.67 change in standard deviation score for weight, a well-established and 
parsimonious method for quantifying growth change in the clinical environment. 
Finally, in common with all cohort studies, residual confounding of the data by unmeasured 
covariates cannot be ruled out. In the cohort at-large, non-responders to the questionnaire 
were of lower socio-economic status (Edwards et al., 2016). However, given that infants 
born into such conditions are more likely to be born preterm, IUGR and have been exposed 
to a less favourable intrauterine growth environment (e.g. tobacco smoke), inclusion of 
these children would be expected to strengthen rather than weaken the associations I have 
presented.  
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 Summary and conclusions 
I have demonstrated that postnatal growth rates are important for future respiratory 
health in preterm-born and term-born children. In the preterm-born population, the 
factors noted to mediate the relationship between rapid postnatal weight gain and later 
wheeze were modifiable. Since preterm-born children are unlikely to have the same 
aetiology of lung disease as their term-born peers, it is important to consider strategies for 
ensuring appropriate growth. Optimising nutrition and diminishing exposure to tobacco 
smoke during pregnancy and beyond are potential interventions which are possible in the 
wider context of reducing the social inequalities related to preterm birth. My additional 
analysis, which reports a similar effect of weight gain on respiratory outcomes of children 
born ‘early term’ is relevant in regards to the debate on the categorisation of gestational 
age and ‘term pregnancy’(ACOG, 2013a), and on timing of such  deliveries (ACOG., 2013b). 
Although I have speculated that dysanapsis may be important, we need to study the 
mechanisms whereby accelerated somatic growth results in increased respiratory 
symptoms in childhood. 
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4 Physical activity in preterm-born 11-year old children born in the 
1990’s 
 Overview 
There is strong evidence that children born preterm have decreased lung function (Kotecha 
et al., 2012, Kotecha et al., 2013), increased respiratory symptoms, admissions to hospital 
for respiratory problems and increased inhaler medication use (Been et al., 2014, 
Paranjothy et al., 2013, Edwards et al., 2016). These effects appear to be inversely 
incremental across a wide range of gestational age including those born ‘near term’ 
(Edwards et al., 2015a). In the previous chapter, it was described that early infant weight 
gain in the first year of life was also associated with increased respiratory symptoms in 
preterm-born school-age children. Consistent with the developmental origins of health and 
disease hypothesis, it is conceivable that such weight gain reflects dysregulated growth 
patterns secondary to developmental adaptations which may induce dysanapsis between 
somatic and respiratory system development.  
In keeping with these concepts is the finding that exercise capacity may also be sub-normal 
in preterm-born children, possibly due to respiratory factors including airway obstruction, 
restricted lungs and associated inflammation but also due to altered cardiometabolic 
processes and neurodevelopmental sequelae (Ridgway et al., 2009). Moreover there is 
evidence that preterm-born children appear to make adaptations during exercise, such as 
increased use of their ventilatory reserve, in order to maintain similar levels of intensity 
when compared to term-born children; they may also suffer from increased rates of 
exercise-induced bronchoconstriction especially if they suffered from BPD/CLD during 
infancy (Joshi et al., 2013). 
PA is an important lifestyle choice  which helps to ameliorate the risk of chronic disease. 
However, studies have shown that few children meet the recommended levels of PA (Chief 
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Medical Officers of England, 2011), with a steep decline occurring during adolescence. 
Preterm-born adults report reduced conditioning leisure time PA and reduced exercise 
capacity compared to those born at term (Kaseva et al., 2012, Svedenkrans et al., 2013, 
Lovering et al., 2014). Since respiratory morbidities track from childhood in to adulthood 
(Bolton et al., 2015),  investigating habitual PA participation in childhood with a view to 
introducing activity programmes might be of great importance for preterm-born children.  
 
What is unclear is if increased respiratory symptoms, reduced lung function and reduced 
exercise capacity are associated with decreased levels of objectively measured PA. One 
possible reason for reduced levels of PA in preterm-born compared with term-born 
subjects could be airway obstruction and associated impaired gas exchange on exertion, 
and the subsequent unpleasant sensations such as fatigue and breathlessness which may 
follow. There have been few such epidemiological studies investigating the levels of 
objectively measured PA in children who were born preterm and who have had lung 
function measurements. A recent systematic review has synthesized the literature (Dahan-
Oliel et al., 2012), but most studies rely on questionnaire data to quantify activity and 
relate mainly to exercise capacity (Clemm et al., 2012, Joshi et al., 2013), or focus on those 
born with extremely low birthweight and who suffered from BPD/CLD (Welsh et al., 2010). 
 
 Aims and hypothesis 
The aims of this study were to investigate objectively measured levels of PA, MVPA, and 
sedentary behaviour in preterm-born children and compare these to term controls. Also, I 
planned to investigate if measures of lung function are correlated to levels of physical 
activity. 
The specific hypotheses were: 
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a) That preterm-born children would participate in significantly less Total PA, less 
MVPA, and would spend more time in sedentary behaviour.  
b) That decrements in lung function, particularly FEV1, would correlate with reduced 
levels of total PA and MVPA. 
 
 Methods 
 Avon Longitudinal Study of Parents and Children 
Data from ALSPAC were used (Boyd et al., 2013). 14,541 pregnant women with an expected 
delivery date of 1st April 1991 to 31st December 1992 were enrolled.  There were 14,062 live 
born infants (13,988 alive at one year) who were subsequently followed up by means of 
questionnaire and clinical assessments. Ethical approval for the study was obtained from the 
ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. 
 
 Physical activity 
Children attending the ALSPAC clinic were invited by the ALSPAC team to wear an 
accelerometer (MTI Actigraph) for a 7-day period during waking hours. The device recorded 
a sample at 1 minute intervals (epochs), which was a compromise between duration of 
epochs and data storage capacity.  The Actigraph has been validated against the criterion 
standard of indirect caliometry and for use in free-living conditions. Children participated in 
an exercise session where they performed 6 activities of increasing intensity whilst wearing 
a portable metabolic unit to measure rate of O2 production and energy expenditure. Cut-
points for accelerometer counts, representative of different levels of intensity were then 
derived using a prediction equation (Mattocks et al., 2007, Mattocks et al., 2008).  Three 
outcomes were used for analyses: average ‘counts per minute’ (cpm) over the period of the 
valid recording, time (in minutes per day) spent at ≥3600cpm (MVPA), and time (in minutes 
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per day) spent at <200cpm (sedentary behaviour). MVPA was used to provide a measure of 
intensity because guidelines for levels of PA in children present recommendations in terms 
of MVPA (Department of Health, 2004). Sedentary time was used because it is possible for 
an individual to spend increased amounts of time sedentary even if they meet guidelines 
for MVPA (Mitchell et al., 2012), and because it has been independently associated with 
risk factors for chronic disease (Mitchell et al., 2009). Inclusion of only participants with 
valid accelerometer data excluded children with severe cognitive or physical impairments.  
 Gestation Groups 
All children with valid PA data were divided into four groups based on gestational age: 25-32 
weeks, 33-34 weeks, 35-36 weeks and 37-43 weeks (term control). Gestational age was 
based on maternal reporting of the last menstrual period and paediatric assessment at birth 
for the majority of the cohort, with antenatal ultrasounds scans only being available in a 
minority of cases in the early 1990s (Lawlor et al., 2008). 
 Lung Function 
Spirometry was performed by the ALSPAC team at the clinic visit according to established 
international guidelines when the children were approximately 7-9 years of age (ATS, 
1995). Measurements of FEV1, FVC and FEF25-75 were converted into z-scores adjusted for 
age, sex and height (Kotecha et al., 2012).  
 Demographics 
Prior to birth the mother completed an antenatal questionnaire which asked her to record 
information regarding smoking habits and her highest level of education which was 
categorised into none, Certificate of secondary education or vocational, O-level, A-level, or 
university degree. Social status was based on the father’s occupation from the same 
questionnaire. Perinatal data on respiratory management were extracted from hospital 
records. 
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  Statistical analysis 
To assess the representativeness of the data available, demographic information was 
compared between participants who attended clinic and provided valid accelerometer data 
and those who did not attend using χ2 tests. This analysis was repeated with participants who 
attended clinic and provided valid data and those attended but did not provide valid data. 
Characteristics of the gestation groups were compared using independent sample t-tests for 
normally distributed data and Mann-Witney U Tests were used for non-normal data. Prior to 
conducting statistical tests, the assumption of normality was tested for all outcome variables. 
At age 11, both variables were found to be significantly positively skewed on visual 
assessment of Q-Q plots.  Loge transformation of Total PA and e2/5 transformation of MVPA 
resulted in normal distributions as shown on the following Q-Q plots (Figure 4-1). Sedentary 
behaviour was normally distributed. At age 15 years, both Total PA and MVPA variables were 
positively skewed. Total PA was normalised by loge and MVPA by square-root 
transformation. Sedentary behaviour was normally distributed. Z-scores were also created 
for each PA variable in order to perform correlations with lung function values.  
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Figure 4-1: Q-Q plots of transformed variables a) Total PA age 11, b) MVPA age 11, c) 
Total PA age 15 and d) MVPA age 15. Normality is observed when data points largely 
follow the line of best fit 
 
One-way ANOVA (with post-hoc multiple comparisons using Bonferroni correction) was 
used to investigate differences in PA between the gestation groups. Levene’s test was 
conducted to assess homogeneity of variance. All analyses were stratified by gender as 
previous studies using this cohort have shown significant differences in PA between boys 
and girls (Riddoch et al., 2007). 
Since low birthweight and obesity have been previously identified as risk factors for reduced 
levels of PA, the analysis was repeated excluding term-born individuals with a z-score of less 
than 10th centile or greater than 80th centile for birthweight (World Health Organisation, 
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2002). Children born between the 20th and 80th centiles were therefore selected as control 
subjects in this secondary sensitivity analysis.   
 
 Results 
Valid PA data at age 11 were available for 5,327 children. 5,025 were term-born (≥37 
weeks’ gestation); 48 were born at 25-32 weeks, 57 were born at 33-34 weeks, and 197 
were born at 35-36 weeks’ gestation. Children born between 25-32 weeks’ gestation had 
significantly increased rates of doctor-diagnosed asthma when compared to the term-born 
controls. At age 15, valid PA data were available for 1,947 children of which 1,829 were 
term; 24 were born at 25-32 weeks, 32 were born at 33-34 weeks, and 62 were born at 35-
36 weeks’ gestational age (Table 4-1).  The maximum duration of ventilation during the 
perinatal period for children with valid accelerometer data was 624 hours (approximately 
26 days); of those children admitted to the neonatal unit, few were receiving supplemental 
oxygen for 5 days or more (Table 4-2). 
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Table 4-1: Characteristics of participants included in the PA analysis 
 25-32w 33-34w 35-36w Term 
Total Liveborn 185 169 522 13,164 
Survivors at 1 year 161 166 520 13,133 
Had PA data @11 48 57 197 5,025 
Median age, years (IQR) 11.6 
(11.4-11.7) 
11.5 
(11.4-11.6) 
11.6 
(11.4-11.7) 
11.5 
(11.4-11.7) 
Mean Height, cm (SD) 148.3 
(8.4) 
148.7 
(5.8) 
151.2 
(8.4) 
150.7 
(7.3) 
Mean Weight, kg (SD) 41.5 
(12.0) 
40.5 
(7.2) 
43.2 
(9.6) 
43.5 
(9.8) 
Had Lung function data @8 38 50 158 4169 
Current asthma @7.6 (%) †* 7/25 
(28) 
8/38 
(21) 
15/118 
(13) 
454/3,343 
(14) 
Had PA data @15 24 32 62 1,829 
Median age, years 15.4  
15.3-15.5) 
15.4 
(15.3-15.6) 
15.4 
(15.3-15.6) 
15.4 
(15.3-15.5) 
Mean Height, cm (SD) 168.4 
(9.5) 
167.3 
(8.7) 
169.2 
(7.6) 
168.8 
(8.3) 
Median Weight, kg (IQR) 59.8 
(51.5-64.7) 
61.2 
(49.1-67.4) 
58.6 
(54.4-66.2) 
59.2 
(53.4-66.6) 
*p<0.05 
†based on reported doctor-diagnosed asthma ever with symptoms and/or treatment in previous 12 
months. Those with both PA and lung function measurements; denominators are given as this 
variable had missing data. 
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Table 4-2: Neonatal characteristics for children with PA measurements at 11 
 25-32w 33-34w 35-36w Term 
Mean Birthweight, g (SD) 1,471 
(453) 
2,246 
(427) 
2,682 
(425) 
3,469 
(476) 
Oxygen at any time (%)* 37 
(77) 
21 
(36) 
9 
(4.5) 
36 
(0.7) 
Numbers (%) receiving 
oxygen treatment for:* 
    
    Less than 1 day 14 (29) 10 (18) 5 (2.5) 26 (0.6) 
    2-4 days 5 (4) 7 (12) 4 (2.0) 7 (0.1) 
    ≥5 days* 18 (38) 4 (7.0) 0 (0) 3 (0.1) 
Ever ventilated (%)* 31 (65) 9 (16) 2 (1.0) 9 (0.2) 
Mean (range) duration of 
ventilation (h)* 
120 (1-624) 76 (9-105) 45 (8-82) 53 (1-576) 
Surfactant (%) 15 (31) 5 (9.0) 0 (0) 1 (0.02) 
*It was assumed the answer was no for children who did not have a neonatal admissions 
questionnaire completed, hence percentages are calculated based on the total number in the group 
who had valid PA data, not the number who had neonatal admissions questionnaires completed. 
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Children who provided valid accelerometry data were more likely to be girls, white, have 
non-smoking mothers with a higher level of education, and be of higher socio-economic 
status when compared with children who did not attend the clinic (Table 4-3). A similar 
pattern was seen in comparison with children who took part in activity monitoring but 
failed to provide valid data (no differences in sex and ethnicity). These results are 
consistent with previous findings in this cohort (Riddoch et al., 2007) and were similar at 
age 15. 
In all gestation groups, females were more sedentary and were significantly less active than 
males. The median levels of MVPA were substantially lower than the recommended levels 
of 60 minutes per day (Preterm females 16.2, males 26.6 min∙day-1; Term females 15.6, 
males 25.5 min∙day-1). There was no strong evidence of differences in Total PA, MVPA or 
sedentary behaviour between children born preterm and those born at term at age 11 
years (Figure 4-2 and Table 4-4).  
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Table 4-3: Demographics of children participating in accelerometry 
 Attended age 11 clinic visit Attended age 15 clinic visit 
 Valid PA data 
N= 5327 
Did not 
attend 
N= 8166 
Valid PA data 
N= 1947 
Did not 
attend 
N= 8726 
Sex§*     
Male 2547 (48%) 4428 (54%) 868 (45%) 4742 (54%) 
Female 2780 (52%) 3736 (46%) 1079 (55%) 3984 (46%) 
Maternal smoking§*     
Smoking 942 (18%) 2355 (32%) 287 (15%) 2539 (32%) 
Non-smoking 4295 (82%) 5093(68%) 1631 (85%) 5483 (68%) 
Socio-economic status§*     
Manual 1893 (38%) 2921 (48%) 636 (35%) 3247 (49%) 
Non-Manual 3047 (62%) 3217 (52%) 1206 (66%) 3405 (51%) 
Ethnicity§*     
Other 195 (4%) 397 (6%) § 68 (4%) 396 (6%) 
White 4887(96%) 6155 (94%) 1807 (96%) 6699 (94%) 
Mother’s education§*     
CSE 660 (13%) 1767 (26%) 188 (10%) 1916 (26%) 
Vocational 428 (8%) 743 (11%) 119 (6%) 826 (11%) 
O Level 1840 (36%) 2286 (34%) 660 (35%) 2534 (35%) 
A Level 1386 (27%) 1308 (19%) 553 (29%) 1369 (19%) 
Degree 843 (16%) 697 (10%) 384 (20%) 704 (10%) 
Gestational age     
Term 5025 (94%) 7660 (94%) 1829 (94%) 8168 (94%) 
35-36 197 (4%) 303 (4%) 62 (1%) 355 (1%) 
33-34 57 (1%) 102 (1%) 32 (2%) 103 (1%) 
25-32 48 (1%) 101 (1%) 24 (3%) 102 (4%) 
§ Age 11 Attendees with valid data Vs. non-attendees: χ2 test, p<0.05 
*Age 15 Attendees with valid data Vs. non-attendees:  χ2 test, p<0.05 
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Figure 4-2 Levels of sedentary, light and MVPA (mins day-1) in males and females at age 11 (top) and age 15 (bottom). Levels of MVPA are noted to make 
up a small proportion of the average minutes per day spent active. Levels of PA decline significantly from age 11 to age 15 years with sedentary 
behaviour increasing at the expense of light-intensity PA. There are no differences in the levels of PA or sedentary behaviour between groups of 
gestational age. 
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Table 4-4: Levels of physical activity by gestation group 
Age 11 25-32w 
N= 48 
33-34w 
N=57 
35-36w 
N=197 
All Preterm 
302 
Term 
N=5025 
Term (20-80th 
centile for BW) 
N= 2803 
Total PA  
(cpm) 
M 649 (551-875) 733 (541-877) 636 (537-771) 658 (540-826) 645 (528-772) 647 (535-771) 
F 567 (501-689) 590 (476-709) 529 (442-617) 544 (459-653) 527 (443-636) 530 (442-630) 
Sedentary 
(min∙day-1) 
M 393 (350-450) 399 (350-440) 407 (360-456) 404 (353-451) 421 (374-464) 419 (375-463) 
F 417 (374-457) 404 (351-467) 432 (401-472) 422 (392-470) 442 (395-483) 441 (394-483) 
Light 
(min∙day-1) 
M 335 (312-382) 336 (284-368) 331 (291-380) 332 (294-380) 333 (295-375) 334 (296-376) 
F 325 (286-362) 332 (296-392) 325 (288-367) 328 (291-367) 317 (280-356) 318 (279-357) 
MVPA  
(min∙day-1) 
M 25.1 (18.2-39.2) 33.5 (20.7-44.7) 25.8 (16.3-36.1) 26.6 (17.0-39.0) 25.5 (15.7-37.9) 25.6 (15.9-38) 
F 19.4 (10.6-30.5) 21.6 (11.4-26.2) 15.2 (9.5-25.3) 16.2 (9.7-25.8) 15.6 (15.6-24.3) 15.9 (9.7-24.3) 
Age 15 25-32w 
N=24 
33-34w 
N=32 
35-36w 
N=62 
All Preterm 
N=118 
Term 
N=1829 
Term (20-80th 
centile for BW) 
N= 992 
Total PA  
(cpm) 
M 445 (389-615) 601 (515-839) 462 (402-574) 516 (411-692) 511 (407-644) 510 (405-641) 
F 352 (283-480) 394 (308-507) 381 (331-474) 379 (321-475) 412 (337-502) 411 (337-497) 
Sedentary 
(min∙day-1) 
M 529 (483-600) 482 (417-575) 526 (490-548) 526 (458-573) 518 (465-562) 519 (468-561) 
F 551 (491-588) 535 (480-579) 546 (481-572) 541 (484-573) 529 (486-569) 533 (492-569) 
Light 
(min∙day-1) 
M 251 (212-288) 286 (252-334) 239 (214-280) 256 (220-297) 250 (215-290) 244 (213-287) 
F 188 (161-262) 244 (201-293) 220 (194-246) 223 (189-252) 234 (202-267) 234 (202-268) 
MVPA  
(min∙day-1) 
M 24 (13.0-46.4) 35.2 (18.0-66.8) 22 (15.6-33.0) 25.2 (14.7-39.4) 26.0 (16.7-41.4) 26.0 (17.0-40.3) 
F 12.5 (7.8-19.0) 18.7 (5.0-27.3) 15.8 (6.7-21.3) 15.4 (7.1-22.0) 14.7 (7.5-25.4) 14.8 (8.0-25.4) 
Data are medians (IQRs) 
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Lung function values for each gestation group compared to term are shown in Table 4-5. 
Children born at 25-32 weeks and at 33-34 weeks’ gestation had statistically significant 
decrements in standardised FEV1: mean difference -0.54 (p<0.05, 95%CI -0.98, -0.11) and -
0.59 (p<0.05 95% CI-0.98, -0.20) and in FEF25-75: mean difference -0.61 (p<0.05 95%CI -1.05, 
-0.18) and -0.53 (p<0.05 95%CI -0.91, -0.15), respectively, when compared to term controls. 
Values in the late preterm group (35-36 weeks) were similar to those born at term. When 
spirometry measures were plotted against values of PA, there were no significant 
correlations; the best model fit was between Total PA and FEV1 in the 25-32 weeks’ 
gestation group (R2=0.1, p=0.06), but numbers in the sub-group were small (38 individuals 
with both measurements).  
 Table 4-5: Difference in standardised lung function measurements in preterm groups 
compared to terms 
 25-32 weeks N=38  Term N=4169   
 Mean SD  Mean SD  Difference 
FEV1 -0.54 0.78  0.0017 1.00  -0.54 (-0.98, -0.11)* 
FVC -0.25 0.88  -0.0002 0.995  -0.24 (-0.68, 0.19)  
FEF25-75 -0.61 1.04  0.0032 1.00  -0.64 (-1.12, -0.15)* 
 33-34 weeks N=50  Term N=4169   
 Mean SD  Mean SD  Difference 
FEV1 -0.59 1.13  0.0017 1.00  -0.59 (-0.98, -0.20)* 
FVC -0.34 1.11  -0.0002 0.995  -0.34 (-0.72, 0.03) 
FEF25-75 -0.53 1.16  0.0032 1.00  -0.56 (-0.99, -0.12)* 
 35-36 weeks N=158  Term N=4169   
 Mean SD  Mean SD  Difference 
FEV1 0.05 0.90  0.0017 1.00  0.05 (-0.17, 0.27) 
FVC 0.047 0.94  -0.0002 0.995  0.05 (-0.17, 0.26) 
FEF25-75 0.029 0.91  0.0032 1.00  0.026 (-0.19, 0.24) 
*p<0.05 
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At 15 years of age levels of MVPA were similar to those at age 11 (Preterm females 15.4, 
males 25.2 min∙day-1; Term females 14.7, males 26.0 min∙day-1), although Total PA was 
significantly reduced and sedentary behaviour increased in both boys and girls. There was 
no evidence of differences in PA between preterm-born children and term controls (Figure 
4-2, Table 4-4)  
  Discussion 
The results of this study show that objectively measured levels of PA, in terms of both 
frequency and intensity, were remarkably similar in both preterm and term-born children 
despite documented deficits in lung function in the former group. No relationship between 
lung function and PA measures was noted in this general population sample.  
Previous studies have shown, using questionnaire based methods, that preterm-born 
children self-report reduced PA when compared with term-born peers (Welsh et al., 2010, 
Joshi et al., 2013). Although these reports are based on subjective measures, they indicate 
at least a perception of reduced capacity for PA that could perpetuate a cycle of self-
limitation which persists into adulthood. Welsh et al. noted that children born extremely 
preterm (≤25 week’s gestation) self-reported lower exercise capability and employed  
increased breathing and lower tidal volumes during peak exercise when compared with 
matched term controls (Welsh et al., 2010), but these observations did not correlate with 
objectively measured accelerometer activity where reductions were not noted between 
the preterm-born and term-born groups. In a recent study, self-reported PA (hours per 
week), was significantly lower in preterm-born children who had suffered from BPD/CLD 
when compared to those did not, and when compared to term-born controls (Joshi et al., 
2013).  Similarly, a study by Clemm and colleagues showed reduced self-reported 
frequency and duration of PA in both extremely preterm-born children and young adults 
when compared with well-matched term controls (Clemm et al., 2012). The disparity 
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between questionnaire data and accelerometer data may be explained by the difficulties in 
recording PA in children. Periods of activity are sporadic and short in duration resulting in 
poor recall by participants; self-reporting using questionnaires do not correlate well with 
directly observed measurements (Riddoch et al., 2004) 
If decrements in lung function were to manifest as reduced PA, this would likely be under 
the scenario in which children choose not to take part due to the symptoms associated 
with exercise limitation (e.g. breathlessness), perhaps in combination with psychosocial 
pressures of being unable to perform.  Given the results of my study it is likely that few 
children are regularly undertaking activity of the intensity required to provoke such adverse 
response. Indeed, in comparison to terms, the preterm group as a whole (<37 weeks’ 
gestation) appear to take part in more MVPA at 11 years of age, raising the possibility that 
low activity levels in term-born children may mask the effect of any differences in lung 
function. Airway obstruction did not appear to hinder exercise performance in the studies 
by Clemm, but incidence of exercise-induced bronchoconstriction and reversibility were 
not reported. It has been recently demonstrated that exercised-induced 
bronchoconstriction, manifested as reduced FEV1, in preterm-born children with and 
without BPD/CLD. This was reversible following administration of salbutamol in the 
BPD/CLD group. The same study also showed that at peak exercise, preterm-born children 
have different breathing patterns, using increased ventilatory reserve to maintain similar 
oxygen uptake at maximal or peak exercise (V̇O2) as term-born children (Joshi et al., 2013). 
Other studies have shown a difference in peak volume of oxygen consumption (V̇O2), as 
well as reduced anaerobic threshold, lower peak workload and increased residual volume 
in preterm-born children (Welsh et al., 2010, Kilbride et al., 2003, Smith et al., 2008) 
especially in those with BPD/CLD. Together these deficits suggest airflow obstruction, 
reduced lung compliance, and gas trapping which may all be results of injury to the 
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developing lung in the postnatal period. Moreover, the reduced DLCO reported in some 
studies would further indicate disruption in the alveolar and pulmonary microvascular 
development in preterm-born children. Emerging studies using hyperpolarised 3He 
Magnetic Resonance Imaging to investigate alveolar size and number in preterm-born 
children should help to elucidate the influence of acinar development, which appears to 
continue in to childhood and beyond (Narayanan et al., 2012, Narayanan et al., 2013), well 
beyond the currently accepted dogma of lung growth being completed by 2 years of age.  
My population sample included few children with a history of ventilation ≥5 days or 
supplemental oxygen, few children born extremely preterm in the ≤32 weeks’ gestation 
group, and did not note differences between the groups for ‘doctor-diagnosed asthma’. 
These factors may in part explain the similar levels of activity. Additionally, given the 
inherent selection bias in cohort studies (selecting those who attended the clinic, those 
with valid accelerometer data, and those with valid lung function measurements) it is likely 
that those with severe cognitive or physical impairments have been excluded, although 
those with degrees of developmental coordination disorder (DCD) may have been. In a 
previous study, boys with probable DCD (between 5th and 15th centile for coordination 
score) were found to have significantly reduced levels of MVPA, but the differences were 
small and levels were similar to those reported in this study (Green et al., 2011). 
It is difficult to disentangle the relative influence of birthweight and gestational age, two 
different developmental constructs, when comparing my results with other studies.  
Ridgway et al. reported no association between PA measured by accelerometer and 
birthweight in a meta-analysis of 4 studies in children (Ridgway et al., 2011). However, 
children most likely to have been born preterm (<1500g birthweight) were excluded from 
the analysis as gestational age was not universally available. In contrast, a meta-analysis by 
Andersen et al. synthesized the results from 13 cohorts of adolescents and adults and 
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showed reduced leisure time PA in participants born with very low or very high birthweight 
(Andersen et al., 2009). The association was strengthened when gestational age was 
included in the model but this analysis was limited by missing data. In a recent study, 12- 
year old children born with high birthweight (>4000g) participated in an additional 1 hour 
per week of outdoor PA than very low birthweight (<2000g) peers, independent of 
gestational age (Gopinath, 2013). When I performed a repeat analysis to remove the 
influence of low birthweight and emerging obesity from the term control group by 
excluding children <20th centile and >80th centile for birthweight, my results remained 
unchanged.   
Kaseva and colleagues reported that very low birthweight preterm-born adults participated 
in significantly less ‘conditioning leisure time PA’ than matched controls who were born at 
term, and extremely low birthweight-born young adults perceive themselves as less 
physically able suggesting that inactivity may track in to adulthood (Kajantie and Hovi, 
2014). Contrastingly, despite markedly reduced lung function, Burns et al. (Burns et al., 
2009), reported no association between reduced FEV1 and cardiorespiratory endurance in 
extremely low birthweight 12-year olds, further indicating that at least during childhood, 
the cardiopulmonary system is able to compensate for airflow limitation. 
Interestingly, although there was no change in levels of MVPA between the ages of 11 and 
15 years, Total PA decreased and sedentary behaviour increased. Previous studies in the 
ALSPAC cohort have shown the increase in sedentary behaviour to be at the expense of 
light intensity PA (Mitchell et al., 2012). Although sedentary behaviour has evolved to be 
considered a separate construct independent from MVPA, a recent meta-analysis 
demonstrated that increased MVPA was associated with reduced cardiometabolic risk 
factors regardless of levels of sedentary behaviour. A modest increase in 20 minutes per 
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day was required to move from the bottom to the top tertile of MVPA (Ekelund et al., 
2013), which given the result of this study is achievable for all preterm-born children.  
 Strengths and limitations 
The main strength of this study is the use of objectively measured PA data collected in the 
‘free living’ environment (Mattocks et al., 2008) using a device validated against criterion 
standards (Mattocks et al., 2007). Data were taken from participants in a large cohort study 
which is representative of the UK population. 
In common with other long term observational studies, there was considerable loss to 
follow-up of participants with valid accelerometry data at ages 11 and by 15 years. None of 
the preterm-born children had both valid accelerometer data and lung function data at age 
15.  Additionally, the children who attended the clinic visits and recorded valid 
accelerometer data were more likely to come from families of higher socio-economic 
backgrounds compared with those who did not attend. However this is unlikely to 
introduce major bias as lower socio-economic status was weakly associated with marginally 
increased PA in the cohort as a whole (Riddoch et al., 2007).  
As levels of PA were low in both term and preterm-born children, the sensitivity of the 
accelerometer may not be sufficient to identify subtle differences between groups. The 
length of epoch used (1 minute) may underestimate the amounts of MVPA as movement in 
children is often sporadic, although any such differences which are missed due to 
measurement error would be of questionable utility. Investigation of vigorous PA only 
(VPA, > 6000 cpm) showed no differences between groups; however, the contribution of 
VPA formed only a small part of MVPA. One possible reason for this is the upper range of 
acceleration which can be measured by the Actigraph is 2.5g. Since more strenuous 
activities such as dancing, jogging/running and jumping can elicit accelerations well above 
this threshold, the Actigraph device was limited in its ability to detect these higher-impact 
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activities. Such activities are more likely to challenge the cardiorespiratory system and thus 
provoke adverse symptoms which may lead to decreased participation in activity. This may 
account for the disparity between questionnaire studies, where children were more likely 
to recall participation in organized activities (such as physical education lessons, attending 
sports clubs), and accelerometry which records mainly habitual activity.  
Lastly, qualitative data on participation in activities such as swimming (as the device was 
removed for water-based activity) and cycling (which is poorly captured by the Actigraph 
device) was not available.  However, previous studies have shown repeating analyses in 
children who did not take part in these activities did not affect the results (Ness et al., 
2007).    
 Summary and conclusions 
I did not observe a difference in objectively measured habitual PA in children born preterm 
compared with term-born children. Given that capacity for exercise is equal to their term-
born peers and appears both safe and beneficial, PA should be encouraged thus forming 
habits persisting in to adulthood. PA has the potential to improve cardiopulmonary health 
and ameliorate the increased risk of chronic lung disease later in life in this vulnerable 
group. This deserves attention and future studies should take advantage of technological 
developments to allow monitoring of participants over the complete range of activity. 
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5 Physical activity and sedentary behaviour in preterm-born 7-year 
old children 
 Overview 
In the previous chapter, I investigated the levels of objectively measured levels of habitual 
PA in 11 and 15-year old children born preterm in the 1990s using data from ALSPAC and 
found no evidence of differences compared to children born at term. However, there were 
some methodological limitations including a possible underestimation in levels of 
Moderate to Vigorous Physical Activity (MVPA) due to the longer accelerometer epoch time 
which may not capture the sporadic PA commonly observed in children. Overall levels of PA 
were also low and this may have masked the effect of preterm birth; thus, it may be better 
to study a younger cohort of children. In this chapter, I now describe an investigation into 
objectively measured levels of physical activity and sedentary behaviour from 7-year old 
preterm children who participated in the Millennium Cohort Study (MCS). This cohort 
reflects the modern era of neonatal care including innovations such as the routine use of 
exogenous surfactant, routine maternal antenatal corticosteroid administration and more 
gentle forms of ventilation. In comparison to the ALSPAC cohort, who were born in the 
early 1990s, these interventions are likely to have improved the respiratory outcomes of 
preterm birth. However, during this time rates of BPD/CLD have stayed largely the same, 
largely due to increased survival at the extremes of viable gestational age (Costeloe et al., 
2012). Additionally, the MCS was designed to disproportionally sample from areas of lower 
socio-economic status and may be a more representative of the preterm population than 
that studied in the previous chapter. 
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 Aims and Hypothesis 
The aims of this study were to compare the levels of physical activity and sedentary 
behaviour in preterm-born children to those of children born at term, and to further 
investigate whether respiratory symptoms and family history of atopy mediate any 
observed relationships between preterm-birth and physical activity. 
My specific hypotheses were: 
I. That preterm-born children would participate in reduced levels of total PA and 
MVPA; and that levels of sedentary behaviour would be increased when compared 
to term-born controls. 
II. That current respiratory symptoms would mediate the observed associations 
between preterm birth and physical activity outcomes. 
 
 Methods 
 Millennium Cohort Study 
I used data from the MCS, a UK-based geographically representative cohort which 
disproportionally sampled areas of ethnic minorities and lower socio-economic status in 
England as well as the devolved nations of the UK (Wales, Scotland and Northern Ireland) 
(Hansen, 2012). The cohort recruited, 18,818 children and families between the years of 
2000-2002 and performed follow-up from the age of nine months and subsequently at 3, 5 
and 7 years of age with data collection ongoing. At the age 7 follow-up, 14,043 of 18,818 
families participated in the home interview where 12,781 of 14,043 participants (91%) 
agreed to wear the activity monitor (University of London, 2008). Valid PA data (at least 10 
hours on at least 2 days) were available for 6,675 participants representing 52% of the 
children included at 7 years of age. After removing those with missing gestational age at 
birth (n=253), 6,422/12,781 (50%) children were included (Figure 5-1). Written informed 
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consent was obtained prior to data collection from the child’s caregiver. Ethics approval 
was given by the Northern and Yorkshire research ethics committee. I used the 
downloadable data which does not contain personal identifiable information.  
 
Figure 5-1 Flow diagram of MCS participants with available PA and gestational age data at 
age 7 
 
 Physical activity 
Children were provided with a uniaxial accelerometer (Actigraph GT1M, Pensacola, Florida, 
USA) to wear around the waist during waking hours for seven consecutive days. The device 
has been validated against criterion standards and the methods for data recording, 
processing and establishing activity ‘cut-point’ thresholds are described in my introduction. 
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(Pulsford et al., 2011). Valid data were considered to be a recording of a minimum of 10 or 
more hours on 2 or more days of recording (Rich et al., 2013b, Pulsford et al., 2011). 
Three outcomes were used in the analysis: Total PA, the average number counts per 
minute over the period of the valid recording; MVPA, defined as average time in minutes 
per day spent at >2241cpm over the period of the valid recording; and sedentary 
behaviour, average time in minutes per day spent at <100cpm. Total PA was used as it 
provides a summary measure of activity and is the variable used for comparison in 
calibration studies (Pulsford et al., 2011). MVPA was used because national guidelines 
recommend at least 60 minutes of MVPA per day (Chief Medical Officers of England, 2011). 
Sedentary behaviour was investigated as it has been described as an risk factor for poor 
health outcomes, independent of MVPA (Mitchell et al., 2009). 
 
 Perinatal data 
Perinatal data on birthweight, admission to the neonatal intensive care unit and length of 
hospital stay were extracted from hospital records by the MCS team (University of London, 
2008). Gestational age was derived from maternal report of the expected due date during 
the 9-month interview, which was based on the date of the last menstrual period and results 
of the antenatal ultrasound scan. These data have been shown to provide an accurate 
estimation when compared to linked hospital database records (Poulsen et al., 2011). 
Children with valid accelerometry data were divided into four groups based on gestational 
age at birth: 25-32, 33-34, 35-36 and 37-43 weeks’ gestation (term control).This approach is 
similar to our other studies on lung function (Kotecha et al., 2012), will allow comparison to 
the previous chapter and that of others as it represents specific stages in lung development 
and children most at risk of lung disease (Boyle et al., 2012, Greenough, 2012). 
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 Respiratory outcomes 
Rates of wheeze and atopy in the last 12 months were derived from interviews conducted 
by the MCS study team during the home visit at 7 years of age. Use of such data for 
assessing respiratory outcomes, using a modified ISAAC questionnaire, is well-established 
and extensively validated (Asher et al., 1995). 
 
 Demographics 
Information on gender, ethnicity, mother’s smoking habits during pregnancy and educational 
qualifications were collected at the home-based interview conducted after 9 months of age 
(University of London, 2003). Highest level of education was categorized into none, other, 
GCSE, A-level, or university degrees.  At the 7 years of age home visit data on the child’s age, 
weight and height were measured, from which BMI was calculated. Social class was based 
on the 5-category UK Office for National Statistics Socio-economic Classification (NS-SEC) 
which relates to maternal employment (last known job) at the age 7 years visit.   
 
 Statistical analysis 
Firstly, in order to assess the representativeness of the available data, χ2 tests were used to 
compare demographics between participants who provided valid PA data and those who 
did not.  
Secondly, I compared birth characteristics of the four groups of gestational age using 
ANOVA for normally distributed data, and used Kruskal-Wallis Tests for non-normal data. 
Since total accelerometer wear time was not consistent across all participants, the methods 
of Griffiths were used to standardise the measures of MVPA and sedentary behaviour 
(Griffiths et al., 2013). This was achieved by introducing a standard day of equal duration 
(735 minutes) for all children which is equal to the mean wear time across all valid days of 
recording. A weighting variable is then computed for each measure of intensity and 
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multiplied with the total time spent at a given intensity. Finally, the weighted total time is 
divided by the value of the standard day to give a weighted mean time spent at an activity 
intensity across the valid days of recording. This procedure was performed using Stata 
(Version 12, StataCorp, Texas USA), applying the syntax provided in the MCS technical 
report on processing of accelerometry data (Griffiths, 2013) . Each PA variable was then 
tested for normality using P-P plots; MVPA was found to have a positively skewed 
distribution and was therefore square-root transformed prior to analysis (Figure 5-2). Total 
PA and sedentary behaviour did not require transformation. 
 
 
Figure 5-2: P-P plots of A) MVPA raw data showing deviation from the line of best fit 
indicative of a positive skew, and B) MVPA transformed data 
 
In order to investigate the effect of gestational age on measures of activity (Total, MVPA or 
sedentary behaviour), I opted to use a series of general linear models. Since results in the 
previous chapter showed a significant difference between levels of activity in males and 
females, the association between gestation group and PA was tested for an interaction 
with gender. As expected there was significant evidence (p<0.001) of an interaction hence 
all analyses were stratified by gender. In model 1 (adjusted for birth factors only), gestation 
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group, single or multiple births, intrauterine growth restriction status (IUGR, defined as 
<10th centile for standardised birthweight [LMS Grow Program; Medical Research Council, 
UK]), admission to the neonatal unit and maternal smoking in pregnancy were included; 
model 2 adjusted for the variables in model 1 plus age, body mass index (BMI) and season 
of accelerometry data collection at the 7-year visit; model 3 adjusted for the variables in 
models 1 and 2 plus social factors at the 7-year visit: ethnicity, maternal education and 
social class;  model 4 adjusted for the variables in models 1, 2 and 3 plus respiratory 
symptoms: current wheeze and atopy. General linear modelling was performed using SPSS 
Statistics (version 20, IBM, Chicago, IL., USA).  
In order to further investigate the mediation of respiratory symptoms (current wheeze and 
atopy) on the association between gestational age and measures of PA, I conducted 
mediation analysis. This enables distinction between the direct effect, which is the 
relationship of the independent variable on the dependent variable, adjusting for the 
mediating variable, and the indirect effect, which is the effect of the independent variable 
on the dependent variable through the mediating variable. Mediation is said to occur if the 
strength of the relationship between the predictor and the outcome is diminished by 
including a mediator (Field, 2013). Mediation analysis was performed with Mplus using 
structural equation modelling (version 7, Muthen and Muthen, Los Angeles, California 
USA). For all analyses p<0.05 was considered statistically significant. 
 
 Results 
After excluding participants without valid accelerometry and gestational age data, 79 
children were born at 24-32 weeks’, 119 were born at 33-34 weeks’, and 275 were born at 
35-36 weeks’ gestation. The control population consisted of 5949 children born at term 
(37-43 weeks’ gestation), Table 5-1. Children born at ≤32 weeks’ gestational age were 
noted to have a significantly lower BMI and had increased incidence of recent wheeze and 
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asthma when compared to those born at term. Rates of atopy were similar between 
gestation groups. Preterm-born children were more likely to be born to mothers who 
smoked during pregnancy; however, there were no significant differences in socio-
economic status when measured by maternal employment or maternal education.  
 
Table 5-1 Characteristics of participants included who had valid PA data and gestational 
age data 
 25-32w 33-34w 35-36w Term 
Total Cohort 253 373 876 17063 
Had PA data at age 7 79 119 275 5949 
Gender, M (%) 37/79  
(46.8) 
57/119  
(47.9) 
135/275  
(49.1) 
2901/5949  
(48.8) 
Mean age, years (SD) 7.3  
(0.3) 
7.2  
(0.2) 
7.2  
(0.2) 
7.2  
(0.2) 
Mean Height, cm (SD) 122  
(5.9) 
122  
(5.6) 
123  
(5.8) 
124  
(5.4) 
Mean Weight, kg (SD)§ 23.3  
(4.4) 
24.3  
(4.2) 
25.2  
(5.1) 
25.2  
(4.5) 
Mean BMI (SD) § 15.5  
(1.96) 
16.2  
(1.9) 
16.5  
(2.4) 
16.4  
(2.4) 
Wheeze at 7 (%) § 17/79  
(21.5) 
12/119  
(10.1) 
34/274  
(12.4) 
661/5941  
(11) 
Asthma at 7 (%) § 19/79  
(24.1) 
24/118  
(20.3) 
47/272  
(17.3) 
878/5936  
(14.8) 
Atopy at 7 (%) 35/79  
(44.3) 
49/119  
(41.2) 
125/274  
(45.6) 
2446/5943  
(41.4) 
Neonatal characteristics  25-32w 33-34w 35-36w Term 
Mean Birthweight, g (SD) § 1619  
(614) 
2147  
(507) 
2683  
(503) 
3452  
(495) 
IUGR§ 9/79  
(11.4) 
22/119  
(18.5) 
25/274  
(9.1) 
522/5944  
(8.8) 
Caesarean section (%) § 44/79  
(55.7) 
60/119  
(50.4) 
102/275  
(37.1) 
1244/5922 
(21.0) 
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Admitted to Neonatal unit (%) § 69  
(87.3) 
87  
(73.1) 
91  
(33.1) 
351  
(5.9) 
Length of stay after 
birth, days (SD) § 
44  
(27.6) 
19  
(20.3) 
8  
(8.4) 
3  
(6.0) 
Breastfeeding (%) § 58/79  
(73.4) 
81/119  
(68.1) 
187275  
(68.0) 
4454/5949  
(74.9) 
Socio-economic characteristics  25-32w 33-34w 35-36w Term 
Maternal smoking in pregnancy (%) §     
Smoking 24/78 
(30.8) 
42/119  
(35.3) 
91/275 
(34.2) 
1636/5944  
(27.5) 
Non-smoking 54/78 
 (69.2) 
77/119  
(64.7) 
181/275  
(65.8) 
4308/5944  
(72.5) 
Employment status (%)     
Management/Professional 28/76  
(36.8) 
33/110  
(30.0) 
86/259  
(33.2) 
2119/5703  
(37.2) 
Intermediate 12/76  
(15.8) 
22/110  
(20.0) 
64/259  
(24.7) 
1115/5703  
(19.6) 
Self employed 7/76  
(9.2) 
11/110  
(10.0) 
15/259  
(5.5) 
446/5703  
(7.8) 
Supervisory/Technical 5/76  
(6.6) 
8/110 
 (7.3) 
12/259  
(4.6) 
260/5703  
(4.6) 
Semi routine/routine 24/76  
(31.6) 
36/110  
(32.7) 
82/259  
(31.7) 
1763/5703 
 (30.9) 
Ethnicity (%)     
White 68/79  
(86.1) 
105/119  
(88.2) 
247/275  
(89.8) 
5261/5938 
 (88.6) 
Other 11/79  
(13.9) 
14/119  
(11.8) 
28/275 
 (10.2) 
677/5938  
(11.4) 
Mother’s education (%)     
None of these 13/79  
(16.5) 
12/119  
(10.1) 
36/275  
(13.1) 
640/6418  
(10.8) 
Other academic 0  
(0.0) 
0/119  
(0.0) 
1/275  
(0.4) 
133/6418  
(2.2) 
GCSE grades D-G 6/79  
(7.6) 
15/119  
(12.6) 
23/275  
(8.4) 
520/6418 
(8.7) 
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GCSE grades (A-C) 27/79 
(34.2) 
41/119  
(34.5) 
107/275  
(38.9) 
1916/6418  
(32.2) 
A or AS levels 5/79 
(6.3) 
10/119  
(8.4) 
22/275  
(8.0) 
676/6418  
(11.4) 
Diplomas in College 8/79  
(10.1) 
17/119  
(14.3) 
29/275  
(10.5) 
648/6418  
(10.9) 
First Degree 16/79  
(20.3) 
22/119  
(18.5) 
51/275 
 (18.5) 
1118/6418  
(18.8) 
Higher degree 4/79  
(5.1) 
2/119  
(2.2) 
6/27  
(2.2) 
297/6418  
(5.0) 
§ p<0.05 
 
In terms of neonatal history, children born at ≤32 weeks’ gestation had a significantly lower 
birthweight, were more likely to be born IUGR, more likely to be born by caesarean section, 
were more likely to be admitted to the neonatal unit, and more likely to have an increased 
length of hospital stay when compared to the term control group (Table 5-1).  
 
There were some small but statistically significant differences between children and 
families who participated in the accelerometry study, and those who did not. Participants 
with valid data were more likely to be female, white, and born at term. Mothers were more 
likely to have achieved a higher educational qualification, have not smoked during 
pregnancy and be of higher socio-economic status (Table 5-2). A previous study 
investigating the demography of non-consent to participate in the accelerometer study 
found consent was less likely for children with limiting illness or disability, those who 
reported exercise less than once per week, and a number of social factors related to 
increased levels of deprivation (Rich et al., 2013a).   
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Table 5-2 Demographics of children participating in accelerometry 
 Participants 
N= 6422 
Non-participants 
N= 12842 
Sex (%)*   
Male 3130/6422 (48.7) 6489/12,336 (52.6) 
Female 3292/6422 (51.3) 5847/12,336 (47.4) 
Maternal smoking in 
pregnancy (%) § 
 
 
 
Smoking 1796/6416 (28.0) 4726/12,294 (38.4) 
Non-smoking 4662/6416 (72.0) 7568/12,294 (61.6) 
Employment status (%) §   
Management/Professional 2337/6012 (38.9) 2565/10,546 (24.3) 
Intermediate 1172/6012 (19.5) 1965/10,546 (18.6) 
Self employed 274/6012 (4.6) 384/10,546 (3.6) 
Supervisory/Technical 352/6012 (5.9) 654/10,546 (6.2) 
Semi routine/routine 1877/6012 (31.2) 4978/10,546 (47.2) 
Ethnicity (%) §   
White 5681/6411 (88.6) 9800/12,300 (79.7) 
Other 730/6411 (11.4) 2500/12,300 (20.3) 
Mother’s education (%) §   
None of these 701/6418 (10.9) 2941/12,272 (24.0) 
Other academic 134/6418 (2.1) 399/12,272 (3.3) 
GCSE grades D-G 564/6418 (8.8) 1424/12,272 (11.6) 
GCSE grades (A-C) 2091/6418 (32.6) 4166/12,272 (33.9) 
A or AS levels 713/6418 (11.1) 1024/12,272 (8.3) 
Diplomas in College 702/6418 (10.9) 885/12,272 (7.2) 
First Degree 1204/6418 (18.8) 1117/12,272 (9.1) 
Higher degree 309/6418 (4.8) 316/12,272 (2.6) 
Gestational age (%)*   
Term 5949 (92.6) 11114/12,143 (91.5) 
35-36 275 (4.3) 601/12,143 (5.0) 
33-34 119 (1.9) 245/12,143 (2.0) 
25-32 79 (1.2) 183/12,143 (1.5) 
* χ2< 0.05; § χ2= <0.001 
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Table 5-3 shows levels of PA by gestation group, presented separately for males and 
females.  Females participated in significantly less PA and spent more time in sedentary 
behaviour. The mean levels of MVPA were close to or exceeded the recommended 
guidelines of 60 minutes per day (Preterm females 55, males 66 min∙day-1; Term females 
55, males 69 min∙day-1). 63% of term-born boys participated in greater or equal to 60 
minutes of MVPA compared to 55% of those born preterm. In females, 34% of those born 
preterm participated in greater or equal to 60 minutes of MVPA compared to 36% of those 
born at term. 
 
Table 5-3 Levels of physical activity by gestation groups adjusted for wear time 
 
25-32w 
N= 79 
33-34w 
N= 119 
35-36w 
N= 275 
All 
Preterm 
N= 473 
Term 
N=5949 
Whole 
cohort 
N=6422 
Total PA M 576 (145) 640 (175) 630 (161) 624 (143) 640 (154) 639 (155) 
(cpm) F 534 (159) 527 (163) 581 (152) 559 (157) 568 (142) 567 (144) 
Sedentary M 404 (45) 385 (48) 383 (50) 386 (49) 384 (49) 384 (49) 
(min∙day-1) F 417 (51) 416 (52) 401 (53) 407 (53) 400 (53) 400 (50) 
Light M 271 (32) 281 (33) 285 (38) 282 (36) 282 (38) 282 (38) 
(min∙day-1) F 265 (38) 269 (39) 276 (41) 272 (40) 280 (39) 279 (39) 
MVPA M 61 (23) 69 (25) 67 (24) 66 (24) 69 (23) 69 (23) 
(min∙day-1) F 52 (21) 51 (22) 58 (20) 54 (21) 55 (19) 55 (19) 
Data are means (SD) 
 
The results of the univariate analyses and the general linear modelling analyses for males 
are presented in Table 5-4 and Table 5-5, respectively. In the minimally adjusted model 
(model 1), gestational age in boys was significantly associated with reduced levels of MVPA 
in the ≤32 weeks’ gestation group when compared to term but not for the 33-34 and 35-36 
week groups. After addition of further sets of variables, this relationship remained 
statistically significant in the fully adjusted model (model 4) (Table 5-5). Although the effect 
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size of gestational age group and contribution to the model fit as a whole were both small; 
when the regression equation derived from model 4 was used to calculate the mean 
predicted values it equated to a difference of approximately 9 minutes per day of MVPA 
between boys born at term (mean predicted MVPA 67.7 min∙day-1) and those born ≤32 
weeks’ gestation (mean predicted MVPA 58.9 min∙day-1) representing over 1 hour of 
decreased MVPA per week. Total PA was also noted to be lower in the ≤32 weeks’ 
gestation group when compared to term in model 1; however, these associations 
attenuated as further variables were added to the model. There was also a significant 
association between gestational age (≤ 32 weeks’ gestation) and increased levels of 
sedentary behaviour for model 1 when compared to term-born controls; this again 
attenuated in models 2 to 4 mainly due to the strong influence of non-white ethnicity and 
higher socio-economic status, both of which were significantly associated with increased 
levels of sedentary behaviour.  
 
Results from univariate analyses, general linear modelling analyses for females are 
presented in Table 5-6 and Table 5-7, respectively. There were no significant associations 
between gestation groups for Total PA, MVPA or sedentary behaviour in the minimally or 
maximally adjusted models. 
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Table 5-4 Univariate analysis of confounders and their association with levels of physical activity (males) 
 Total PA   MVPA   Sedentary   
 B 95% CI p-value B 95% CI p-value B 95% CI p-value 
SDS Birthweight -2.78 -8.13, 2.62 0.32 0.03 -0.08, 0.02 0.24 -0.31 -2.02, 1.40 0.72 
IUGR          
<10th Centile 10.5 -9.00, 30.0 0.29 0.03 -0.14, 0.20 0.75 -4.77 -11.0, 1.41 0.13 
≥10th Centile Ref   Ref   Ref   
Singleton          
Singleton 3.08 -31.3, 37.5 0.86 0.06 -0.25, 0.36 0.71 0.24 -10.7, 11.2 0.97 
Multiple Ref      Ref   
NNU Admission          
Yes -16.29 -34.2, 1.63 0.08 -0.14 -0.30, 0.02 0.08 5.40 -0.30, 11.10 0.06 
No Ref   Ref   Ref   
Maternal Smoking          
Yes 21.4 9.27, 33.5 0.01 0.17 0.06, 0.28 0.002 -2.99 -6.83, 0.86 0.13 
No Ref   Ref   Ref   
Social Class (Mothers 
last employment) 
         
Manage & Prof -19.5 -32.9, -6.03 0.005 -0.15 -0.27, -0.03 0.01 4.99 0.74, 9.24 0.02 
Intermediate -9.67 -25.6, 6.24 0.23 -0.11 -0.25, 0.03 0.13 3.21 -1.82, 8.23 0.21 
Small emp/self em -33.8 -55.9, -11.8 0.003 -0.30 -0.49, -0.10 0.003 4.91 -2.06, 11.9 0.17 
Lo sup/technical -7.23 -34.9, 20.5 0.67 0.00 -0.25, 0.24 1.00 2.39 -6.36, 11.1 0.59 
Routine Ref   Ref   Ref   
Ethnicity          
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White 23.1 6.15, 40.1 0.008 0.03 -1.20, 0.18 0.69 -2.30 -7.70, 3.10 0.40 
Other Ref   Ref   Ref   
Age -5.16 -27.0, 16.7 0.64 0.05 -0.15, 0.24 0.64 10.4 3.44, 17.3 0.003 
Wheeze at 7          
Yes -7.22 -23.1, 8.69 0.37 -0.10 -0.24, 0.04 0.18 0.19 -4.87, 5.25 0.94 
No Ref   Ref   Ref   
BMI at 7 -7.95 -8.50, -3.40 <0.001 -0.08 -0.10, 0.05 <0.001 -0.25 -1.06, 0.57 0.55 
Season of 
accelerometry 
         
Winter -103 -124, -82.1 <0.001 -0.80 -0.99, -0.61 <0.001 30.0 23.2, 36.6 <0.001 
Autumn -84.4 -103, -66.2 <0.001 -0.61 -0.77, -0.44 <0.001 25.8 20.0, 31.6 <0.001 
Summer -38.0 -54.7, -19.5 <0.001 -0.32 -0.48, -0.17 <0.001 7.90 2.32, 13.47 0.006 
Spring Ref   Ref   Ref   
Mothers Education          
None 27.6 -2.35, 57.6 0.07 0.14 -0.12, 0.41 0.30 -14.9 -24.4, -5.37 0.002 
Other -14.5 -62.4, 33.5 0.55 -0.17 -0.59, 0.25 0.43 7.60 -7.65, 22.8 0.33 
GCSE G-D 26.6 -4.40,57.5 0.09 0.08 -0.20, 0.35 0.59 -9.04 -18.9, 0.80 0.07 
GCSE A-C 7.20 -19.5, 34.0 0.60 -0.09 -0.33, 0.15 0.46 -6.22 -14.7, 2.28 0.15 
A/AS level 6.69 -23.2, 36.5 0.66 -0.09 -0.35, 0.18 0.52 -4.27 -13.8, 5.22 0.38 
Higher diploma -0.07 -29.7, 29.6 1.00 -0.14 -0.41, 0.20 0.28 -5.11 -14.5, 4.32 0.29 
First Degree -10.2 -38.2, 17.8 0.48 -0.18 -0.43, 0.07 0.16 -0.12 -8.99, 8.76 0.98 
Higher degree Ref   Ref   Ref   
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Table 5-5 Results of general linear models regressing activity variables on gestation groups adjusting for confounders (males) 
MALES   Total PA  MVPA*  Sedentary 
  n ß 95% CI p-value  ß 95% CI p-value  ß 95% CI p-value 
Model 1 ≤32 29 -67.2 -128, -5.91 0.03  -0.59 -1.13, -0.05 0.03  20.1 0.62, 39.5 0.04 
 33-34 44 -1.92 -53.0, 49.1 0.94  -0.08 -0.53, 0.37 0.72  2.03 -14.2, 18.2 0.81 
 35-36 104 -13.9 -46.0, 18.3 0.40  -0.19 -0.48, 0.09 0.19  0.73 -9.49, 11.0 0.89 
 Term 2377 Ref    Ref    Ref   
Model 2 ≤32 29 -61.6 -122, -1.37 0.05  -0.58 -1.12, -0.05 0.03  15.58 -3.57, 34.7 0.11 
 33-34 44 -1.12 -51.1, 48.9 0.97  -0.09 -0.53, 0.36 0.70  1.22 -14.7, 17.13 0.88 
 35-36 103 -13.2 -44.8, 18.5 0.41  -0.20 -0.48, 0.08 0.16  -0.31 -10.4, 9.77 0.95 
 Term 2366 Ref    Ref    Ref   
Model 3 ≤32 28 -59.8 -121, 1.58 0.06  -0.60 -1.15, -0.06 0.03  14.39 -5.01, 33.8 0.15 
 33-34 43 7.06 -44.0, 58.1 0.79  -0.04 -0.49, 0.42 0.88  -0.25 -16.4, 15.9 0.98 
 35-36 99 -13.7 -45.9, 18.5 0.41  -0.20 -0.49, 0.08 0.16  -0.23 -10.4, 10.0 0.96 
 Term 2263     Ref    Ref   
Model 4 ≤32 28 -58.7 -120, 2.81 0.06  -0.58 -1.12, -0.03  0.04  14.60 -4.85, 34.0 0.14 
 33-34 43 6.93 -44.1, 58.0 0.79  -0.04 -0.49, 0.41 0.87  -0.36 -16.5, 15.8 0.97 
 35-36 98 -13.9 -46.2, 18.5 0.40  -0.20 -0.49, 0.08  0.16  0.05 -10.2, 10.3 0.99 
 Term 2261 Ref    Ref    Ref   
Model 1: adjusted for single or multiple births, intrauterine growth restriction status, admission to the neonatal unit and maternal smoking in pregnancy 
Model 2: as model 1 but additionally adjusted for body mass index, and season of accelerometry data collection 
Model 3: as model 2 but additionally adjusted for ethnicity, maternal education and socio-economic status (mother’s last known employment) 
Model 4: as model 3 but additionally adjusted for current wheeze, atopy 
*MVPA beta values are square root transformed 
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Table 5-6 Univariate analysis of confounders and their association with levels of physical activity (females) 
 Total PA   MVPA   Sedentary   
 B 95% CI p-value B 95% CI p-value B 95% CI p-value 
SDS Birthweight 1.38 -3.21, 5.98 0.56 0.004 -0.04, 0.05 0.85 -1.56 -3.15, 0.03 0.06 
IUGR          
<10th Centile -15.6 -33.1, 1.86 0.08 -0.09 -0.25, 0.06 0.23 5.33 -0.66, 11.3 0.08 
≥10th Centile Ref   Ref   Ref   
Singleton          
Singleton 24.9 -5.12, 55.3 0.11 0.13 -0.14, 0.40 0.34 -11.8 -22.4, -1.33 0.03 
Multiple Ref   Ref   Ref   
NNU Admission          
Yes -15.0 -32.5, 2.53 0.09 -0.17 -0.33, -0.02 0.03 5.30 -0.78, 11.4 0.09 
No Ref   Ref   Ref   
Maternal Smoking          
Yes 18.0 7.14, 29.0 0.001 0.12 0.02, 0.21 0.02 -4.38 -8.13, -0.63 0.02 
No Ref   Ref   Ref   
Social Class (Mothers 
last employment) 
         
Manage & Prof -20.7 -32.8, -8.69 0.001 -0.15 -0.25, -0.04 0.008 9.41 5.22, 13.6 <0.001 
Intermediate -7.92 -22.2, 6.32 0.28 -0.08 -0.21, 0.05 0.23 4.23 -0.71, 9.18 0.09 
Small emp/self em -4.49 -24.3, 15.4 0.66 -0.05 -0.22, 0.13 0.61 0.67 -6.22, 7.56 0.85 
Lo sup/technical -4.24 -28.7, 20.2 0.73 -0.05 -0.27, 0.16 0.63 1.86 -6.62, 10.3 0.67 
Routine Ref   Ref   Ref   
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Ethnicity          
White 36.2 21.1, 51.4 0.001 0.11 -0.02, 0.25 0.11 -6.90 -12.2, -1.64 0.01 
Other Ref   Ref   Ref   
Age -37.6 -57.5, -17.7 0.001 -0.25 -0.43, -0.08 0.005 13.7 6.84, 20.6 0.001 
Wheeze at 7          
Yes 7.50 -9.32, 24.31 0.38 0.06 -0.09, 0.21 0.45 -4.05 -9.87, 1.77 0.17 
No Ref   Ref   Ref   
BMI at 7 -3.03 -5.30, -0.76 0.009 -0.04 -0.06, -0.02 <0.001 -0.41 -1.20, 0.38 0.31 
Season of 
accelerometry 
         
Winter -96.7 -116, -77.4 <0.001 -0.82 -0.10, -0.65 <0.001 26.4 19.7, 33.2 <0.001 
Autumn -90.1 -107, -73.6 <0.001 -0.70 -0.85, -0.55 <0.001 28.3 22.5, 34.0 <0.001 
Summer -27.8 -43.9, -11.8 <0.001 -0.29 -0.43, -0.14 <0.001 5.54 -0.03, 11.1 0.05 
Spring Ref   Ref   Ref   
Mothers Education          
None 25.7 -0.44, 52.0 0.05 0.21 -0.03, 0.44 0.08 -18.9 -27.9, -9.82 <0.001 
Other -30.3 -68.4, 7.86 0.12 -0.20 -0.54, 0.14 0.25 -1.30 -14.5, 11.7 0.85 
GCSE G-D 19.7 -7.59, 47.0 1.16 0.12 -0.12, 0.36 0.32 -14.7 -24.1, -5.27 0.002 
GCSE A-C 18.78 -4.76, 42.3 0.12 0.08 -0.12, 0.29 0.43 -15.3 -23.4, -7.16 <0.001 
A/AS level -10.7 -37.1, 15.6 0.42 -0.14 -0.37, 0.10 0.25 -4.37 -13.5, 4.73 0.35 
Higher diploma 7.78 -18.9, 34.4 0.57 -0.01 -0.24, 0.23 0.96 -8.36 -17.6, 0.84 0.08 
First Degree 5.64 -19.1, 30.3 0.65 0.02 -0.20, 0.24 0.87 -8.14 -16.7, 3.39 0.06 
Higher degree Ref   Ref   Ref   
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Table 5-7 Results of general linear models regressing activity variables on gestation groups adjusting for confounders (females) 
FEMALES n  Total PA  MVPA*  Sedentary 
   ß 95% CI p-value  ß 95% CI p-value  ß 95% CI p-value 
Model 1 ≤32 27 -39.4 -98.5, 19.7 0.19  -0.27 -0.80, 0.24 0.30  18.01 -2.27, 38.3 0.08 
 33-34 47 -26.0 -72.3, 20.4 0.27  -0.24 -0.65, 0.17 0.26  11.77 4.12, 27.6 0.15 
 35-36 101 16.7 -13.3, 46.7 0.27  0.21 -0.05, 0.48 0.11  -2.18 -12.5, 8.10 0.68 
 Term 2456 Ref    Ref    Ref   
Model 2 ≤32 27 -43.2 -100, 14.0 0.14  -0.32 -0.83, 0.19 0.21  18.0 -1.47, 37.7 0.07 
 33-34 47 -25.5 -70.3, 19.2 0.26  -0.24 -0.64, 0.16 0.24  11.2 -4.27, 26.6 0.16 
 35-36 101 17.9 -11.1, 46.8 0.23  0.22 -0.04, 0.48 0.09  -2.62 -12.6, 7.37 0.61 
 Term 2453 Ref    Ref    Ref   
Model 3 ≤32 26 -35.6 -93.3, 22.1 0.23  -0.29 -0.81, 0.22 0.27  16.7 -3.16, 36.9 0.10 
 33-34 40 0.83 -46.7,48.3 0.98  0.01 -0.42, 0.43 0.98  5.11 -11.3, 21.5 0.54 
 35-36 92 7.73 -22.4,37.9 0.62  0.13 -0.14, 0.40 0.36  0.19 -10.2, 10.6 0.97 
 Term 2323 Ref    Ref    Ref   
Model 4 ≤32 26 -35.2 -92.9, 22.6 0.23  -0.29 -0.81, 0.23 0.27  16.9 -3.11, 36.9 0.10 
 33-34 40 0.38 -47.2, 47.9 0.99  0.002 -0.43, 0.43 0.99  6.36 -10.1, 22.8 0.45 
 35-36 92 8.00 -22.1, 38.1 0.60  0.13 -0.14, 0.40 0.36  0.40 -10.1, 10.9 0.94 
 Term 2320 Ref    Ref    Ref   
Model 1: adjusted for single or multiple births, intrauterine growth restriction status, admission to the neonatal unit and maternal smoking in pregnancy 
Model 2: as model 1 but additionally adjusted for body mass index, and season of accelerometry data collection 
Model 3: as model 2 but additionally adjusted for ethnicity, maternal education and socio-economic status (mother’s last known employment) 
Model 4: as model 3 but additionally adjusted for current wheeze, atopy 
*MVPA beta values are square root transformed 
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The results of the mediation analyses confirm the outcome of the general linear modelling 
presented above. Although gestational age was found to be a significant predictor of 
increased wheeze in boys, there was no evidence that wheeze or atopy mediated the 
association between gestational age and MVPA (indirect effect for wheeze ß= 0.006 p=0.3; 
indirect effect for atopy ß= 0.001 p=0.7: Figure 5-3). The mediation analyses for both males 
and females on both MVPA and sedentary behaviour are shown in Figure 5-4, Figure 5-5, 
and Figure 5-6).   
 
Figure 5-3 Mediation analysis of the effects of wheeze and atopy on the association 
between gestational age at birth and levels of MVPA in 7-year old boys. The direct effect 
of gestational age on MVPA was significant, however, current wheeze, nor atopy 
mediated this relationship.  
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Figure 5-4 Mediation analysis of the effects of wheeze and atopy on the association 
between gestational age at birth and levels of MVPA in 7-year old girls. The direct effect 
of gestational age on MVPA was not statistically significant, commensurate with the 
results of the general linear model (Table 5-7). There was no evidence of mediation 
through current wheeze and atopy. 
 
 
Figure 5-5 Mediation analysis of the effects of wheeze and atopy on the association 
between gestational age at birth and levels of sedentary behaviour in 7-year old boys. 
Gestational age was not significantly associated with sedentary behaviour (direct effect), 
are per results of the general linear model (Table 5-5). There was no evidence of 
mediation through current wheeze and atopy. 
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Figure 5-6 Mediation analysis of the effects of wheeze and atopy on the association 
between gestational age at birth and levels of sedentary behaviour in 7-year old girls. The 
direct effect, which represents the association between decreasing gestational age on 
levels sedentary behaviour, adjusted for current wheeze and atopy, was statistically 
significant. However, there was no evidence of mediation by current wheeze and atopy 
(both indirect effects non-significant).  
 
 
 Discussion 
Using data from a large cohort study of children born during the surfactant era, I have 
shown that birth at ≤32 weeks’ gestation is a statistically significant factor in predicting 
reduced levels of MVPA in 7-year old boys after adjustment for birth, growth and socio-
economic factors. This equated to approximately a one-hour difference in MVPA over the 
course of a week between boys born at ≤32 weeks’ gestation when compared to those 
born at term. There was also some association between decreased levels of total physical 
activity and increased levels of sedentary behaviour in boys born at ≤32 weeks’ gestation 
when compared to those born at term; these were not statistically significant in the fully 
adjusted models. None of the above findings were replicated in females. 
182 | P a g e  
 
 
In the previous chapter, the analysis using data from the ALSPAC study showed no 
differences in Total PA, MVPA or sedentary behaviour in 11-15 year-old preterm-born 
children when compared to term controls. The decrements in lung function previously 
observed in preterm-born children within ALSPAC were also not correlated with reduced 
activity. However, overall levels of activity were low. In contrast, children participating in 
the MCS showed significantly higher levels of MVPA, meeting or exceeding the 
recommended guidelines. In comparison, another UK-based cohort of 7 year old children 
conducted by Basterfield et al. showed that only 10% of boys and 3% of girls met the 
national guidelines for MVPA when the cut-point was set at 3,200cpm (Basterfield et al., 
2011).  
There are a number of possible reasons for these differences. Firstly, the 15 second data 
collection epoch used in the current study is more likely to detect MVPA, which occurs in 
short, sporadic bursts in young children (Riddoch et al., 2004). This may be reflected in the 
differences in proportions of vigorous activity making up MVPA (32% of MVPA in MCS and 
7% in ALSPAC). Secondly, the cut-point used to derive the MVPA variable are lower 
(>2241cpm) in the MCS, possibly leading to an over-estimation. When the thresholds used 
by Basterfield were applied to the MCS data, the proportion of boys and girls meeting 
MVPA guidelines decreased from 63% and 38% to 14% and 0.4% respectively (Griffiths et 
al., 2013). Longitudinal data from Basterfield et al. also demonstrated a significant decrease 
in MVPA and a rise in sedentary behaviour between the ages of 7 and 9 years. One possible 
explanation for these differences is that younger children are more likely to spend time in 
habitual ‘free-living’ play activities than 9 or 11 year olds who are undergoing a transition 
to middle/high school education with formalised physical education lessons, heightened 
social pressures, and increased exposure to screen-based activities.  
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Similarly, differences in sedentary behaviour between cohorts are difficult to compare due 
to variation in the accelerometer cut-point used, for example: <100cpm in the MCS, 
<200cpm in ALSPAC and <1100 in the Gateshead Millennium Study (Basterfield et al., 
2011), the latter of which captures a proportion of light intensity PA as defined in the MCS 
or ALSPAC. Although I also did show that the ≤32 weeks’ gestation group had increased 
levels of sedentary behaviour compared to term-born boys, this association was not robust 
to the addition of other explanatory variables in terms of maintaining statistical 
significance. However, this still does equate to over 14 minutes of additional sedentary 
time per day for the ≤32 weeks’ gestation group compared to term-born controls. This 
could reflect a preference for this group of children to choose to spend less time active.     
 
It is interesting that markers of lower socio-economic status (maternal smoking history) 
were associated with less time spent in sedentary behaviour and increases in total PA and 
MVPA. In contrast, markers of higher status (mother’s last known employment, higher level 
of maternal education) where associated with decreased Total PA, decreased MVPA, and 
increased sedentary time. Children of non-white ethnicity was also significantly associated 
with lower Total PA and more time spent sedentary. The observed differences between 
socio-economic groups were small and without a clear trend, consistent with previous 
studies (Riddoch et al., 2007). Sedentary behaviour is not merely the absence of PA, but 
reflects a specific engagement in activities of low energy expenditure (Reilly et al., 2008), 
and may be highly dependent upon the context of the activity. For example, having a 
parent with higher levels of education has been associated with increased sedentary 
behaviour during school hours, whereas increased MVPA during the same period has been 
associated with children from families of lower socio-economic status (Pulsford et al., 
2013).  More research is warranted in this area to determine the reasons for differences in 
PA between socio-economic and ethnic groups.  
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In a recent study by our group, increased rates of exercise-induced bronchoconstriction 
and reduced levels of PA in preterm-born children were observed using data from a self-
completed questionnaire (Joshi et al., 2013). This led me to propose the hypothesis in this 
thesis that experiencing such symptoms of airway obstruction on exertion is a conceivable 
pathway to reduced levels of activity. A previous study described that children with asthma 
may exercise less to avoid the unpleasantness of these sensations (Glazebrook et al., 2006). 
Other questionnaire-based studies also support the hypothesis that preterm-born children 
consider themselves less active. Clemm et al. and Welsh et al. both demonstrated reduced 
levels of self-reported PA; however, both these studies included only children with ≤28 
weeks' and <26 weeks’ gestation, respectively (Clemm et al., 2012, Welsh et al., 2010). 
Furthermore, in the latter study, questionnaire responses did not correlate with 
accelerometry which may be attributed to the differing types of activity recorded when 
using subjective or objective methods (Riddoch et al., 2004).  
 
Somewhat surprisingly, my findings suggest that despite preterm-born children 
demonstrating significantly increased rates of current wheeze, this was not a mediating 
factor in the relationship between gestational age and levels of physical activity. It is likely 
that the reporting of respiratory symptoms at the time of assessment was accurate as the 
questionnaire used in the MCS is well validated and collected during a home visit where 
answers could be clarified. Although it is difficult to compare my study with those focusing 
on low birthweight, such studies often contain a significant proportion of participants who 
were born preterm, especially in the very low birthweight and extremely low birthweight 
groups (<1500g and <1000g birthweight, respectively). A summary of these studies showed 
that reductions in exercise capacity were present from an early age - consistent with the 
modest differences found in our recent systematic review (Edwards et al., 2015b). This may 
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reflect the ability of the cardio-respiratory system to compensate for any airway 
obstruction during exertion, especially due to the availability of ventilatory reserve (Joshi et 
al., 2013); however, this is accompanied with a diminished ability to perform tests of motor 
function and strength-based tasks, with differences in habitual physical activity only 
manifesting from adolescence onwards (Siebel et al., 2012). Other potential mediators of 
PA in preterm-born children, therefore, may include differences in body composition such 
as muscle mass and fat mass (Bott et al., 2007), and limitations imposed by 
neurodevelopmental sequelae of preterm birth (Rogers et al., 2005, Burns et al., 2009). 
Similar reasons could possibly help to explain why in my results, lower levels of MVPA in 
preterm-born boys born at ≤32 weeks’ gestation but not in girls. Peacock et al. suggested 
that respiratory and neurological outcomes following preterm birth may be worse in males 
than in females, especially at the extremes of gestation (Peacock et al., 2012). Also, sex-
typed behaviour emerges early in childhood and ‘male typical’ activities have been linked 
to increased levels PA by late childhood (Mattocks et al., 2010); it is conceivable that 
preterm-born boys with milder forms of developmental coordination disorder, which has 
been linked to decreased MVPA, spend less time in male typical activities due to reduced 
self-perception of abilities and difficulties with keeping up with their peers (Green et al., 
2011).       
 
Notwithstanding, since PA has the potential to improve cardio-respiratory health, preterm-
born children should be encouraged to participate in adequate levels in order to develop 
positive attitudes towards exercise. Although the 9-minute difference in MVPA per day in 
boys of ≤32 weeks’ gestation was small, this equated to over 1 hour a week and this may 
have some clinical utility. An increase of 9 minutes would improve the proportion of 
preterm-born boys meeting daily MVPA recommendations from 55% to approximately 
73%. Achieving such improvements may be of heightened importance given the clear 
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evidence of a steep decline in PA which has been observed during adolescence and 
consistent reporting of decrements in exercise capacity and PA in preterm-born adults. 
Both point towards detraining of the cardio-respiratory system which may have 
implications for the development of early-onset chronic respiratory disease and thus 
deserves further surveillance. The benefit of introducing active plans to promote PA in 
preterm-born children also needs evaluation. 
 
 Strengths and limitations 
The main strengths of the work presented in this chapter are the use of recent data from a 
large contemporary cohort which sampled from the whole of the UK and from a diverse 
range of socio-economic backgrounds. The Actigraph device used has been well validated 
and in contrast to other studies (including that in chapter 4) used a shorter sampling epoch 
thus allowing for capture of shorter periods of MVPA. One limitation is the accelerometer 
required removing for contact sports or water-based activities, and does not capture 
bicycle riding adequately. However, the age of children in this study makes participation in 
contact sports less likely than those conducted in older cohorts. In any case, these data 
reflect habitual activity rather than sports participation. Additionally, the sample was taken 
from a proportion of the MCS who participated in the home visit and provided valid 
accelerometry data; the study by Rich et al. showed that non-consent rates were higher in 
children with a limiting illness or disability (Rich et al., 2013a). Such selection bias reduces 
the possibility of including children with severe physical or cognitive impairments. In 
common with many longitudinal studies, there is some attrition over time and my analyses 
are limited by the data available. Other data on socio-economic status such as the Index of 
Multiple Deprivation were available but this is calculated differently in the four devolved 
nations of the UK. Although the participants included in my analyses were of higher socio-
economic status it is reasonable to consider that the results are generalisable as lower 
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socio-economic status was associated with increases in physical activity (Griffiths et al., 
2013). Finally, although banding of gestation into categories will result in a small degree of 
misclassification, treating of the data in this manor is reflective distinct stages of lung 
development and allows comparison with other studies.  
 
 
 Summary and conclusions    
In conclusion, I have shown small but important differences in objectively measured 
physical activity in 7-year old boys who were born very preterm when compared to term-
born controls. Children born in the MCS reflect the more immature graduates of modern 
neonatal care including gentler ventilation, maternal antenatal corticosteroid 
administration and exogenous surfactant therapy. The difference in cut-points for levels of 
activity make comparisons of similar studies difficult; however, it appears that preterm-
born children are capable of participating in adequate levels of habitual physical activity. 
This requires surveillance due to the declines in PA and increased sedentary behaviour that 
have been shown to occur throughout childhood and adolescence. 
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6 General Discussion 
The aim in this final chapter is, firstly, to summarise results from each of my studies and detail 
my key contributions. Secondly, I shall contextualise these within the scope of the current 
literature.  After considering the strengths and limitations of my work, I will discuss the clinical 
relevance of my results on the management of preterm-born children and suggest areas of 
future study. The sections on strengths and limitations, and clinical relevance are combined for 
Chapters 2 & 3, and 4 & 5, as they present complementary data. I shall conclude with a brief 
thesis summary. 
 
 Chapter 2: Association of foetal size and growth trajectory with 
respiratory symptoms in preterm-born and term-born children 
 Overview and principal findings 
In this first study, my principal question was: “Does foetal size, or growth trajectory, predict 
increased incidence of respiratory symptoms in preterm-born children?” The rationale for this 
question was based upon the ‘developmental origins of health and disease hypothesis’, which 
describes that adverse insults in utero, and the timing of these events, have a profound impact 
on the developing foetus. Moreover, the foetus makes developmental adaptations to mitigate 
this adversity in order to protect developing organs and systems. Such programming of 
development may be detrimental to future health if conditions after birth do not match those 
during gestation. Historically, studies investigating foetal origins of disease have used 
birthweight as a proxy for foetal growth. More recently, foetal biometry, obtained from 
antenatal ultrasound scans, has found favour as a research tool to study the association with 
later health outcomes. The results of these studies in relation to the respiratory system, the 
focus of this thesis, have been mixed; however, two studies noted that foetal growth restraint 
between the first and second, or second and third trimesters were related to poorer 
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respiratory outcomes in childhood. Preterm-born children undoubtedly have increased 
respiratory sequelae in childhood and are more likely to be born small for gestational age, an 
indication of poor growth during foetal life. Thus, I decided to investigate if foetal size and 
growth trajectory, particularly growth faltering (deceleration) in preterm-born children would 
impact on the incidence of respiratory symptoms including wheeze, use of inhaled medication, 
and hospital admissions for chest-related problems. Contrary to this hypothesis, I noted that 
both growth acceleration and deceleration were associated with increased respiratory 
morbidity in preterm born children. Specifically, accelerated growth (>0.67 SD increase in 
foetal measurement) from the first trimester until birth was associated with increased wheeze-
ever (OR 2.21 95%CI 1.25, 2.32). When growth patterns between trimesters were investigated, 
growth deceleration between the 1st and 2nd trimester was associated with increased wheeze-
ever (OR 1.59 95% CI 1.01, 2.51). Increased risk for wheeze-ever was noted when growth was 
accelerated between the 2nd and 3rd trimester (OR 1.60 95% CI 1.15, 2.22). 
 
6.1.1.1 Comparison with other studies 
The mechanisms behind the observed associations between foetal growth and respiratory 
outcomes in epidemiological studies are not known. However, maternal smoking during 
pregnancy is strongly associated with IUGR birth. Both epidemiological and animal models 
point to the adverse influence of nicotine on the developing respiratory system, with the 
effects on respiratory health persisting into childhood and beyond (Maritz and Harding, 2011). 
Researchers from the Generation R study identified that continued maternal smoking during 
pregnancy was associated with increased risk of wheezing in early childhood (Duijts et al., 
2012).  
Data from large cohort studies have recently provided proof-of-concept that the use of foetal 
biometry is valid as a research method in assessing the impact of growth on later health 
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outcomes. However, mine is the first to specifically assess foetal growth patterns in preterm-
born children and thus difficult to compare with the existing literature. In common with the 
Aberdeen cohort, my study relied upon routinely collected data; unfortunately, due to the 
limitations of the available databases, I was unable to obtain ultrasound reports for all 
participants. Moreover, the standard scanning protocols dictated that different measurements 
were available in each of the 1st trimester and 2nd trimester scans. This limited the application 
of a more statistically sophisticated measure of growth change such as that proposed by 
Royston (Royston, 1995), since the multilevel modelling required uses raw data as oppose to 
standardised scores. Therefore, I opted to use the same method of assessing growth change as 
the Generation R cohort (>0.67 SD change) under the assumption that z-scores (adjusted for 
gestation and gender) of crown-rump length, head circumference or femur length, and 
birthweight are compatible measures of growth. Foetal biometry was collected prospectively 
in all three trimesters in both the Rotterdam and Southampton cohorts under a research 
protocol. Third trimester scans are not routine in standard antenatal care. In any case, in 
reference to the preterm-born population included in the RANOPS study, the mean gestation 
of those with foetal biometry was 34 weeks’ (Table 2-1), the same gestation at which 3rd 
trimester scans were performed in the Southampton study. Thus, a future study investigating 
the associations of preterm birth, foetal growth and later health outcomes would necessarily 
have to have an adapted protocol such that serial scans are performed earlier in pregnancy, 
perhaps at approximately 30 weeks’ gestation. An interesting finding within the Southampton 
cohort was that growth faltering in the first to second trimester was linked to non-atopic 
wheeze, whereas faltering in the second to third trimester was associated with atopic wheeze. 
This is consistent with my results which noted that growth deceleration between the 1st and 
2nd trimester was similarly associated with increased wheeze-ever. Both acceleration and 
deceleration from the 2nd to 3rd trimester were associated with wheeze-ever.  To date, the 
RANOPS cohort does not have any direct data on atopic status (i.e. results of skin prick 
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testing), however family history of atopy was abstracted from the questionnaire. Although this 
was strongly related to respiratory outcomes in univariate analysis (Table 2-3), family history of 
atopy was not significant in the statistical analysis performed when modelling with measures 
of foetal growth change. This is in keeping with the primary analysis of the RANOPS cohort 
which established that ‘prematurity-associated wheeze’ phenotype is unlikely to include atopy 
as one of its determinants (Edwards et al., 2016). 
Nutrition is another key determinant of foetal growth (Lumey et al., 2007) and may be sub-
optimal due to a combination of maternal stature (underweight/overweight), dietary intake, 
and placental insufficiently. Animal models note that extreme restriction of nutrients 
significantly affects lung growth and development (Lechner, 1985). The role of specific food 
groups in benefiting in utero respiratory development is not defined, however, a varied diet 
with limited amount of processed foods, but high in fish and vegetables including antioxidants, 
may be optimal (Netting et al., 2014). The study of the Aberdeen cohort noted that maternal 
serum levels of the micronutrient vitamin E in the lowest quartile was associated with 
decreased CRL in the first trimester when compared to vitamin E levels in the highest quartile 
(Turner et al., 2010). The same group had previously demonstrated that deficits in maternal 
vitamin E intake was associated with increased incidence of wheeze-ever at 5 years of age 
(Devereux et al., 2007). A possible mechanism may include removal of oxidant species, such as 
those found in tobacco smoke. For example, pre-and-post natal antioxidant-rich dietary 
supplementation prevented nicotine-related lung damage in rat models (Maritz et al., 2011). 
 Chapter 3: Associations between infant weight gain and childhood 
respiratory symptoms in preterm-born and term-born children 
 Overview and principal findings 
The research question for my second study was: “Following preterm birth, is weight gain in 
infancy associated with increased respiratory symptoms later in childhood? What are the 
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important factors mediating this relationship?” These investigations were based upon the 
growing evidence base regarding the influence of postnatal weight gain during infancy on 
respiratory health in childhood and beyond. The management of growth of preterm infants 
both on the neonatal unit and post-discharge is challenging to health professionals and the 
optimal rates of growth are not known; thus, investigating the effect of rapid weight gain 
specifically in a preterm-born cohort of children would answer an important question. The 
results of my study were in line with the stated hypothesis, that infant weight gain between 
birth and 9 months of age was indeed associated with increased respiratory symptoms. 
Specifically, a >0.67 SD gain in weight between birth and 9 months of age was associated with 
increased wheeze-ever (OR 1.22; 95% CI 1.02, 1.45) in preterm-born children. The association 
appeared to be greatest in the ≥5 years of age group. Furthermore, the combination of birth at 
the extremes of gestation (≤32 weeks’ gestation) and rapid weight gain resulted in the poorest 
respiratory outcome when compare to term-born controls (OR 5.04; 95% CI 3.36, 7.54). This 
trend was present across the continuum of gestational age. 
To compare my results with other studies, I conducted similar analysis with the available data 
in term-born children and noted that >0.67 SD weight gain was significantly associated 
wheeze-ever (OR 1.38; 95% CI 1.13, 1.69). The combination of ‘early term’ birth (37-38 weeks’ 
gestation) and rapid infant weight gain also resulted in a poorer respiratory outcome, with an 
OR of 2.25 (95% CI 1.48, 3.48) for wheeze-ever compared to children born at term. 
Finally, by conducing mediation analysis, I identified gestational age at birth and current 
maternal smoking as modifiable factors through which the association between rapid infant 
weight gain and increased wheeze in preterm-born children may, in part, be explained.  
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 Comparison with other studies 
My results are in keeping with the other studies investigating the association between 
accelerated infant weight gain and respiratory health in childhood. However, the majority of 
studies did not focus on preterm-born children, with the exception of the meta-analysis 
performed by Sonnenschein-Van der Voort et al. (Sonnenschein-van der Voort et al., 2014). I 
opted to measure weight gain between birth and approximately 9 months of age, a period of 
rapid growth. The analyses were repeated using weight gain between birth and 24 months as 
lung development in terms of alveolar number increases rapidly during this period (Lucas et 
al., 2004). Moreover, the majority of catch-up growth has occurred by two years of age (Taal et 
al., 2013, den Dekker et al., 2016) and performing this analysis would allow for comparison to 
other studies who monitored a similar period of growth (Flexeder et al., 2012, Claudia et al., 
2016, Magnus et al., 2015). In my analysis, a difference of >0.67SD in weight z-score was used 
to quantify accelerated weight gain, a parsimonious and easily interpretable measurement 
which is used clinically to monitor growth change. However, since more statistically complex 
methods have been recently used, I opted to use a multilevel modelling approach as described 
by Royston to validate my results. This allowed the use of all the available weight data, but also 
allowed the inclusion of each participant regardless of the number of datapoints available, in 
contrast to other recently employed methods.  
My results indicated that accelerated weight gain up to 9 months of age was associated with 
respiratory symptoms in both preterm and term-born children after adjustment for potential 
confounders. When weight gain between birth and 24 months was used as the primary 
exposure variable, few outcomes were statistically significant. However, it is worthy of note 
that a number of associations were of a similar magnitude to the results presented at 9 
months of age. Fewer participants were included in the analysis at 24 months (e.g. n=3425 at 9 
months and n=1819 at 24 months), therefore, the sample size may have been insufficient and 
reduced the precision of the effect estimates. Another possibility is that the majority of lung 
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growth may have occurred during the first 9-12 months of life, thus associations with 
increased respiratory symptoms were stronger than those observed when weight gain was 
defined over a period of 24 months. Comparing studies is complicated by the variation in the 
period over which weight gain is measured. Notwithstanding, my results are consistent with 
studies where the respiratory outcome, manifesting as increased symptoms or reduced lung 
function, is measured in early childhood (van der Gugten et al., 2012, Magnus et al., 2015, Pike 
et al., 2010), at school age (Magnus et al., 2015, Popovic et al., 2016, Flexeder et al., 2012, 
Belfort et al., 2016), and in adolescence (Claudia et al., 2016). Thus, there appears to be 
tracking of the effect of rapid infant weight gain on respiratory health at least until the age of 
15 years, and potentially beyond.  With the exception of the study by Belfort, all were 
conducted in term-born children only. This study noted that rapid BMI gain in the first year of 
life, but not linear growth, was associated with higher odds of asthma at four years of age 
(Belfort et al., 2016). These results suggest that gain in somatic mass may be impacting upon 
the developing respiratory system. Furthermore, a study using data from the Generation R 
cohort reported that accelerated weight gain in the neonatal period, between birth and term-
equivalent gestational age, was associated with markers of cardiovascular disease and 
diabetes in preterm-born young adults (Kerkhof et al., 2012). Similar results were noted with 
weight gain in the first year of life, which was associated with increased percentage body fat 
and higher serum triglyceride levels.  
An emerging theme from the results of my work and others is the potential role of accelerated 
weight gain in defining phenotypes of lung disease. Phenotypes have been well defined within 
the term-born population (Henderson et al., 2008), however data are lacking describing 
patterns of symptoms in preterm-born children. Within this context, my results raise the 
question of whether rapid weight gain within the first year of life predisposes to a particular 
wheeze phenotype, whereas a similar magnitude of weight gain over a longer period (e.g. two 
years), does not. Interestingly, the cross-sectional data from the RANOPS cohort used in my 
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analysis identified a stronger effect of weight gain on ‘wheeze-ever’ in preterm-born children 
≥5 years of age compared to those <5 years of age. A similar effect was observed in the term 
born population, however, the magnitude of the difference between the two age groups was 
smaller. In both instances, the odds of doctor-diagnosed asthma in children aged ≥5 years 
tended to be related to weight gain in the preterm group (OR 1.21; 95% CI 0.89, 1.64, Table 3-
4) and was significantly related in the term-born group (OR 2.02; 95%CI 1.37, 2.98, Table 3-9). 
Thus, one possible explanation of the increased effect size in children aged ≥5 years could be 
an emerging ‘asthma-related’ phenotype of which accelerated infant weight gain is one 
potential determinant.  
To date, degree of prematurity is not included in methods of predicting later asthma (Castro-
Rodriguez, 2010), whereas paediatricians consider this information crucial in assessing the 
nature of early (Bush and Nagakumar, 2016) and late respiratory disease (Bolton et al., 2015). 
My results demonstrate that lower gestational age impacted on the effect of weight gain on 
childhood respiratory health across the spectrum, including in children born ‘early term’ (37-38 
weeks’). This finding is pertinent due to the rising number of births during this period, 
especially due to increased rates of caesarean section and growing evidence to suggest that 
relative immaturity, as opposed to caesarean section delivery, explains the increased 
respiratory symptoms in such children (Edwards et al., 2015a). 
Another theme relates to the mechanisms whereby accelerated weight gain may impact on 
childhood respiratory health. Infants with reduced lung function in the first weeks and months 
of life have poorer respiratory outcomes in childhood (Turner et al., 2008, Haland et al., 2006), 
especially those born at low birthweight (Lucas et al., 2004). The decrements appear to track 
into adolescence and early adulthood (Stern et al., 2007, Mullane et al., 2013). Since these 
deficits are present from birth, there is strong evidence that lung growth during foetal life 
predisposes to adverse respiratory outcomes. Moreover, preterm birth may further 
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exacerbate the effects of growth restriction due to pulmonary inflammation associated with 
neonatal respiratory distress and subsequent dysregulated lung growth (Kallen et al., 2013). 
One explanation is the concept of dysanapsis whereby somatic growth occurs at a faster rate 
than growth of the airways. As a result the airways are smaller in comparison to lung volume. 
For example, moderately preterm-born children (32-34 week’s gestation) were noted to have 
no difference in FVC compared to term controls but had reduced forced expiratory flows and 
lower FEV0.5/FVC ratios at two months of age (Friedrich et al., 2007). When these 
measurements were repeated at 24 months, similar differences were present between the 
preterm and term-born groups, however, longitudinal analysis revealed tracking of lung size 
with somatic growth but no catch-up in terms of respiratory function. These data are 
complemented by other large cohort studies which also identified a disparity between lung 
volume, airway calibre and poorer respiratory outcomes in childhood (Sonnenschein-van der 
Voort et al., 2015), including an early wheeze phenotype (Turner et al., 2008). Rapid weight 
gain in infancy may, therefore, reflect excessive somatic growth which promotes dysanapsis 
and contributes to the observed decrements in lung function and increased rates of 
symptoms. 
Within the preterm-born population of the RANOPS cohort, the results of my analysis 
identified current maternal smoking, rather than antenatal smoking, as a mediator of the 
association between weight gain and increased rates of wheeze. Antenatal smoking was noted 
to be related to wheeze in univariate analysis (p<0.10), but was not significant in the 
multivariable models. Underestimation of the prevalence of antenatal smoking may explain 
this lack of effect (Shipton et al., 2009), moreover, women’s smoking habits tend not to change 
such that those who smoke during pregnancy continue to do so postnatally (Le Souef, 2000).  
Thus, it is difficult to assess these effects independently. Notwithstanding, the deleterious 
effect of exposure to tobacco smoke on lung health is consistent with other studies in preterm-
born (Hoo et al., 1998) and low birthweight children (Caudri et al., 2007). The effects of 
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nicotine exposure on the developing foetus in utero is well described. In relation to lung 
development, evidence from animal models demonstrates lung hypoplasia, including fewer 
and larger saccules thus reducing the overall surface for gas exchange (Collins et al., 1985). 
Also, the structural and functional development of the small airways may be affected (Elliot et 
al., 2003) leading to poor lung function which is evident soon after birth (Stick et al., 1996). A 
recent study noted that maternal smoking in pregnancy, and hypertension, were associated 
with increased rates of BPD/CLD at 36 weeks’ postmenstrual age and respiratory disease 
within the first two years of life (Morrow et al., 2017). 
Postnatally, exposure to environmental tobacco smoke has been noted to increase the risk of 
early wheeze and respiratory tract infections (Tager et al., 1993). Reports from longitudinal 
analysis of children exposed to parental smoking indicate deficits in lung function, especially in 
children with wheeze (Sherrill et al., 1992). The mechanisms of how postnatal tobacco smoke 
exposure affects lung function and increases the propensity for wheezy illness in childhood are 
not known. However, one possibility with regards to structural development is thickening of 
the large airway wall, which increases airway resistance (Elliot et al., 1999). Other potential 
explanations include increased bronchial hyper-responsiveness and increased sensitivity to 
allergens (Martinez et al., 1992). 
As described above, dysanapsis relates to a mismatch between somatic growth (including the 
lungs), and growth of the respiratory tract. This raises the question, what is the composition of 
the body mass gained during a period of accelerated weight gain? A recurring theory in the 
literature is that such weight gain relates to the deposition of excess adipose tissue (Popovic et 
al., 2016, Claudia et al., 2016, Flexeder et al., 2012, Kerkhof et al., 2012). In the recent study by 
Gishti, weight gain in infancy was associated with increased total body and abdominal fat mass 
(Gishti et al., 2014). This may impose an additional deleterious effect on lung health by 
increasing the mechanical pressure on the lungs and diaphragm, thus decreasing functional 
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residual capacity and increasing the inspiratory effort required to achieve normal tidal volumes 
(Vijayakanthi et al., 2016).  
A more complex notion is the modulation of immune pathways through release of pro-
inflammatory agents, such as leptin, from adipocytes (Guler et al., 2004). This may increase 
susceptibility to early infections such as respiratory syncytial virus (RSV), which are implicated 
in childhood respiratory disease, especially in those with a history of preterm birth (Gijtenbeek 
et al., 2015). For preterm-born children, who already have an increased risk of infection 
(Greenough et al., 2004), this is highly pertinent. The effect of preterm birth on the 
development of body composition are not widely known, and current results are conflicting. A 
study by Bott and colleagues reporting on differences in energy expenditure in preterm-born 
children with BPD/CLD noted reduced fat mass in participants with severe airway obstruction 
when compared to BPD/CLD children with health controls. In contrast, a study by Vardar-Yagli 
noted fat-free mass was reduced in children with BPD/CLD but found no differences in fat 
mass  (Bott et al., 2007, Fewtrell et al., 2004, Vardar-Yagli et al., 2015). However, there is 
strong evidence that excess infant weight gain predisposes to later obesity (Ong and Loos, 
2006), which in turn is a risk-factor for respiratory disease. Data from the Isle of Wight birth 
cohort demonstrated that an early trajectory of obesity from infancy was associated with 
increased risk of developing asthma in late adolescence (Ziyab et al., 2014). This is possibly in 
part due to leptin-mediated, systemic low-grade inflammation associated with increased fat 
mass and an altered metabolic profile (Vijayakanthi et al., 2016). Systemic inflammation has 
been noted to correlate with reductions in pulmonary function (Rastogi et al., 2012) and 
increased bronchial hyper-responsiveness (Baek et al., 2011). 
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 Chapters 2 & 3: Strengths and limitations 
The main strengths of my studies presented in Chapters 2 and 3 is the use of data from a large 
cohort of preterm-born children (RANOPS). This cohort was specifically designed to investigate 
the respiratory symptomology of such children using validated parent-reported 
questionnaires.  The availability of demographic data from NWIS also allowed for the 
adjustment of numerous confounders within the statistical analyses I applied. 
Notwithstanding, no epidemiological study can rule out residual confounding due to 
unmeasured covariates. For example, particularly relating to foetal growth, it would have been 
interesting to have data on incidence of maternal complications of pregnancy and labour (e.g. 
hypertension, pre-eclampsia, chorioamnionitis). However, I was able to include IUGR as a 
confounder in my analysis and did not note strong associations with respiratory outcomes. The 
RANOPS cohort sampled the preterm-born population across an age range of 1-11 years, 
which allowed assessment of my research questions during early childhood and at school-age. 
This may give some insight in to the differential effects of the exposures I have studied (foetal 
growth, infant weight gain) on respiratory outcomes at different stages of life. However, it is 
noted that the data used were cross-sectional rather than longitudinal, thus, separating the 
cohort in to children aged ≤5 and >5 years of age used different participants in each analysis. 
This will have limited my ability to accurately study change in effects over time. Despite this 
limitation, I observed some hypotheses-generating differences between age-groups which 
warrant further study. Specifically, if foetal growth or infant weight again are associated with a 
particular phenotype of respiratory disease. Again, longitudinal data are required to explore 
this question in more detail. 
The problems of non-response and loss to follow-up are ubiquitous in cohort studies. The 
availability of demographic data for the whole cohort (including non-responders to the 
questionnaire survey) allowed assessment of the generalisability of my results. Within the 
RANOPS cohort, questionnaire return was linked to higher levels of socio-economic status. The 
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overall response rate was also noted to be relatively low (27%) and it is possible that 
responders were families whose children suffer from a relatively increased prevalence or 
severity of respiratory symptoms. Thus, there is inherent selection bias which may affect my 
results. However, the incidence of intrauterine growth restriction and preterm birth are higher 
in mothers of lower socioeconomic status, secondary to alcohol and tobacco smoke exposure, 
and poor nutrition. Postnatally, infants would also be more likely to be exposed to 
environmental tobacco smoke, and be more likely to be formula fed. Therefore, one would 
expect that inclusion of families from disadvantaged backgrounds would strengthen my results 
rather than weaken them.  
My analyses in Chapter 2 used retrospective foetal biometry data which was limited to the 
routine data collected at antenatal ultrasound clinics. Unfortunately, availability of the data for 
the whole population of RANOPs questionnaire responders was constrained by restrictions to 
data access and linkage.  No single measurement was available for both scans. Therefore, I 
opted to standardise each for gestational age and gender, using the difference in z-scores 
between measurements to calculate growth change. This was under the assumption that each 
standardised measurement reflected a similar level of growth. It must also be noted that the 
references growth charts (Altman and Chitty, 1994) used are based upon data collected in 
England during the late 1980s and early 1990s and may not reflect the population I have 
studied. However, the same charts are widely used clinically to assess foetal growth, including 
in Wales, despite reservations by methodologists (Royston, 1995). The availability of serial 
measurements of a single parameter would have enabled calculation of conditional growth as I 
later implemented in chapter 3 and as used in the Southampton Women’s study (Pike et al., 
2010).  Similarly, it would have been optimal to investigate change in foetal abdominal 
circumference and calculate estimate foetal weight to assess IUGR during gestation as well as 
at birth.  A recent study noted that suspected foetal growth restriction, combined with IUGR at 
birth, was associated with increased rates of BPD/CLD when compared to infants born IUGR 
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with no evidence of foetal growth restriction, or controls of normal birthweight (Monier et al., 
2017). Moreover, I was not able to assess the symmetry or asymmetry of IUGR using, for 
example, ponderal index ([weight/length3]*100), as data on birth length was not available. 
However, it has been noted that birthweight is a better predictor of body asymmetry than 
ponderal index (Haggarty et al., 2004). 
A key strength of my study in Chapter 3 was the volume of measurements which were 
available for use in modelling weight gain.  The large majority of the population included had 
at least 2 measurements (birthweight, and weight at approximately 9 months of age) to allow 
calculation of change in weight by comparing z-scores at these timepoints. These z-scores 
were produced using the UK 1990 reference population which was compiled from a composite 
of anthropometric studies conducted between the late 1970s and mid 1990s (Cole et al., 
1998). Consequentially, these standards may not be appropriate as a reference source for 
growth in contemporary cohorts of preterm-born infants and children who have undergone a 
very different neonatal course.  However, the UK 1990 population is still favoured for use for 
monitoring of birthweight and early weight gain in preterm infants as the recently adopted 
WHO reference charts do not include data from preterm-born children (Wright et al., 2008). 
The WHO charts are then favoured up to 2 years of age (Standards, 2007). A further strength 
of my work is calculating the measures of conditional growth change, which avoids the use of 
reference charts and uses the available data as an internal standard to produce z-scores.  The 
associations observed in this secondary analysis were similar to the parsimonious method of 
classifying rapid weight gain as >0.67 SD change in weight, which adds validity to my results. 
Finally, a further limitation of cohort studies is the ability to only demonstrate association, not 
causation, due to the effect of measured or unmeasured variables, and due for the possibility 
of reverse causation. By using mediation analysis, which imposes a system of causal inference 
between the included variables (Hayes, 2013), I have attempted to ascertain the factors 
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through which a potential causal relationship between rapid weight gain during infancy and 
respiratory outcomes in preterm-born children may be explained.  
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Figure 6-1 Summary of potential factors involved in determining the respiratory health of preterm-born children and later effects on physical activity 
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 Chapters 2 & 3: Clinical relevance and future work  
Within the first half of my thesis, I established the importance of altered foetal growth 
trajectory, and infant weight gain on respiratory health outcomes in children. My results 
highlight the additional burden preterm birth imposes on both these measures of 
development. A conceptual diagram, Figure 6-1, outlines the role of foetal growth and the 
contribution of known risk factors for adverse birth outcomes, including both prematurity 
and IUGR, consistent with the “developmental origins of health and disease hypothesis”, 
and that of a “predictive adaptive response”. In utero modifications to the structural 
development and maturation of the respiratory system adversely affects respiratory health, 
with the adverse effects on lung function being evident soon after birth. A ‘second hit’ 
occurs if the infant is born preterm and suffers from the associated pulmonary 
inflammation and respiratory insufficiency, as well as the deleterious effects of the 
necessary neonatal care. Dysregulated immunological and metabolic processes may 
contribute to rapid gain in weight early in life, which is coupled to dysanaptic lung growth 
as well as an increased susceptibility to respiratory infections. These processes culminate in 
the poor respiratory outcomes observed in preterm-born children which are present across 
the continuum of gestational age.        
Optimising foetal growth by minimising antenatal exposure to noxious substances such as 
tobacco smoke, and by improving the quality of maternal nutrition, would serve to improve 
outcomes for many pregnancies where there is an increased risk of preterm birth 
(McCowan et al., 2009). However, it is acknowledged that reducing the rates of maternal 
smoking in pregnancy is complex, and is closely linked to levels of social deprivation 
(Shipton et al., 2009). Initiatives such as the ‘Gestation Related Optimal Weight’ (GROW) 
software, developed by the Perinatal Institute Gestation Network, provide valuable tools to 
assess foetal wellbeing and timing of growth change (Figueras and Gardosi, 2011) which are 
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customised to the individual foetus. Thus, surveillance strategies which aid in identifying 
risk factors and markers of poor foetal growth, such as intrauterine growth restriction, are 
best placed to provide guidance to families and support health professionals (RCOG, 2013). 
Moreover, this increased surveillance may serve to decrease the risk of preterm birth, 
especially in late gestation by means of elective caesarean section. 
Establishing a feeding regimen in preterm-born infants which represents the rate of in 
utero growth (15g/kg/day) is challenging in the neonatal period. This may be due to the 
immaturity of the gut and the requirement to rely on parenteral nutrition, and also 
increased caloric requirements (Agostoni et al., 2010). Once enteral feeds are tolerated, 
the emphasis is placed upon maximising intake in order to promote growth, however, 
nutritional deficits are still prevalent (Embleton et al., 2001). Moreover, at term-equivalent 
age, preterm-born children have been shown to have increased body fat percentage which 
is largely explained by reductions in fat-free mass (Johnson et al., 2012). Post-discharge, the 
optimal growth rate for preterm infants is not known (Kleinman, 2009), however, data 
from the MCS cohort indicate that preterm-born children remain disproportionally shorter 
and lighter when compared to term-born controls at the ages of three and five years (Boyle 
et al., 2012) . My results support the notion that carefully balancing the nutritional intake 
of preterm-born infants to achieve maximal growth, but avoiding disproportionate gain in 
weight compared to length, may help avoid the potentially deleterious effects of 
accelerated weight gain whilst supporting overall development (Singhal et al., 2003, 
Kerkhof et al., 2012). Encouraging, or extending the use of breast milk could support this 
strategy, especially given the protective effects noted on early respiratory health (Elliott et 
al., 2008, Dogaru et al., 2012).  
Finally, within the literature presented and used for comparison against my results in 
Chapters 2 and 3, most studies use lung function, or a definition of asthma as the primary 
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outcome for investigating the effect of foetal growth trajectory and infant weight gain. 
Asthma is a multi-factorial disease, the symptoms of which may change markedly with age, 
thus, several phenotypes have been proposed, each of which may have different risk 
factors (Henderson et al., 2008). Data from the RANOPS cohort (used in the first half of this 
thesis), and others, have challenged the notion that respiratory symptoms, such as wheeze, 
in preterm-born children have the same aetiology as asthma (Edwards et al., 2016). For 
example, preterm-born children have bronchial lability and reversible airway obstruction 
commonly found in asthma, but do not exhibit eosinophilic airway inflammation (Baraldi et 
al., 2005). Thus, a future epidemiological study might use longitudinal data to define 
wheeze phenotypes existing within the preterm-born population and to explore the role of 
foetal growth and accelerated infant weight gain amongst other risk factors. Doing so may 
help guide the longer-term management of preterm-born children, including identifying 
the most appropriate strategy for optimal growth in preterm infants. A future clinical study 
might focus on longitudinal measures of weight, length and body composition in infancy 
and beyond, in combination with pulmonary function testing. Use of novel modes of testing 
such as the forced oscillation technique, and inert gas multiple-breath washout, may be 
effective in detecting deficits in both distal and peripheral airway function (Gray et al., 
2016, Udomittipong et al., 2008).  This may delineate the role of nutrient intake and tissue 
accretion on later respiratory health. Use of duel-energy X-ray absorptiometry or air 
displacement plethysmography, rather than other techniques such bioelectric impedance, 
would be advantageous to obtain accurate measures of fat mass and lean mass (Bott et al., 
2006).  
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 Chapter 4: Physical activity in preterm-born 11-year old children born 
in the 1990’s 
 Overview and principal findings 
The research question for this study was: “What are the levels of objectively measured PA 
in preterm-born children when compared to term-born controls. Are levels of physical 
activity related to the decrements in lung function observed in these children?” The 
hypothesis for this study based upon the reduced lung function and increased respiratory 
symptoms observed in previous studies within our research group (Kotecha et al., 2013, 
Kotecha et al., 2012). Moreover, exercise testing within a population of preterm-born 
children with, and without BPD/CLD had established evidence of exercise-induced 
bronchoconstriction and increased use of ventilatory reserve (Joshi et al., 2013). The same 
study noted reduced levels of physical activity in preterm-born children (reported via 
questionnaire) when compared to term-born controls, which was consistent with the 
limited literature available. However, there was a paucity of evidence on whether these 
respiratory sequelae translated to reduced levels of objectively measured PA in preterm-
born children. Contrary to my hypotheses, I did not observe any differences between 
preterm-born children and those born at term in the ALSPAC cohort, even at the extremes 
of gestation. Boys born ≤32 weeks’ gestation were participating in an average of 24 
minutes per day of MVPA compared with 26 minutes in term-born children at 11 years of 
age.   Further to this, there was no correlation with measures of lung function. As a result 
of these observations, I opted not to proceed with further analysis (for example 
multivariable regression). However, it was noted that there was a significant gender 
difference within the whole study population, with girls participating in significantly less PA. 
Furthermore, there was a decline in activity levels (and a rise in sedentary behaviour) 
between 11 and 15 years of age.  At both ages, average levels of MVPA were considerably 
lower than the recommendation of at least 60 minutes per day. 
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 Comparison with other studies 
As noted above, there was a significant difference between boys and girls at both 11 and 
15 years of age. The influence of gender on rates of PA may have its origins in early 
childhood (Mattocks et al., 2010) with the divergence continuing through to school age and 
beyond (Golombok et al., 2008). The decline in total PA, and the rise of sedentary 
behaviour at the expense of light intensity PA over the period of early adolescence into 
early adulthood has also been described in the ALSPAC cohort (Riddoch et al., 2007, 
Mitchell et al., 2012). Thus, the overall low rates of PA may be one explanation for my 
findings. However, in contrast, questionnaire studies have consistently observed reduced 
PA in low birthweight and preterm-born children (Joshi et al., 2013, Welsh et al., 2010). It is 
possible that self-reported questionnaires capture different domains of PA, such as high-
intensity exercise or sports participation, which do not correlate well with accelerometer 
data (Riddoch et al., 2004). Moreover, the majority of previous studies in children have 
relied on proxy reports of activity completed by parents (Keller et al., 2000, Kriemler, 2005, 
Wocadlo and Rieger, 2008, Svien, 2003, Kilbride et al., 2003). It is not clear, therefore, 
whether parent’s perceptions of their child’s physical ability is affected by their history of 
preterm-birth (Kilbride et al., 2003) or indeed whether they restrict activity based on 
perceptions of disability or adverse responses to exercise (Keller et al., 2000).   
Since ALSPAC is comprised of a general sample of the population, the numbers of preterm-
born children included are relatively low compared to a specifically-designed preterm-born 
cohort. This may be a further explanation for the lack of observed associations, however, 
researchers from the EPIcure study similarly did not report any differences in PA as 
measured by accelerometer, despite comparing the most immature preterm-born children 
against term-born controls (Welsh et al., 2010). 
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If decrements in lung function are not a determinant of PA in preterm-born children, other 
factors may be more important. Within the ALSPAC cohort at-large, reduced PA has been 
associated with increased fat mass (Ness et al., 2007, Riddoch et al., 2009). In contrast, 
vigorous PA was beneficial to measures of bone quality (Tobias et al., 2006, Sayers et al., 
2011) whereas duration, rather than intensity of PA may be more important for 
cardiovascular health (Leary et al., 2008). Developmental coordination disorder (Green et 
al., 2011) and myopia (Deere et al., 2009) were also associated with reductions in PA. 
Contextually this could be important as preterm-born children are more likely to have 
neuromotor problems which could socially limit participation in more vigorous types of 
activity, such as organised sports, which correlate with higher rates of MVPA (Koorts et al., 
2011).    
As mentioned earlier in this chapter, body composition has not been widely studied in 
preterm-born children; however, of note for continuity with the first half of my thesis, van 
Deutekom and colleagues recently assessed the influence of accelerated infant weight gain 
in term-born low birthweight children and physical fitness at approximately 9 years of age 
(van Deutekom et al., 2015). This study noted that low birthweight, followed by accelerated 
weight gain was associated with lower scores on the Léger multistage fitness test when 
compared to children of normal birthweight and normal infant weight gain. This was not 
mediated by fat-free mass, or objectively measured MVPA or sedentary behaviour. 
Decreased handgrip strength was also associated with low birthweight, and this effect was 
substantially mediated by fat-free mass but not MVPA or sedentary behaviour, indicating 
deficits in neuromuscular fitness. 
Increased rates of neurodevelopmental deficits in preterm-born children are well 
recognised, even in those born at the moderate gestations (Odd et al., 2013). For example, 
the study by Burns and colleagues noted lower scores in tests of motor coordination, which 
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was a more potent predictor of maximal V̇O2 than respiratory function in 13-year old 
children (Burns et al., 2009). Similar associations appear to persist into adolescence (Rogers 
et al., 2005) and adulthood (Ridgway et al., 2009). Thus, neuromotor sequelae of preterm 
birth including reduced coordination and muscle strength appear to be at least equally 
important as respiratory function in imposing limitations, perceived or otherwise, on the 
ability of preterm-born children to actively participate in life-functional activities and are 
present from mid-childhood. Over time, these limitations may impose a detraining effect 
which impacts upon exercise capacity in late adolescence and early adulthood- around the 
time when differences in habitual PA appear (at least in questionnaire-based studies). This 
may have consequences for the long-term risk of respiratory disease as evidence suggests 
that decrements in lung function and exercise capacity remain significant, even in relatively 
unimpaired preterm-born individuals.  
 Chapter 5:  Physical activity and sedentary behaviour in preterm-born 
7-year old children 
 Overview and principal findings 
The research question for this final chapter was: “What are the levels of objectively 
measured physical activity and sedentary behaviour in 7-year old preterm-born children 
compared to those born at term. Do current respiratory symptoms and family history of 
atopy mediate these relationships?” My hypotheses were similar to those presented in 
chapter four, however, using data from the more recent Millennium Cohort Study provided 
an opportunity to examine these associations earlier in childhood, prior to the steep 
decline in activity which occurs during adolescence. Moreover, the MCS recruited 
participants at the turn of the century, with children born preterm more likely to have 
benefited from advances in neonatal care when compared to participants in the ALSPAC 
cohort. Additionally, the accelerometer used in MCS captured data in 15-second epochs, 
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making it a more sensitive tool to measure the short bursts of activity observed in younger 
children. 
In line with my hypothesis, I noted that boys born ≤32 weeks’ gestation participated in 7 
minutes less MVPA per day when compared to term controls. This equated to over 1 hour 
per week, and the results were robust to adjustment for a number of potential 
confounders. In contrast, current wheeze or atopy were not identified as significant 
mediators, indicating that poor respiratory health is not on the causal pathway between 
preterm birth and levels of objectively measured PA in young children. 
 Comparison with other studies 
In comparison with the results of my study in chapter 4 which used data from the ALSPAC 
cohort, I noted that both males and females met, or exceeded the national guideline for 
participation in MVPA in the MCS study. These observations need to be interpreted with 
caution, as the cut-points used to define intensity of PA vary between studies due to the 
utilisation of different calibration protocols (Mattocks et al., 2007, Pulsford et al., 2011). 
However, there was still a significant gender gap thus indicating that disparities in levels of 
PA are already established by the age of 7 years. 
In keeping with the potential mechanisms of adiposity gain and associated inflammation as 
a result of rapid infant weight gain discussed earlier in this chapter, it is interesting to note 
that increased BMI was univariately associated with reductions in total PA and MVPA, but 
not sedentary behaviour. In multivariable analysis, BMI explained the highest proportion of 
unique variance in the model compared to any of the other independent variable, except 
for season of accelerometry data collection (winter). Thus, one limitation of the available 
data is lack of information on body composition. Investigating whether the association 
between preterm birth and PA was mediated via fat-mass, or fat-free mass would be 
interesting to study. BMI has limitations as a proxy for specific measures of body 
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composition as increased activity is positively associated with lean mass (Ness et al., 2007). 
Notwithstanding, it is reasonable to speculate that emerging obesity may be an important 
factor in predicting reduced PA. The absence of an association between BMI and sedentary 
behaviour might be explained by the relative importance of MVPA in promoting loss of fat 
mass (Mitchell et al., 2009).  In interpreting these observations, one must be wary of 
reverse causality (i.e. that reduced PA promotes obesity) (Riddoch et al., 2009). A study 
using data from the Southampton Women’s Study reported that time spent in vigorous PA 
was independently and inversely associated with total body adiposity, measured by dual x-
ray absorptiometry (DXA), in 4-year old children (Collings et al., 2013). Lower intensity PA 
was not associated with fat mass and, moreover, sedentary behaviour was not associated 
with adiposity. 
The largest associations with increased sedentary behaviour were the season of 
accelerometry data collection (winter), non-white ethnicity and higher socio-economic 
status. The study by Brodersen noted that school-age children of Asian descent were less 
physically active, whereas children of black ethnicity were more sedentary than white 
peers, but had similar amounts of MVPA (Brodersen et al., 2007). These data, along with 
my results, indicate that PA and sedentary behaviour have different socio-economic 
determinants.  
It was surprising that wheeze was not noted to be a significant mediator of the observed 
association between preterm birth and measures of PA. The rates of wheeze reported from 
the MCS are lower at age 7 than in earlier studies using this cohort at age 5 (Boyle et al., 
2012) and in other cohorts (Vrijlandt et al., 2013). One possibility is that respiratory 
function of preterm-born children may have improved by age 7 such that unpleasant 
symptoms such as wheeze do not impair participation in PA. A study of term-born IUGR 
children within our research group noted that ‘catch up’ growth, defined as >0.67 SD 
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increase in weight between birth and 8 years of age, was associated with an improvement 
of lung function deficits compared to those without catch-up, albeit still reduced compared 
to non-IUGR children (Kotecha et al., 2010). This is supported by the notion of continued 
lung growth and repair in childhood (Narayanan et al., 2012). As recommended earlier in 
this chapter, defining wheeze phenotypes in preterm-born children may elucidate 
particular groups who are at risk of reduced PA.  
 
 Chapters 4 & 5: Strengths and limitations 
The key strength of the two studies undertaken in the second half of this thesis relate to 
the objective measurement of PA, and to the availability of this data within large 
longitudinal cohorts. 
As with all large-scale cohort studies, there was attrition in the number of participants who 
remained involved across the follow-up period in both cohorts. Availability of PA data was 
limited to only a proportion of ALSPAC (38% at 11 years of age) and MCS (52% at 7 years of 
age) who were initially enrolled. I noted that in both instances, there was a clear socio-
economic trend, with valid data more likely to be available from girls, participants of white 
ethnicity, and families whose mothers had received higher levels of education and who 
were non-smokers.  
Since the incidence of preterm birth is closely linked to deprivation, a limitation of my work 
could be the potential under-representation of the group under study. Children born ≤32 
weeks’ gestation comprised 0.9% of the participants with valid accelerometry data in 
ALSPAC, and 1.2% in MCS. These numbers are broadly representative of the cohorts at 
large, where the incidence of preterm birth ≤32 weeks’ gestation are 1.1% and 1.6% in 
ALSPAC and MCS, respectively. Moreover, they are representative of the national rates of 
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preterm birth in England and Wales, with 11,400/693,169 (1.6%) being born a with a valid 
record of gestation age in 2015 (McLaren, 2016). 
The other key limitation in interpreting my results is the differences between calibration 
protocols applied by the ALSPAC and MCS teams to derive cut-points for various intensities 
of activity.  The most closely-allied study to mine, in relation to investigation of the effect of 
gestational age on later levels of PA, was performed in the EPIcure cohort. This study used 
the same accelerometer count cut-off for MVPA as described in the calibration study 
performed by the ALSPAC team, but used the same device as provided to families in the 
MCS cohort. The EPIcure team reported only 8 minutes per day of MVPA in 11-year old 
children born at <25 weeks’ gestation compared to 11 minutes in term-born controls 
(Welsh et al., 2010). The epoch length was not noted, however these levels are lower than 
my report in Chapter 4 (19 minutes in girls born ≤32 weeks’ gestation and 16 in term-born 
controls). In both calibration studies, cut-points were defined by metabolic equivalent 
values assigned to a battery of self-paced activities. Differences in defining the additional 
variables required to calculate energy expenditure, including basal metabolic rate, may 
therefore, be responsible for the higher cut- points for MVPA in ALSPAC (and EPIcure) thus 
underestimating the true volume of MVPA within these cohorts (Pulsford et al., 2011).  
Choice of epoch length is also a consideration, and more contemporary studies favour the 
use of short epochs in children to capture more intermittent periods of activity. Longer 
epochs are thought to be disadvantageous as the average count over the epoch is the value 
recorded. Thus, short bursts of high intensity activity may be ‘averaged out’ by relative 
inactivity over the rest of the period, leading to an underestimation of vigorous PA. The 
study by Reilly noted that recalculation of their accelerometry data into epoch lengths of 
15 and 60 seconds resulted in a statistically significant reduction in MVPA from 28 minutes 
to 17 minutes per day, respectively, in 4 to 5-year old children (Reilly et al., 2008). The 
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authors question the clinical value of these differences, however it is worthy to note this 
equates to over an hour a week, which does not seem insignificant given the overall low 
levels observed in my two studies. 
Finally, a further limitation of accelerometry is the failure to accurately capture activities 
where the trunk remains stable, such as cycling, as well as water-based activities and 
contact sports. However, direct observation studies have noted that the majority of free-
living activities which children choose to participate in are largely locomotor in boys and 
girls aged between 5 and 11 years of age (Sleap and Warburton, 1996). 
 Chapters 4 & 5: Clinical relevance and future work 
Although there is much subjectively reported PA data, there is a relative paucity of data on 
objectively measured PA in preterm-born children. My studies have added to this limited 
evidence-base and noted small differences in objectively measured MVPA in 7-year-old 
boys born ≤32 weeks’ gestation, but not at 11 years of age. Other reports in older children 
(Welsh et al., 2010), and adults (Kaseva et al., 2015), have presented similar results. 
Notwithstanding, existing questionnaire-based studies, which rely on self-reporting, appear 
to demonstrate that reductions in habitual PA manifest in adolescence and early 
adulthood. Moreover, at an age when physical fitness generally peaks, a large study of 
preterm-born 18 to 25-year olds noted reductions in exercise capacity (Svedenkrans et al., 
2013). This is clinically relevant as peak lung function is attained at a similar time (Burrows 
et al., 1977). The conceptual diagram, Figure 6-1, outlines the potential pathways linking 
preterm birth with reduced participation in PA during childhood. Aside from respiratory 
function, these pathways may also include alterations in body composition (increased fat 
mass, and/or decreased fat-free mass) which may be related to lower muscle strength. 
Neuromotor sequelae of preterm-birth could lead to poorer physical fitness if this limits 
participation in certain types of vigorous activity. Social factors, including exclusion from 
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activity by peers, or by concerned parents may also contribute to a gradual detraining 
effect that manifests as lower self-perception of ability by early adulthood.        
Encouragingly, longitudinal follow-up studies note positive associations between exercise 
habits and peak V̇O2 in 18-year olds born extremely preterm, indicating a similar training 
potential as term-born controls (Clemm et al., 2015). Interventions in the form of training 
programmes are challenging but beneficial for cardiopulmonary rehabilitation after severe 
COPD exacerbations (Man et al., 2015), but few studies have assessed whether similar 
interventions in children may improve lung function and reduce symptoms. A systematic 
review noted an overall increased peak V̇O2, but not respiratory function, in asthmatics of 
varying severity, using methods as diverse as swimming, ball sports, and group aerobic 
activities. The interpretation of lung function data were complicated by the lack of studies 
including data on the derivation of predicted values and on inhaled medication use 
(Crosbie, 2012). A study by Varray and colleagues conducted in 12-year old atopic children 
with reversible airway obstruction noted some of the challenges involved in designing a 
training programme. They reported on an individualised swimming protocol (6 months 
duration: 3 months aerobic, followed by 3 months high intensity) and looked to observe 
improvements in physical conditioning relative to baseline exercise capacity. Compared to 
the control group, maximal V̇O2 was significantly improved in the training group, 
specifically after the aerobic portion of the intervention. In contrast, no improvements in 
lung function were observed (Varray et al., 1991). This resulted in reduced subjective 
reports of intensity of wheezing, and reduced anxiety in regards to control of 
exacerbations. The authors suggest that the potential mechanism, in the absence of 
improvements in respiratory function, is that frequent exercise trains ventilatory adaption 
which maximises the individual’s ability for gas exchange. This hypothesis is supported by 
exercise data in preterm-born children which noted similar adaptation including increased 
use of ventilatory reserve (Joshi et al., 2013) and of respiratory rate (Kriemler, 2005) to 
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maintain peak V̇O2. In contrast, the authors are cautious in promoting high-intensity 
training which did not demonstrate improvements in exercise capacity, and which may 
provoke exercise-induced exacerbations.  
Thus, future studies could investigate the efficacy of similar aerobic programmes in 
optimising the longer-term outcomes of preterm-born children who have increased risk 
factors for respiratory disease (Caskey et al., 2016). This could be coupled to trials of 
inhaled bronchodilators to reduce the incidence of exercise-induced bronchoconstriction, 
however, more data in regards to the mechanisms of respiratory disease and response to 
treatment in this vulnerable group of children are required first. One must also consider 
that whilst exercise capacity is a function of physiology and symptom limitation, being 
physically active can be viewed as a behaviour (Singh, 2014). The effect of pulmonary 
rehabilitation on increasing PA in adult patients has been limited (Cindy Ng et al., 2012). 
Thus, a successful study would benefit from an intervention to promote behavioural 
change in in addition to an exercise programme (Cruz et al., 2014). In children, an 
opportunity exists to instigate behavioural change early in childhood, prior to the declines 
in PA I have observed in my studies. Novel strategies are required early in life to increase 
levels of activity with respiratory problems and researchers should include families as well 
as healthcare professionals in designing future studies (Jago et al., 2017).  
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 Thesis Summary 
My thesis brings together data from three independent cohorts to describe the impact of 
foetal growth trajectory and infant weight gain on the respiratory symptoms of preterm-
born children. It then investigates the influence of these symptoms on measures of physical 
activity in childhood through into adolescence. My results have demonstrated that 
deviations from the ‘normal’ foetal growth trajectory are important in defining later 
respiratory health, possibly due to developmental programming in utero. Thus, optimising 
the management and monitoring of growth during pregnancy may serve to reduce the 
adverse outcomes associated with preterm birth, especially being small for gestational age. 
My second study, using data from the same cohort, highlighted the influence of 
accelerated weight gain during infancy on adverse respiratory outcomes in childhood. In 
particular, the mediating effects of gestational age and maternal smoking were identified. 
The ‘dose-dependent’ effect of gestation was noted to be present across the whole range, 
and adds weight to the growing evidence-base for the re-classification of ‘term’ delivery. 
Moreover, these results implicated tobacco smoking as a key modifiable factor which is 
also highly relevant to the discussion presented on foetal growth. The second half of my 
thesis takes forward the respiratory sequelae of preterm birth and investigates if deficits in 
lung function and increased symptoms are associated with decreased levels of physical 
activity. My results indicated that decrements in moderate-to-vigorous PA exist in  7-year 
old boys who were born at ≤32 weeks’ gestation. In contrast, levels of PA at the ages of 11 
and 15 were remarkably similar in both the preterm and term-born groups, perhaps due to 
the overall low levels of PA at this age. An intervention to improve participation in PA 
would therefore be required early in life and would need to consider the complex social 
factors involved.   
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9 APPENDICES 
 Appendix 1: RANOPS participant information 
Parent Information Sheet: 
 RANOPs 
 
Project title: Respiratory and neurological outcomes in children born preterm study  
Principal Investigator: Professor Sailesh Kotecha. 
 
Thank you for reading this information sheet about the RANOPs study. 
We would like to invite you and your child to take part in our research study based at the 
Department of Child Health at Cardiff University. Before you and your child decide whether 
to take part by completing the questionnaire, it is important for you to understand why the 
study is being performed and what it involves.  Please take time to read the following 
information and if you have any questions, please feel free to contact us with any questions. 
Thank you for taking the time to read this leaflet.   
 
What is the purpose of this study? 
We already know that some babies who are born very prematurely (i.e. more than 10 weeks 
prematurely) sometimes develop breathing and developmental problems as a baby and as a 
child. However, it is not clear if babies who are born only slightly prematurely (4 – 8 weeks 
prematurely) are also at risk of developing breathing and developmental problems. We would 
like to further study the symptoms of children who were born prematurely and compare their 
symptoms to those of children who were born on time. This will establish if children born only 
slightly prematurely need to be followed up closely during childhood. 
 
Why have you been chosen to take part? 
You have been invited to take part in our study because your child was born between 1st 
September 2003 and 31st August 2011. We are inviting families with children who were born 
prematurely and also families with children who were born on time - a total 24,000 children 
from Wales between the ages of 1 and 9 years are being invited to take part in this study. 
 
Do I have to take part? 
It is entirely your own and your child’s decision whether you want to complete and return the 
questionnaire. If you decide to take part we would be delighted if you can complete the 
enclosed questionnaire. If possible and only if you agree, we would like to contact you to 
clarify any answers you give and also to invite you to future similar studies. If, at any time, 
you change your mind, you are free to withdraw any information you have given about your 
child and do not need to give a reason why. A decision to withdraw at any time, or a decision 
not to take part, will not affect the care that you or your child receives. 
 
What will I be asked to do if I decide to take part? 
If you decide to take part, please complete the enclosed questionnaire and return it to us in 
239 | P a g e  
 
the pre-paid envelope. 
 
The questionnaire should only take you 15 – 20 minutes to complete but please do not hesitate 
to contact Dr Martin Edwards on telephone 02920 743927 or by email 
(edwardsmo@cardiff.ac.uk) if you have any queries. 
 
With your permission we would like to (i) contact you to clarify any questions that you may 
have answered, or (ii) to send questionnaires or invite you to future studies, and (iii) ask you 
if we may access information about your child specifically from the health database records 
here in Wales. These form part of the questionnaire and please do let us know if we may or 
may not contact you in the future.  
 
What will happen to the information I provide? 
From the information we collect, our primary aim is to compare symptoms between children 
who were born prematurely with symptoms of children who were born on time especially from 
a breathing and development point of view. The information will help guide future planning of 
health care services for children born prematurely. 
 
What are the possible disadvantages and risks of taking part? 
We do not anticipate any disadvantages in taking part but please do not hesitate to contact 
us if you have any concerns or questions.  
 
What are the possible benefits of taking part? 
There are no direct benefits to your child for taking part. The information you provide may 
help us establish the best way of monitoring prematurely born children in the future. 
 
Will my taking part in this study be kept confidential? 
The information collected in this study will be kept strictly confidential. The questionnaire only 
contains the date of birth of your child and a study number. Only if you give us permission, 
shall we be allowed other information including your child’s medical history. Any information 
will only be accessible by members of the research team. No individual names or details that 
can identify any children will be included in any future study reports or publications.  
 
What will happen to the results of the study? 
The results will be written up as medical papers for publication in medical journals and for 
presentations at medical meetings. 
 
Who is organising and funding the research?  
This study is being organised and funded by the Department of Child Health at Cardiff 
University. We have also applied for research funding to medical charities. 
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Who has reviewed the study? 
The study has been reviewed and approved by the South East Wales Research Ethics Committee 
(REC). 
 
What should I do if I have any concerns about the study? 
If you have any questions about the study, please contact Professor Sailesh Kotecha or Dr Martin 
Edwards. If you remain unhappy and wish to complain formally, you can do this through NHS 
Complaints Procedure. 
 
Dr Martin Edwards     Professor Sailesh Kotecha 
Clinical Research Fellow  Professor of Paediatrics and Child 
Health  
University Hospital of Wales    University Hospital of Wales 
Child Health      Child Health 
Heath          Heath 
Cardiff    CF14 4XN    Cardiff   CF14 4XN 
Tel:   029 20 74 3927    Tel:   029 20 74 4187 
Email:   edwardsmo@cardiff.ac.uk   Email:  Kotechas@cardiff.ac.uk  
What do I do now? 
Thank you for reading our Information Pack and we would be delighted if you complete the 
questionnaire and return it in the pre-paid envelope. 
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 Appendix 2: RANOPS questionnaire for children aged <5 years 
Study No:   
 
 
xxxxx     
Health questionnaire for preschool children (<5 years old)  
Today’s date: ________________________2013     
Person completing the questionnaire:  Mother        
Father        
Other         
 
1. Has your child ever had wheezing or whistling in their chest at any time in their life? 
 Yes                      No                Unsure             
IF YOU HAVE ANSWERED “NO” PLEASE GO TO QUESTION 4. 
2. In the last three months , during the day time (i.e. when awake) does your child: 
 Not at all a few days some days most days every day 
a.  Wheeze:        
b.   Cough:        
c.   Short of breath:      
d.   Rattly chest:      
e.   Snuffly:      
3. In the last three months , during the night time (i.e. when asleep) does your child: 
 Not at all a few nights some nights most nights every night 
a.  Wheeze:        
b.   Cough:        
c.   Short of breath:      
d.   Rattly chest:      
e.   Snore:      
4. How many colds has your child had in the last three months? 
 
None        1 to 3                        more than 3                  always has a cold            
IF YOU HAVE ANSWERED “None” PLEASE GO TO QUESTION 6. 
5. When my child has had a cold in the last three months, s/he has a: 
 Not at all a few colds some colds most colds every cold 
a.  Wheeze:        
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b.   Cough:        
c.   Short of breath:      
d.   Rattly chest:      
e.   Snuffly:      
6. When my child does NOT have a cold, in the last three months, s/he has a:  
 Not at all a few days some days most days every day 
a.  Wheeze:        
b.   Cough:        
c.   Short of breath:      
d.   Rattly chest:      
e.   Snuffly:      
7. When my child has been more active (e.g. crawling, walking or when excited),  
in the last three months, s/he has a:  
 Not at all a few days some days most days every day 
a.  Wheeze:        
b.   Cough:        
c.   Short of breath:      
d.   Rattly chest:      
e.   Snuffly:      
8. Has your child ever been diagnosed with asthma by a doctor? 
 
 Yes                      No               Unsure             
 
 
9. Is there a family history of: 
 Yes No        
a. Asthma          
b. Eczema          
c. Hayfever          
d. Allergies      
 
   
 
 
10. In the last 12 months, has your child ever used any regular asthma inhalers (pumps) or medicines? 
 
 Yes                      No               Unsure              
If yes, please provide the name (or colour of the pump) with details of how often used: 
_________________________________________________________________________________ 
11. In the last 12 months, has your child had any chest infections? 
 Yes                      No               Unsure             
 
 
 
12. In the last 12 months, how many chest infections has your child had? 
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None        1 to 3                        4 to 10                    More than 10          
 
13. In the last 12 months, how many courses of antibiotics has your child had? 
 
None        1 to 3                        4 to 10                    More than 10          
14. In the last 12 months, how many admissions (overnight or longer) has your child had to  
hospital for breathing problems? 
None        1 to 3                        4 to 10                    More than 10          
15. Does the child’s mother smoke cigarettes? 
 Yes                      No                Unsure             
If yes, how many per day?  
1 to 10       11 to 20                          More than 20           
If the child’s mother smokes did she smoke during the pregnancy? 
 Yes                      No                Unsure             
16. Does the child’s father smoke cigarettes? 
 Yes                      No                Unsure             
If yes, how many per day?  
1 to 10       11 to 20                          More than 20           
17. Do any other house members smoke cigarettes? 
 Yes                      No                Unsure             
If yes, how many per day for the whole household?  
(please add up all the cigarettes which are smoked by everyone living in the same household  
including the mother). 1 to 10      11 to 20                          More than 20           
18. Who else lives at the same household as the child? 
Mother                          Father               Brother/s        Sister/s      Other     
19. Has your child ever been diagnosed with any breathing problems (e.g. asthma, CF, TB etc.)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
__________________________________________________________________________________ 
 
20. Has your child ever been diagnosed with any other conditions (e.g. diabetes, epilepsy etc.)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
__________________________________________________________________________________ 
 
244 | P a g e  
 
21. Does your child have any problems with moving (crawling, walking, running etc…)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
__________________________________________________________________________________ 
  
22. Does your child have any problems with using their hands (holding, throwing, catching, writing etc…)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
__________________________________________________________________________________ 
23. Does your child have any problems with their speech (delayed, limited, impediment etc…)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
__________________________________________________________________________________ 
24. Does your child have any problems with their vision (partially sighted, registered blind etc…)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
__________________________________________________________________________________ 
25. Does your child have any problems with their hearing (partially hearing, wears hearing aids etc…)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
__________________________________________________________________________________ 
 
26. Does your child have any problems with their behaviour (hyperactive, disruptive, aggressive etc…)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
___________________________________________________________________________________ 
27. Does your child have any learning difficulties (developmental delay)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
___________________________________________________________________________________ 
 
Thank you for filling in the form. The following section asks how you are happy for us to use the data  
or to contact: 
A. If we need to clarify some of your answers, would you be willing to be contacted? 
 Yes                      No               Please initial the box here  
Address, Telephone number &/or email: 
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___________________________________________________________________________________ 
 
 
B. Most admissions and GP visits in Wales are stored in computer database.  As part of this study, 
we would also like to study how children in Wales have used their GPs or have had admission to  
hospitals. Would you be happy for us to use your son’s or daughter’s records on these databases? 
 Yes                      No               Please initial the box here  
C. We may plan similar studies in the future, would you be willing to be contacted in the future?
 Yes                      No               Please initial the box here  
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 Appendix 3: RANOPS questionnaire for children aged ≥5 years 
Study No:   
 
xxxxx     
Health questionnaire for school age children (>5 years old)  
Today’s date: ________________________2013     
Person completing the questionnaire: 
Mother        
Father        
Other         
 
28. Has your child ever had wheezing or whistling in their chest at any time in the past? 
 Yes                      No               Unsure              
IF YOU HAVE ANSWERED “NO” PLEASE GO TO QUESTION 10. 
29. Has your child had wheezing or whistling in the chest in the last 12 months? 
 Yes                      No               Unsure             
IF YOU HAVE ANSWERED “NO” PLEASE GO TO QUESTION 10. 
30. How many attacks of wheezing has your child had in the last 12 months? 
 
None        1 to 3                        4 to 12                      More than 12           
31. In the last 12 months, how often, on average, has your child’s sleep been disturbed due to wheezing? 
a. Never woken with wheezing   
 
b. Less than one night per week  
 
c. One or more nights per week 
 
32. In the last 12 months, has wheezing ever been severe enough to limit your child’s speech to only one  
or two words at a time between breaths? 
 
 Yes                      No               Unsure              
33. Has a doctor ever told you that your child has asthma? 
 Yes                      No               Unsure              
34. In the last 12 months, has your child’s chest sounded wheezy during or after exercise? 
 
 Yes                      No               Unsure              
35. In the last 12 months, has your child had a dry cough at night, apart from a cough associated with a  
cold or a chest infection? 
 
 Yes                      No               Unsure              
36. In the last 12 months, has your child ever used any regular asthma inhalers (pumps) or medicines? 
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 Yes                      No               Unsure              
If yes, please provide the name (or colour of the pump) with details of how often used: 
__________________________________________________________________________________ 
37. Is there a family history of: 
 Yes No      
a. Asthma   
     
b. Eczema   
     
c. Hayfever   
     
d. Allergies   
     
38. In the last 12 months, has your child had any chest infections? 
 Yes                         No                    Unsure                   
39. In the last 12 months, how many chest infections has your child had? 
 
None        1 to 3                        4 to 10                    More than 10         
40. In the last 12 months, how many courses of antibiotics has your child had? 
 
None        1 to 3                        4 to 10                    More than 10         
41. In the last 12 months, how many admissions (overnight or longer) has your child had to hospital  
for breathing problems? 
None        1 to 3                        4 to 10                    More than 10         
42. Does the child’s mother smoke cigarettes? 
 Yes                        No                      Unsure           
If yes, how many per day?  
 1 to 10    11 to 20                       More than 20        
If the child’s mother smokes did she smoke during the pregnancy? 
 Yes                       No                   Unsure              
43. Does the child’s father smoke cigarettes? 
 Yes                      No                   Unsure              
If yes, how many per day?  
 1 to 10       11 to 20                          More than 20        
44. Do any other house members smoke cigarettes? 
 Yes                      No                   Unsure              
If yes, how many per day for the whole household?  
(Please add up all the cigarettes which are smoked by everyone living in the same household) 
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 1 to 10       11 to 20                          More than 20        
45. Who else lives at the same household as the child? 
 Mother                          Father                 Brother/s        Sister/s     Other     
  
46. Has your child ever been diagnosed with any breathing problems (e.g. asthma, cystic fibrosis,  
BPD, etc.)? 
  Yes                      No               Unsure              
If yes, please provide some details: 
____________________________________________________________________________________ 
47. Has your child ever been diagnosed with any other conditions (e.g. diabetes, epilepsy etc.)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
____________________________________________________________________________________ 
48. Is your child on any medication? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
____________________________________________________________________________________ 
49. Does your child take part in any physical activity such as cycling, swimming or dancing?  
 
 Yes                      No               Unsure              
If yes, please provide some details of how often and for how long: 
____________________________________________________________________________________ 
50. Does your child have any learning problems? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
____________________________________________________________________________________ 
51. Does your child have any problems with their behaviour (hyperactive, disruptive, aggressive etc…)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
____________________________________________________________________________________ 
52. Does your child have an educational statement? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
____________________________________________________________________________________ 
53. Does your child have any problems with moving (difficulty running, use of a wheelchair etc…)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
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____________________________________________________________________________________ 
  
54. Does your child have any problems with using their hands (difficulty writing, poor ball skills etc…)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
____________________________________________________________________________________ 
55. Does your child have any problems with their speech (delayed, limited, impediment etc…)? 
 
 
Yes                      No               Unsure              
If yes, please provide some details: 
____________________________________________________________________________________ 
56. Does your child have any problems with their vision (partially sighted, registered blind etc…)? 
 
 Yes                      No               Unsure              
If yes, please provide some details: 
_____________________________________________________________________________________ 
57. Does your child have any problems with feeding (needs help cutting up food, has a  
gastrostomy etc…)? 
  Yes                      No               Unsure              
If yes, please provide some details: 
_____________________________________________________________________________________ 
 
Thank you very much for filling in the form.  
The following section asks how you are happy for us to use the data or to contact you: 
D. If we need to clarify some of your answers, may we contact you? 
 Yes                      No               Please initial the box here  
Address, Telephone number &/or email: 
____________________________________________________________________________________ 
E. Most admissions and GP visits in Wales are stored in computer databases. As part of this study,  
we would also like to study how children in Wales have used their GPs or have had admission to  
hospitals. Would you be happy for us to use your son’s or daughter’s records on these databases? 
 Yes                      No               Please initial the box here  
F. We may plan similar studies in the future, would you be willing to be contacted in the future?
 Yes                      No               Please initial the box here  
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